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Abstract 
Q fever, caused by the small obligate intracellular, gram-negative pathogenic bacterium Coxiella burnetii, is 
primarily an occupationally-acquired zoonotic disease most commonly reported in people working in the 
livestock and meat industries who have direct or indirect contact with infected animals.  The main preventive 
tool for Q fever is a vaccine (Q-VAX®, Seqirus, Australia) that is recognised to be highly effective and 
providing long lasting protection. Its implementation requires pre-vaccination screening tests using serology 
and skin tests conducted in parallel. This is because the vaccine has more side effects in persons who have 
already had the disease Q fever, so testing for prior immunity is necessary before vaccination to avoid 
unwanted vaccine side effects.  However, outbreaks of Q fever continue to be recorded in abattoirs and Q fever 
continues to be an important public health issue in Australia. The incidence of Q fever remains high especially 
in Queensland and New South Wales (NSW) though there is good evidence of improved Q fever control as a 
result of the implementation of the Q fever vaccination program. There is evidence that the Q fever vaccination 
has not been fully implemented because of the high incidence of Q fever among individuals targeted by past 
vaccination program.  
Therefore, this PhD thesis was mainly intended to assess the overall effectiveness of the Q fever vaccination 
program, and the associated Q fever notification and hospital admission rates, and the most risky exposures for 
the occurrence of Q fever in Queensland, Australia.  Chapter 1 presents a literature review on Q fever at global 
and Australia levels. In chapter 2, I conducted a systematic review and meta-analysis on the seroprevalence of 
Q fever. Chapter 3 addresses estimation of vaccine failure rate and duration of immunity for Q fever using Cox 
proportional hazard model. I then explicitly addressed the accuracy of the Q fever pre-screening test using 
Bayesian latent class analysis in chapter 4. In chapter 5, I assessed the demographic and vaccination status 
factors associated with the incidence of Q fever infection using a case control design. In chapter 6, I modelled 
the rate of Q fever notification and hospitalization, and identified the associated factors using Poisson and 
Negative Binomial regression models. In chapter 7, I conducted a risk assessment using the enhanced Q fever 
exposure surveillance data using multiple correspondence analysis (MCA) technique. Finally, chapter eight 
highlight key findings, discuss them, and summarize the thesis.  
In summary, the results presented in this Thesis, address the knowledge gap regarding the incidence of Q fever 
in vaccinated individuals and the duration of immunity of the Q fever vaccine and the accuracy of the pre-
screening tests thereby addressing the overall effectiveness of the Q fever vaccination program and the 
resulting Q fever notification and admission rates in the Queensland. It presents evidence of the protective 
effect of being vaccinated using the Q fever vaccine and longer duration of immunity of the vaccine though 
non-adherence to the vaccination protocol was observed. In addition, it also presents evidence of reduction of 
the Q fever notification and admission rates as a result of the implementation of the Q fever vaccination 
program. Moreover, being exposed to paddock dust, working with wool, assisting and observing animal birth, 
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and working in shearing and shed were foudnd to be the most risky exposures. Working inside abattoir, having 
abattoir exposure, being previously screened and vaccinated for Q fever were the second risky exposures for Q 
fever.  
The greater incidence observed in unvaccinated individuals considered immune during the pre-vaccination 
screening may suggest that pre- vaccination screening is sub-optimal among this study population. Hence, a 
greater awareness of these issues among medical practitioners may help better protect all workers at risk of Q 
fever. Targeted Q fever screening and vaccination should be maintained in order to help lower the burden of Q 
fever in the study population. We recommend using serological tests for pre-vaccination screening in this high 
risk population (i.e., phase out skin test). Moreover, re-thinking and revitalizing of government 
sponsored/funded Q fever vaccination program is implicated. Furthermore, future, investigation of the 
distribution of the Q fever vaccination services within each of the public health units and its role in mitigating 
the burden of Q fever is indicated. The need for personal protective equipment, such as fine dust masks (N95), 
should be considered as an adjunct to compulsory Q fever vaccination to protect workers in high risk 
occupations. 
 
 
 
 
 
 
 
 
 
 
 4  
Declaration by author 
This thesis is composed of my original work, and contains no material previously published or written by 
another person except where due reference has been made in the text. I have clearly stated the contribution by 
others to jointly-authored works that I have included in my thesis. 
 
I have clearly stated the contribution of others to my thesis as a whole, including statistical assistance, survey 
design, data analysis, significant technical procedures, professional editorial advice, financial support and any 
other original research work used or reported in my thesis. The content of my thesis is the result of work I have 
carried out since the commencement of my higher degree by research candidature and does not include a 
substantial part of work that has been submitted to qualify for the award of any other degree or diploma in any 
university or other tertiary institution. I have clearly stated which parts of my thesis, if any, have been 
submitted to qualify for another award. 
 
I acknowledge that an electronic copy of my thesis must be lodged with the University Library and, subject to 
the policy and procedures of The University of Queensland, the thesis be made available for research and study 
in accordance with the Copyright Act 1968 unless a period of embargo has been approved by the Dean of the 
Graduate School.  
 
I acknowledge that copyright of all material contained in my thesis resides with the copyright holder(s) of that 
material. Where appropriate I have obtained copyright permission from the copyright holder to reproduce 
material in this thesis and have sought permission from co-authors for any jointly authored works included in 
the thesis. 
 5  
Publications included in this thesis 
Woldeyohannes, Solomon M., Gilks, Charles F., Baker, Peter, Perkins, Nigel R. and Reid, Simon A. (2018) 
Seroprevalence of Coxiella burnetii among abattoir and slaughterhouse workers: A meta-analysis. One Health, 
6 23-28. doi:10.1016/j.onehlt.2018.09.002. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6  
In the following manuscripts submitted for publication, I have performed the statistical analysis and 
interpretation of the findings and contributed to manuscript preparation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 7  
 
Submitted manuscripts included in this thesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 8  
Publications during candidature 
2019 
Y. Assefa; S. Woldeyohannes; Y. A. Gelaw; Y. Hamada; H. Getahun. Screening tools to exclude active 
pulmonary TB in high TB burden countries: systematic review and meta-analysis. INT J TUBERC 
LUNG DIS. 2019. 
Wendy A.Goodwin; Kirby Pasloske; Helen L.Keates; Millaganamada Gedara Ranasinghe; Solomon 
Woldeyohannes;  Nigel Perkins. Alfaxalone for total intravenous anaesthesia in horses. Veterinary 
Anaesthesia and Analgesia. 2019 
2018 
Assefa, Yibeltal; Assefa, Yalamzewod; Woldeyohannes, Solomon; Hamada, Yohhei; Getahun, Haileyesus. 
Three-month daily Rifampicin and Isoniazid compared to six or nine-month Isoniazid for treating latent 
tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review. 
European Respiratory Journal, 2018 
Tadele Amare, Solomon Meseret Woldeyohannes, Tebkew Yeneabat, and Kelemua Haile. Prevalence and 
Associated Factors of Suicide ideation and attempt among Adolescent High School students in Dangila Town, 
Northwest Ethiopia". Psychiatry Journal. 2018 
Luke D Knibbs, Solomon Woldeyohannes, Guy B Marks and Christine T Cowie. Damp housing, gas stoves, 
and the burden of childhood asthma in Australia. Med J Aust 2018; 208 (7): 299-302.  
2017 
Darsene, H., Ayele Geleto,  Abebaw Gebeyehu and  Woldeyohannes SM. Magnitude and predictors of 
undernutrition among children aged six to fifty nine months in Ethiopia: a cross sectional study. Archives of 
Public Health 75(1): 29. 
2016 
Getnet A, Woldeyohannes SM, Bekana L, Mekonen T, Fekadu W, Menberu M, Yimer S, Assaye A, Belete A, 
Belete H: Antiepileptic Drug Nonadherence and Its Predictors among People with Epilepsy. Behavioural 
Neurology 2016, 2016:6. 
 9  
Reid SA, McKenzie J, Woldeyohannes SM. One Health research and training in Australia and New Zealand. 
Infection Ecology & Epidemiology 2016, 6:10.3402/iee.v3406.33799. 
Admasu M, Kifle M, Tefera Y, Nega A, Woldeyohannes SM, Rai Sharma H. HIV/AIDS risk perception and 
behavior of college students of the Metekel Zone, Benishangul Gumuz regional state, Ethiopia. Vulnerable 
Children and Youth Studies 2016, 11(2):180-192. 
Adane WGk, Alemie GA, Woldeyohannes SM, Gelaw YA. Prevalence and associated factors of khat use 
among university students in the University of Gondar, northwest Ethiopia. Journal of Substance Use 2016:1-6. 
Guideline: 
Latent tuberculosis infection: Updated and consolidated guidelines for programmatic management 2018: 
Published and can be found at http://www.who.int/tb/publications/2018/latent-tuberculosis-infection/en/ 
Conference Abstracts: 
The 5th International One Health Congress organized by the University of Saskatchewan, from 22nd June 
to 25th June 2018, TCU Place, Saskatoon, Canada 
Oral presentation 
Solomon M. Woldeyohannes, Peter Baker, Charles Gilks, Nigel Perkins and Simon Reid. Q fever vaccine 
failure rate, duration of longevity of immunity and associated demographic factors in Australia 
Solomon M. Woldeyohannes, Peter Baker, Charles Gilks, Nigel Perkins and Simon Reid. The accuracy of pre-
vaccination screening for Q fever and the extent of exposure – Bayesian latent class analysis 
Poster presentation 
Solomon M. Woldeyohannes, Peter Baker, Charles Gilks, Nigel Perkins and Simon Reid. Q fever Exposure 
Risk Set: Application of Multiple Correspondence Analysis (MCA) 
Joint International Society for Clinical Biostatistics and Australian Statistical Conference 2018, 26 – 30 
August 2018, Melbourne Convention and Exhibition Centre, Australia 
Poster presentation 
Solomon M. Woldeyohannes, Peter Baker, Charles Gilks, Nigel Perkins and Simon Reid. Application of 
Bayesian latent class analysis for assessing the accuracy of pre-vaccination screening tests for Q fever and 
determination of the extent of prior exposure 
 10  
W Goodwin, S Woldeyohannes, S Pratt, A Cunneen, T Farry, M McEwen, J Rainger, G Truchetti & N Perkins. 
Prospective evaluation of three anaesthetic recovery scoring systems in horses.  
 
 
 11  
Contributions by others to the thesis  
This thesis consists of eight chapters. The first chapter presents my review of the literature on Q fever both at 
global and Australia levels with editorial input from my supervisors. Chapter two is a meta-analysis on the 
seroprevalence of Q fever among workers considered to be at higher risk and published in One Health journal 
with myself as the lead author and my supervisors as co-authors. Chapter three to seven are organized chapter 
by chapter which are written entirely by me (with editorial input from my supervisors). All modelling and 
analysis was conducted by myself, with advice from PhD supervisory team. Chapter eight summarizes and 
discuss the key findings. 
Chapter 1 
This chapter was written by myself, with editorial input from my primary supervisor Associate Professor 
Simon Reid and Dr. Kathryn Greenwood who edited the first part of the background information on Q fever 
bacteriology, epidemiology and treatment. 
Chapter 2  
This chapter was written and analysed by myself, with editorial input from my PhD supervisors: Associate 
Professor Simon Reid, Dr. Peter Baker, Professor Charles Gilks and Professor Nigel Perkins. This chapter is 
published in One Health journal. 
Chapter 3 
This chapter is being prepared for submission to Epidemiology and Infection journal. The idea for the 
manuscript was conceptualised by Associate Professor Simon Reid, Professor Nigel Perkins and myself. I 
developed the problem formulation, with advice from my supervisors Associate Professor Simon Reid, Dr. 
Peter Baker, Professor Charles Gilks and Professor Nigel Perkins. Professor Nigel Perkins covered the cost for 
accessing the data from the Australian Q fever vaccination registry. I designed the study and conducted the 
analyses, with feedback on the design and analysis results from all of my supervisors. I wrote the chapter, with 
editorial input from all of my supervisors and Dr. Luke Knibbs. 
Chapter 4 
This chapter is being prepared for submission to Lancet. The idea for the manuscript was conceptualised by me 
and my supervisors Associate Professor Simon Reid and Dr. Peter Baker. The modelling of accuracy of the Q 
fever pre-screening tests was conducted by myself, with input from Associate Professor Simon Reid and Dr. 
Peter Baker. I wrote the chapter, with editorial input from all of my supervisors. 
 12  
Chapter 5 
The idea was conceptualised by myself. Associate Professor Simon Reid, Professor Nigel Perkins, Professor 
Charles Gilks and Dr. Peter Baker participated in the design of the study. I wrote the chapter, with editorial 
input from all of my supervisors. Associate Simon Reid critically reviewed the first draft of the report.  
Chapter 6 
The idea was conceptualised by myself. Associate Professor Simon Reid, Professor Nigel Perkins, Professor 
Charles Gilks and Dr. Peter Baker participated in the design of the study. I wrote the chapter, with editorial 
input from all of my supervisors. Associate Simon Reid critically reviewed the first draft of the report.  
Chapter 7 
The idea was conceptualised by myself. Associate Professor Simon Reid, Professor Nigel Perkins, Professor 
Charles Gilks and Dr. Peter Baker participated in the design of the study. I wrote the chapter, with editorial 
input from all of my supervisors. Associate Simon Reid critically reviewed the first draft of the report.  
Chapter 8  
This chapter, summarize and discuss the key findings my PhD project, synthesize conclusion and future 
directions.  
 
 
 
 
 
 
 
 
 
 
 13  
Statement of parts of the thesis submitted to qualify for the award of another degree 
 None. 
 
 
 14  
Research Involving Human or Animal Subjects  
This project was completed with approval from the Medical Research Ethics Committee, University of 
Queensland (protocol number: 2016000696).  Data from NOCS and QHAPDC databases was obtained with 
approval under the Public Health Act (2005) (PHA). Data from the Q Fever Vaccination Register was obtained 
with permission from the Register Technical Advisory Committee. 
 
 15  
Acknowledgements 
First and foremost I am extremely grateful for my primary supervisor Associate Professor Simon Reid, for the 
continuous support of my PhD study and for his patience, motivation, and immense knowledge, and life in 
general. I am particularly grateful to him for agreeing to be my potential supervisor which opens the 
opportunity to receive scholarship and for opening up the world of moving to Australia. I couldn’t have 
imagined a better PhD supervisor.  
I would like to thank Dr. Peter Baker, Professor Charles Gilks and Professor Nigel Perkins, my associate 
supervisors, for their support from the inception, design, and analysis of the project providing me with support 
and encouragement when it was most needed. The success of each project is testament to the valuable 
contributions you have all made. I am also particularly grateful to Professor Nigel Perkins, for his giving me 
the opportunity not only on my research, but also my career as statistical consultant that opens a new era in 
veterinary science research. My sincere thanks also goes to Kathryn Greenwood, for reading and editing the 
literature review section of my thesis, for her exemplary attention to detail, her creativity, and for inspiring me 
to aim high.   
My sincere thanks also goes to the many other researchers I collaborated with to make this thesis possible. To 
others who collaborated on my literature review, particularly Associate Professor Stephen Lambert and Dr. 
Luke Knibbs, who so unselfishly serving as reviewer and chair during my candidature and mid-candidature 
reviews.  
During this PhD project I formed a number of collaborations throughout the School of Public Health (SHP) and 
School of Veterinary Science (SVS). I would like to thank staffs and students at both schools who positively 
influenced me in one or another way.  
I am also grateful for the funding I received to make this thesis possible: the Australian International 
Postgraduate Research Scholarship and the University of Queensland Centennial Scholarship. In addition, I am 
thankful for the International One Health Congress (IOHC) organisation which enabled me to present the 
findings of my PhD project in the 5th International One Health Congress organized by One Health Platform 
Foundation and the University of Saskatchewan, Saskatoon, Canada. 
Finally, I am thankful for my friends and family for being so supportive and understanding of how difficult it is 
to lead a balanced life while undertaking a PhD. 
 16  
Financial support 
 
This research was supported by an Australian Government Research Training Program Scholarship. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 17  
Keywords 
Q fever, C. burnetii, Vaccination, Q-VAX®, Pre-screening, Notification and Admission, Risk Factors, 
Queensland, Australia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 18  
Australian and New Zealand Standard Research Classifications (ANZSRC) 
ANZSRC code: 111706 Epidemiology, 50% 
ANZSRC code: 010402 Biostatistics, 50% 
Fields of Research (FoR) Classification 
FoR code: 1117 Public Health and Health Services, 50% 
FoR code: 0104 Statistics, 50% 
 19  
Table of Contents  
Abstract .................................................................................................................................................................. 2 
Table of Contents ................................................................................................................................................. 19 
List of Figures & Tables ...................................................................................................................................... 22 
List of Tables ................................................................................................................................................... 22 
List of Figures .................................................................................................................................................. 25 
Abbreviations ....................................................................................................................................................... 27 
CHAPTER 1: Background ................................................................................................................................... 30 
1.1. Introduction to Q fever (Coxiella Burnetti) ......................................................................................... 30 
1.2. Epidemiology ....................................................................................................................................... 33 
1.2.1. Prevalence and distribution of Coxiella burnetii ......................................................................... 33 
1.2.2. Reservoirs .................................................................................................................................... 34 
1.2.3. Transmission Route...................................................................................................................... 34 
1.2.4. Sources of infection for humans .................................................................................................. 34 
1.2.5. Risk Factors ................................................................................................................................. 35 
1.2.6. Dose response .............................................................................................................................. 40 
1.2.7. Persons at risk for Q fever ............................................................................................................ 40 
1.2.8. Control and Prevention ................................................................................................................ 40 
1.3. Treatment ............................................................................................................................................. 41 
1.4. Laboratory Diagnosis ........................................................................................................................... 41 
1.4.1. Serology ....................................................................................................................................... 41 
1.4.2. Culture methods ........................................................................................................................... 42 
1.4.3. Molecular methods ....................................................................................................................... 42 
1.5. Coxiella burnetii in Australia ............................................................................................................... 42 
1.5.1. Q fever notification in Australia .................................................................................................. 42 
1.5.2. Reservoirs .................................................................................................................................... 43 
1.5.3. People at risk of Q fever in Australia ........................................................................................... 44 
1.5.4. Prevention and control: Q fever vaccine (Q-VAX®) ................................................................... 44 
1.5.5. Occupational epidemiology of Q fever in Australia .................................................................... 46 
1.5.6. Economic burden of Q fever in Australia .................................................................................... 46 
1.6. Significance .......................................................................................................................................... 47 
 20  
1.7. Research Questions, Hypotheses and Objectives................................................................................. 47 
1.8. Ethical and Public Health Act (PHA) 2005 approvals ......................................................................... 49 
CHAPTER 2: Seroprevlance of Coxiella Burnetii among abattoir and slaughterhouse workers: A Meta-
Analysis ............................................................................................................................................................... 50 
Abstract ............................................................................................................................................................ 51 
Background ...................................................................................................................................................... 52 
Materials and Methods ..................................................................................................................................... 52 
Results .............................................................................................................................................................. 53 
Discussion ........................................................................................................................................................ 59 
CHAPTER 3: Q fever vaccine failure rate, duration of immunity and associated demographic factors in 
Queensland, Australia, 1991-2016 ....................................................................................................................... 68 
Background ...................................................................................................................................................... 68 
Methods ........................................................................................................................................................... 69 
Results .............................................................................................................................................................. 74 
Discussion ........................................................................................................................................................ 84 
Conclusion ....................................................................................................................................................... 86 
CHAPTER 4: Diagnostic accuracy of the Q fever screening tests and determination of the extent of exposure to 
Q fever using Bayesian latent class analysis (BLCA) ......................................................................................... 88 
Background ...................................................................................................................................................... 88 
Methods ........................................................................................................................................................... 89 
Results .............................................................................................................................................................. 91 
Discussion ...................................................................................................................................................... 103 
Conclusions .................................................................................................................................................... 106 
CHAPTER 5: Factors associated with the incidence of Q fever infection: demographic and vaccination status 
factors ................................................................................................................................................................. 107 
Background .................................................................................................................................................... 107 
Objective ........................................................................................................................................................ 107 
Method ........................................................................................................................................................... 108 
Results ............................................................................................................................................................ 109 
Discussion ...................................................................................................................................................... 113 
Conclusion ..................................................................................................................................................... 116 
CHAPTER 6: Rate of Q fever notification and hospitalization, and identification of associated factors. ........ 117 
Background .................................................................................................................................................... 117 
 21  
Objectives ...................................................................................................................................................... 118 
Methods ......................................................................................................................................................... 118 
Results ............................................................................................................................................................ 120 
Q fever notifications data ........................................................................................................................... 120 
Results of Q fever admissions data ............................................................................................................ 132 
Approximating severity of Q fever ............................................................................................................ 142 
Discussion ...................................................................................................................................................... 145 
CHAPTER 7: Q fever Exposure Risk Set: Application of Multiple Correspondence Analysis (MCA) ........... 149 
Background .................................................................................................................................................... 149 
Objective ........................................................................................................................................................ 151 
Methods ......................................................................................................................................................... 151 
Results ............................................................................................................................................................ 152 
Discussion ...................................................................................................................................................... 160 
Conclusion ..................................................................................................................................................... 162 
CHAPTER 8: Summary of key findings, discussion, conclusions and future directions .................................. 163 
Bibliography ...................................................................................................................................................... 167 
Appendix ............................................................................................................................................................ 189 
Appendix 4.1: Details of the Bayesian Latent Class Analysis ....................................................................... 189 
Model formulation and description ............................................................................................................ 189 
Derivation of probabilities for two conditionally independent diagnostic tests. ........................................ 197 
Elicitation of Priors .................................................................................................................................... 198 
Appendix 7.1: Multiple Correspondence Analysis (MCA) ........................................................................... 201 
 
 
 
 
 22  
List of Figures & Tables 
List of Tables 
Chapter 1 
Table 1. 1 Summary of the main risk factors of infection with C. burnetii, the associated risk estimates and 
major related studies. ........................................................................................................................................... 38 
 
Chapter 2 
Table 2. 1 Table Mixed-effects meta-regression model results on the seroprevalence of Q fever in abattoir and 
slaughterhouses. ................................................................................................................................................... 55 
Table 2. 2 Characteristics of studies that included abattoir and slaughterhouse workers. ................................... 62 
Table 2. 3 Characteristics of studies that included abattoir and slaughterhouse workers (continued). ................ 63 
Table 2. 4 PubMed Search Strategy: Articles search history and strategy for abattoirs and slaughterhouse 
workers. ................................................................................................................................................................ 64 
Table 2. 5 MEDLIN-EMBASE search history: Articles search history and strategy for abattoirs and 
slaughterhouse workers. ....................................................................................................................................... 65 
Chapter 3 
Table 3. 1 Demographic and Q fever vaccination information for individuals from Queensland recorded in the 
Q fever Vaccination Register (1991-2016). Table cells represent counts along with percent in brackects. ........ 75 
Table 3. 2 Annual incidence of Q fever in vaccinated and unvaccinated individuals from Queensland recorded 
in the Q fever Vaccination Register per 100,000 person years of follow up (1991-2016). ................................. 76 
Table 3. 3 Life table for estimating duration (in years) from vaccination to first onset of Q fever at 0.5, 1, 5, 10, 
15 and 20 years of follow up for vaccinated and unvaccinated individuals ........................................................ 76 
Table 3. 4 Cox proportional hazard model results on demographic and vaccination factors associated with the 
duration (in years) from vaccination to first onset of Q fever, 1991-1999, Queensland, Australia (Full Cohort 
Data) ..................................................................................................................................................................... 77 
TABLE 3. 5 Column percentages of the demographics characteristic of cases and controls for the duration of 
the study between January 1, 1991 and December 31, 2016 ............................................................................... 79 
Table 3.6 Life/Risk Table for individuals at 0.5, 1, 5, 10, 15 and 20 follow up years after vaccination with Q-
VAX® and individuals unvaccinated in Queensland (1991-2016). ...................................................................... 79 
Table 3.7 Log Rank test for comparing the distribution of Q fever infection free survival times ....................... 80 
Table 3.8 Cox proportional hazard model results on demographic and vaccination factors associated with the 
duration (in years) from vaccination to first onset of Q fever, 1991-1999, Queensland, Australia (Nested Case-
Control) ................................................................................................................................................................ 82 
Table 3.9 Table of correlation coefficients between transformed survival time and the scaled Schoenfeld 
residuals, a chi-square, and the two-sided p-value ............................................................................................... 83 
Chapter 4 
Table 4. 1 Socio demographics of Q fever pre-screening test service users, 1991-2016, Queensland, Australia.
 ............................................................................................................................................................................. 91 
Table 4. 2 The distribution of Q fever serology and skin test results, and the general practitioners (GP)  
interpretation, 1991-2016, Queensland, Australia ............................................................................................... 94 
Table 4. 3 Cross-tabulation of serology and skin test results, and general practitioners (GPs) interpretation, 
1991-2016, Queensland, Australia. ...................................................................................................................... 95 
Table 4. 4 Cohen’s Kappa estimates for serology and skin test results, and the general practitioners (GPs) 
interpretation, 1991-2016, Queensland, Australia ............................................................................................... 96 
Table 4. 5 Serology and skin test results for the 4 sub populations Bayesian latent class model ........................ 96 
 23  
Table 4. 6 The prevalence of Q fever exposure, sensitivity (Se), specificity (Sp), negative predictive value 
(NPV), positive predictive value (PPV) of serological and skin tests, and the credible intervals (CI), 1991-2016, 
Queensland, Australia .......................................................................................................................................... 97 
Table 4. 7 The Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV) of 
serology and skin tests, and the estimated prevalence of Q fever exposure among workers in a meat processing 
plant, 1991-2016, Queensland, Australia. ............................................................................................................ 98 
Table 4. 8 The sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV) of 
serological and skin tests, and the estimated prevalence of Q fever exposure among workers in a meat 
processing plant, 1991-2016, Queensland, Australia ......................................................................................... 100 
Table 4. 9 The sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV) of 
serology and skin tests, and the estimated prevalence of Q fever exposure among workers in a meat processing 
plant, 1991-2016, Queensland, Australia ........................................................................................................... 102 
 
Table 4.1. 1 Diagnostic accuracy measures for independent diagnostic tests .................................................... 190 
Table 4.1.2 Likelihood contributions of the various combinations of test outcomes for conditionally 
independent tests ................................................................................................................................................ 192 
Table 4.1.3 Observed data from two diagnostic tests, in the absence of a gold standard .................................. 194 
Table 4.1. 4 Probabilities for each test results combinations for two conditionally independent diagnostic tests
 ........................................................................................................................................................................... 197 
Table 4.1. 5 The sensitivity and specificity of serology methods from previously published literature considered 
as priors for the sensitivity and specificity of serology test. .............................................................................. 199 
 
Chapter 5 
Table 5. 1 Column percentages of the demographics characteristic of cases and controls for the duration of the 
study between January 1, 1991 and December 31, 2016, .................................................................................. 110 
Table 5. 2 Multivariable logistic regression model results on the incidence of Q fever, 1991-2016, Queensland, 
Australia ............................................................................................................................................................. 111 
Table 5. 3 Predicted probabilities of the incidence of Q fever infection, 1991-2016, Queensland, Australia ... 112 
Table 5.4 Model goodness of fit summary table for the multivariable logistic regression model of the incidence 
of Q fever infection, 1991-2016, Queensland, Australia. .................................................................................. 112 
Chapter 6 
Table 6. 1 Socio demographics of notified cases of Q fever, 1991-2016, Queensland, Australia ..................... 121 
Table 6. 2 Average Q fever notification rate per 100,000 midyear populations by age and sex, 1991-2016, 
Queensland, Australia ........................................................................................................................................ 123 
Table 6. 3 Multivariable Negative Binomial regression Model for the annual Q fever notification rate with age 
and sex adjusted populations as offset, 1991-2016, Queensland, Australia. ..................................................... 125 
Table 6. 4 Model Goodness of fit summary table for Poisson and negative binomial models on the Q fever 
notification rate, 1991-2016, Queensland, Australia. ........................................................................................ 126 
Table 6. 5 ANOVA table for the Poisson and negative binomial models on the Q fever notification rate, 1991-
2016, Queensland, Australia. ............................................................................................................................. 126 
Table 6. 6 Negative binomial regression model for the annual Q fever notification rate with age and sex 
adjusted populations as offset, 1991-2016, Queensland, Australia. .................................................................. 129 
Table 6. 7 Model Goodness of fit summary for the Poisson and negative binomial models on the Q fever 
notification rate, 1991-2016, Queensland, Australia. ........................................................................................ 130 
Table 6. 8 ANOVA for the Poisson and negative binomial models on the Q fever notification rate, 1991-2016, 
Queensland, Australia. ....................................................................................................................................... 130 
Table 6. 9 Demographic and admission characteristics of hospitalised Q fever patients, 2001-2015, Queensland, 
Australia. ............................................................................................................................................................ 133 
 24  
Table 6. 10 Average age and length of hospital stay for Q fever admitted patients, 1991-2016, Queensland, 
Australia ............................................................................................................................................................. 134 
Table 6. 11 Age and Sex specific annual rate of Q fever admission per 100,000 populations .......................... 136 
Table 6.12 Negative binomial model on the rate of hospital admissions, 2001-2015, Queensland, Australia. . 138 
Table 6.13 Model Goodness of fit summary table for Poisson and negative binomial models on the rate of 
hospital admissions, 2001-2015, Queensland, Australia. .................................................................................. 138 
Table 6.14 ANOVA for Poisson and negative binomial models on the rate of hospital admissions, 2001-2015, 
Queensland, Australia. ....................................................................................................................................... 139 
Table 6. 15 Poisson regression model on the rate of hospital admissions, 2001-2015, Queensland, Australia. 141 
Table 6. 16 Model Goodness of fit summary table for Poisson and negative binomial models on the rate of 
hospital admissions, 2001-2015, Queensland, Australia. .................................................................................. 142 
Table 6. 17 ANOVA for Poisson and negative binomial models on the rate of hospital admissions, 2001-2015, 
Queensland, Australia. ....................................................................................................................................... 142 
Table 6. 18 Q fever notifications that required admission, 2001-2015, Queensland, Australia ........................ 143 
Chapter 7 
Table 7.1 Frequency distribution of responses of notified cases of Q fever from the enhanced Q fever exposure 
data, 1991-2016, Queensland, Australia ............................................................................................................ 153 
Table 7.2 Eigenvalues: the variances and the percentage of variances explained by each dimension. ............. 154 
 
Table 7.1. 1 Q fever exposure information from enhanced Q fever notification surveillance data, 1991-2016, 
Queensland, Australia ........................................................................................................................................ 203 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 25  
List of Figures  
Chapter 1 
Figure 1. 1 Pathophysiology of Q fever. .............................................................................................................. 32 
Figure 1. 2 Q fever notifications rate per 100,000 population, 1991 to 2018 and year-to-date notifications, 
received from State and Territory health. ............................................................................................................ 43 
Chapter 2 
Figure 2. 1 Forest plot of seroprevalence of C. burnetii among abattoirs and slaughterhouse workers in 19 
included studies stratified by outbreak status. ..................................................................................................... 55 
Figure 2. 2 Forest plot of the seroprevalence of C. burnetii among abattoirs and slaughterhouse workers 
stratified by year. ................................................................................................................................................. 57 
Figure 2. 3 Forest plot of the seroprevalence of C. burnetii among abattoirs and slaughterhouse workers 
stratified by country. ............................................................................................................................................ 58 
Figure 2. 4 Search strategy decision tree ............................................................................................................. 67 
Chapter 3 
Figure 3. 1 Diagram showing the linked Q fever data and the flow of sample selection for the study from the 
three databases containing information on Q fever: NOCS, QHAPDC and Q fever Vaccination Registry, 1991-
2016, Queensland, Australia. ............................................................................................................................... 70 
Figure 3. 2 Kaplan Meier survival curves showing the distribution of Q fever infection free survival time for 
vaccination status, gender, age and job variables for at risk population studied between January 1, 1991 – 31 
December 31, 2016, Queensland, Australia. ........................................................................................................ 81 
Figure 3. 3 Plots of the log cumulative hazard function against log (time) and the cumulative hazard function 
plot for the Cox-Snell residuals. .......................................................................................................................... 84 
Chapter 4 
Figure 4.1 Distribution of age, sex and job of the Q fever vaccination service users, 1991-2016, Queensland, 
Australia. .............................................................................................................................................................. 92 
Figure 4.2 The distribution of serology and skin test results, and the general practitioner (GP) interpretation, 
1991-2016, Queensland, Australia ....................................................................................................................... 93 
 
Figure 4.1.1 Diagram showing possible test results and the corresponding probabilities of occurrence for the 
test results combinations. ................................................................................................................................... 189 
 
Chapter 5 
Figure 5. 1 Digram showing the incident cases of Q fever in vaccinated and unvaccinated individuals, 1991-
2016, Queensland, Australia. ............................................................................................................................. 108 
Figure 5. 2 ROC curve for predictive performance of the multivariable logistic regression model for the 
incidence of Q fever infection, 1991-2016, Queensland, Australia. .................................................................. 113 
Chapter 6 
Figure 6. 1 Q fever notification by Sex, Age and Public Health Units, from 1991 to 2016, Queensland, 
Australia ............................................................................................................................................................. 122 
Figure 6. 2 Q fever notification by vaccination program period and  public health units, from 1991 to 2016, 
Queensland, Australia ........................................................................................................................................ 123 
 26  
Figure 6. 3 Trend of Q fever notification rate per 100,000 population by sex, age and year, from 1991 to 2016, 
Queensland, Australia. ....................................................................................................................................... 124 
Figure 6. 4 Mean-variance relationship for the Poisson and Negative Binomial models on the Q fever 
notification rate, 1991-2016, Queensland, Australia. ........................................................................................ 127 
Figure 6. 5 Mean-variance relationship for the Poisson and negative binomial models on the Q fever 
notification rate, 1991-2016, Queensland, Australia. ........................................................................................ 131 
Figure 6. 6 Q fever admissions by Age, Sex, Marital Status and Charge Status, 1991-2016, Queensland, 
Australia. ............................................................................................................................................................ 134 
Figure 6. 7 Monthly and yearly Q fever admissions, 1991-2016, Queensland, Australia. ................................ 135 
Figure 6. 8 Age and Sex specific Q fever admission rates, 1991-2016, Queensland, Australia. ....................... 137 
Figure 6. 9 Mean – variance relationship plot for Poisson and negative binomial models on the rate of hospital 
admissions, 2001-2015, Queensland, Australia. ................................................................................................ 140 
Figure 6. 10 Proportion of Q fever notifications that were admitted, 2001-2015, Queensland, Australia ........ 144 
Chapter 7 
Figure 7.1 Scree plot showing the percentage of variance explained by the first 10 principal components of the 
MCA on the Q fever exposure variables. ........................................................................................................... 155 
Figure 7.2 The graph of categories for the first two principal components (28.0% of the explained inertia) is 
provided for the Q fever exposure variables. ..................................................................................................... 156 
Figure 7.3 Bar plot showing the top 10 contributing categories of the Q fever exposure variables on dimension 
1. ........................................................................................................................................................................ 157 
Figure 7.4 Bar plot showing the top 10 contributing categories of the Q fever exposure variables on Dim 2. . 158 
Figure 7.5 Scatter plot of the first top 10 contribution of Q fever expousre variables ...................................... 159 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 27  
Abbreviations  
ABS – Australian Bureau of Statistics 
AMPC – Australian Meat Processor Corporation  
AR – Attack Rate 
AUC – Area Under the Curve  
BSPHU – Brisbane Southside Population Health Unit  
CDC – Centres for Diseases Control and Prevention 
CDNA – Communicable Diseases Network Australia  
CFS – Chronic Fatigue Syndrome  
CF – Complement Fixation Test 
CI – Confidence/Credible Interval 
CovSe: covariance term on sensitivity 
CovSp: covariance term on specificity 
CSL – Commonwealth Serum Laboratories 
CURB – Confusion, Urea, Respiratory Rate, Blood Pressure 
DF = Degrees of Freedom 
DIC: deviance information criterion 
DoH – Department of Health 
DoT/ICM – Defect in Organelle Trafficking/Intracellular Multiplication 
DNA – Deoxyribonucleic Acid 
EFSA – European Food Safety Authority  
ECDC – European Centres for Diseases Control and Prevention 
EIA – Enzyme Immunoassay  
ELISA – Enzyme Linked Immunosorbent Assays 
HR – Hazard Ratio 
ID50 – Infective Dose – the dose that could cause over disease in 50% of exposed individuals  
ILLD50 – Illness Dose 
InfD50% – Infective Dose 
IgM – Immunoglobulin M 
IgG – Immunoglobulin G 
IgA – Immunoglobulin A  
IFA – Indirect Immunofluorescence Assay 
IMS – Infection Management System 
LCV – Large Cell Variant 
LPS – Lipopolysaccharide 
 28  
MCMC – Markov Chain Monte Carlo 
Micro-IFT – Micro Immunofluorescence Test  
MLA – Meat and Livestock Australia 
MST – Multispacer Sequence Typing 
NCSI – Nijmegen Clinical Screening Instrument 
NHMRC – National Health Medical Research Council 
NIH – National Institute of Health 
NNDS – National Notifiable Diseases Surveillance 
NNDSS – National Notifiable Diseases Surveillance System  
NOCS – Notifiable Conditions System 
NQFMP – National Q fever Management Program 
NSW – New South Wales 
OR – Odds Ratio 
PCI – Bayesian posterior credible interval 
PCR – Polymerase Chain Reaction 
PM – Particulate Matter 
PPD – Bayesian posterior probability of difference 
qPCR – Quantitative Polymerase Chain Reaction 
Q – Query 
QFS – Q fever Fatigue Syndrome  
QHAPDC – Queensland Health Admitted Patient Data Collection 
QLD – Queensland 
QoL – Quality of Life 
qPCR – Quantitative Polymerase Chain Reaction 
Q-VAX® – Q fever Vaccine 
ROC – Receiver Operating Characteristics 
rRNA – Ribosomal Ribonucleic Acid  
rtPCR – Real-Time Polymerase Chain Reaction 
RR – Relative Risk/Risk Ratio 
SA – South Australia 
SCV – Small Cell Variant 
Se – Sensitivity  
SE – Standard Error 
Separ – Sensitivity of Parallel Testing 
Seser – Sensitivity of Serial Testing 
SLA – Statistical Local Area 
 29  
SLP – Spore Like Particle 
Sp – Specificity  
Sppar – Specificity of Parallel Testing 
Spser – Specificity of Serial Testing 
SSD – Statistical Subdivisions  
Std.Dev. = Standard Deviation 
T4SS – Type IV Secretion System 
TLR2 – Toll-Like Receptor 2 
TLR4– Toll-Like Receptor 4 
TT – Transfusion Transmission  
WHO – World Health Organization 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 30  
CHAPTER 1: Background 
1.1. Introduction to Q fever (Coxiella burnetti) 
Q fever (“Q” stands for query) was the name given following the investigation of abattoir associated outbreak 
of febrile illnesses in Brisbane, Queensland, Australia in 1937 (McCaughey 2014; Reller & Dumler 2015). The 
cause of Q fever is the bacterium called Coxiella burnetii (European Food Safety Authority & European Centre 
for Disease Prevention and Control 2014; Maurin & Raoult 1999) and has a size of 0.2–1.0 μm (Gürtler et al. 
2014). Recent phylogenetic studies have demonstrated that C. burnetii classified under the seventh subgroup of 
Proteobacteria (Fournier, Pierre-Edouard  & Raoult 2009; Raoult & Marrie 1995) in the order Legionellales 
and the family Coxiellaceae (Krieg & and Holt 1984).  
C. burnetii sustains its survival within hosts and in the environment by readily transmitting between hosts and 
environmental reservoirs and by undergoing a phase variation cycle through its cell variants (Gürtler et al. 
2014; Marrie, Thomas J. & Raoult 2015; Reller & Dumler 2015). This characteristic is partially attributed to 
the capacity of the pathogen to undergo a sporogenic differential cycle (Marrie, Thomas J. & Raoult 2015; 
Reller & Dumler 2015), especially the small cell variant (SCV), bestow the bacterium high resistance to 
adverse physical and environmental stress (heat, pressure, drying) and to common chemical agents and 
disinfectants (Raoult & Marrie 1995). 
Infectivity of C. burnetii is high (van Leuken et al. 2015) with a few organisms capable of causing Q fever 
disease (Reller & Dumler 2015) and human beings are considered accidental hosts (European Food Safety 
Authority & European Centre for Disease Prevention and Control 2014). Up to 60% of infections with the 
agent are asymptomatic (Hartzell et al. 2008; Maurin & Raoult 1999; Parker, NR, Barralet & Bell 2006; Raoult, 
Marrie & Mege 2005) or only cause a self-limiting febrile illness (Chiu & Durrheim 2007; Marrie, Thomas J. 
& Raoult 2015). There is evidence of a dose-response effect related to the incubation period, with an incubation 
period as short as two days occurring on occasion (Marrie, Thomas J. & Raoult 2015).  
After an average incubation period of 20 days (range, usually 1 to 39 days) the host becomes ill with severe 
headache, fever, chills, fatigue, and myalgia (Gürtler et al. 2014). The course of illness varies between two days 
to more than one year (Hopper et al. 2016). Two forms of Q fever, acute and chronic, are identified (Brouqui et 
al. 1993; Dupont, Thirion & Raoult 1994; Marrie, Thomas J. & Raoult 2015; Merhej et al. 2012; Raoult & 
Marrie 1995; Tissot Dupont et al. 1992). Between 1–5% Q fever infections advance to extreme fatigue (Porter 
et al. 2011). Although it has not been substantiated, more recent evidence by Gürtler et al., (2014) reported 5–
15% rate of transition from acute to chronic Q fever (Gürtler et al. 2014).  
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Approximately 60% of initial infections with C. burnetii are asymptomatic (CDC 2002). Severe acute Q fever 
infection presents as pneumonia, hepatitis, endocarditis, osteomyelitis and meningitis or encephalitis 
(Angelakis & Raoult 2010; Chiu & Durrheim 2007; Gunaratnam et al. 2014; Hartzell et al. 2008; Marrie, 
Thomas J. & Raoult 2015; Maurin & Raoult 1999; Parker, NR, Barralet & Bell 2006; Raoult, Marrie & Mege 
2005). Illness related burden during the first month was estimated to be a mean of eight days and 15 days not 
being able to work (Hopper et al. 2016). In addition, Hopper et al., (2016) indicated that severity of acute 
illness to be predictor of prolonged duration of symptomatic illness and may last up to a mean of 227 days 
(Hopper et al. 2016). 
Most chronic Q fever infection resulted in endocarditis (Angelakis & Raoult 2010; Arricau-Bouvery & 
Rodolakis 2005; Brouqui et al. 1993) usually occurs from 60 to 70% of all cases (Million, Lepidi & Raoult 
2009) and is often fatal (Arricau-Bouvery & Rodolakis 2005; Brouqui et al. 1993; CDC 2011). Cardiovascular 
disease are long-term sequelae (Parker, NR, Barralet & Bell 2006) and myocarditis is the leading cause of death 
in humans (Fournier, Pierre-Edouard et al. 2001). Four years after the initial Q fever infection, chronic fatigue 
syndrome (CFS) was found in 46% Q fever patients from the 2007 Q fever outbreak (Limonard et al. 2016). 
Previous investigation using a case control design also demonstrated presence of chronic fatigue syndrome was 
found in 20% of Q fever cases (Ayres et al. 2002). Earlier study by Ayres et al. (1998) found 42.3% of chronic 
fatigue syndrome among Q fever cases using a case control study (Ayres et al. 1998). 
Only 5% of symptomatic patients require hospitalisation (Roller & Dumper 2015) and about 1-2% of the cases 
end up with death (Kampschreur et al. 2010; Kermode et al. 2003; Tissot Dupont et al. 1992). In patients with 
chronic Q fever, this mortality toll can reach up to 13% (Kampschreur et al. 2014).  
The natural history of Q fever in humans is shown in Figure 1.1. 
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Figure 1. 1 Pathophysiology of Q fever.  
Source: Adopted from Raoult, D., et al. (2005). "Natural history and pathophysiology of Q fever." Lancet 
Infect Dis 5(4): 219-226 (Raoult, Marrie & Mege 2005).  
Although most infection with Q fever are related to exposure to farm animals (Marrie, T. J. 1990; Nourse et al. 
2004), non-animal contact incidence of Q fever were reported (Aitken 1987; Maurin & Raoult 1999). 
Transmission also occurs between humans (Milazzo, Adriana et al. 2001). A case report from a South 
Australian town documented the possibility of getting infected during sexual activity (Milazzo, Adriana et al. 
2001). This sexual activity related infection of Q fever in human was also evidenced following the detection of 
Q fever among nine Polish shepherds and their wives (Kruszewska, Lembowicz & Tylewska-Wierzbanowska 
1996). Q fever infection due to aerosolization of infectious excreta from the human placental was suspected 
(Amit et al. 2014). 
The zoonotic origin of almost all human infections is well evidenced (CDC 2015; European Food Safety 
Authority & European Centre for Disease Prevention and Control 2014; Honarmand 2012; McCaughey 2014; 
van Schaik & Samuel 2012). Transmission to humans from the main reservoirs of Q fever infection such as 
farm animals, domestic ruminants and pets is through aerosolization of birth products (European Food Safety 
Authority & European Centre for Disease Prevention and Control 2014; Maurin & Raoult 1999). Infection with 
C. burnetii infection can result in abortion in goats, sheep and cattle (European Food Safety Authority & 
European Centre for Disease Prevention and Control 2014).  Evidence of metritis and infertility in cattle related 
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to infection with C. burnetii was documented (European Food Safety Authority & European Centre for Disease 
Prevention and Control 2014). C. burnetii infection in mammals and other species causes pneumonia and poor 
prognosis of birth related outcomes such as abortion, stillbirth and giving birth to weak babies (Arricau-
Bouvery & Rodolakis 2005). Between 3% to 80% abortion rate from pregnant mammals have been evidenced 
(Arricau-Bouvery & Rodolakis 2005).  
1.2. Epidemiology  
1.2.1. Prevalence and distribution of Coxiella burnetii 
Since its discovery and description in Australia in 1937 by E.H. Derrick (Derrick 1983; Dyer 1949)  as a 
clinical disease, infection caused by C. burnetii has brought about several Q fever outbreaks and the disease has 
become endemic worldwide (Dupont, Thirion & Raoult 1994; Kaplan, M & Bertagna, P 1955; Maurin & 
Raoult 1999; World Health Assembly 1950). Since then, the public health importance of infection caused by C. 
burnetii is recognized in many countries (Maurin & Raoult 1999). Regional variation in the epidemiology of C. 
burnetii infection in humans has been documented (Parker, NR, Barralet & Bell 2006; Tissot Dupont et al. 
1992).  
Several repeated outbreaks of Q fever were recorded in Germany (CDC 1997),  the Netherlands (Koene et al. 
2011; Schneeberger et al. 2014), Spain (Aguirre Errasti et al. 1984; Alonso et al. 2015), France (Armengaud et 
al. 1997; King et al. 2011; Tissot-Dupont et al. 1999), Switzerland (Bellini et al. 2014; CDC 1984; Dupuis et al. 
1987; World Health Organization 1991), Israel (a large outbreak of Q fever in an urban school) (Amitai et al. 
2010), USA (CDC 1986, 2011; Robyn et al. 2015; Stoker & Thompson 1953), Hungary (Gyuranecz et al. 
2014) and Australia (Graves & Islam 2016; O'Connor, Tribe & Givney 2015).  In Britain, Q fever in man was 
first reported in 1949 and since 1975, human infection with C. burnetii resulted in reported cases ranging from 
100 to 200 per year (Aitken 1987). Most of the Q fever infections were sporadic in nature with infrequent 
outbreaks (Aitken 1987).  There is growing evidence that the disease is common on the African continent 
(Njeru et al. 2016).  
The largest ever reported outbreak of Q fever in humans occurred in The Netherlands (Roest et al. 2011). Close 
proximity to small ruminants that experience abortion waves and the presence of susceptible humans in large 
numbers were the possible reasons for the outbreak to occur (Roest et al. 2011). Sustained transmission from 
common sources such as goat farms resulted in a total of 4,026 human cases (Schneeberger et al. 2014). 
It is possible that the number of cases of Q fever is under estimation because Q fever can be misdiagnosed due 
to its non-specific presentation, the passive nature of the surveillance systems and since up to 60% of Q fever 
acute infections with C. burnetii are asymptomatic (Dahlgren, F. S. et al. 2015; Fournier, P-E, Marrie, TJ & 
Raoult, D 1998; Maurin & Raoult 1999; Raoult 1996; Tissot Dupont et al. 1992). 
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Finally, since a variety of case definitions have been used in different countries, the resulting magnitude of Q 
fever associated burden cannot be known exactly; being either an underestimation or overestimation (van 
Loenhout et al. 2015). As in many other countries, there is high probability that of under estimation in the 
number of cases of Q fever reported in Australia (Peter et al. 1985). 
1.2.2. Reservoirs 
The most commonly reported reservoirs of C. burnetii are goats, sheep and cattle (CDC 2015; European Food 
Safety Authority & European Centre for Disease Prevention and Control 2014; Hartzell et al. 2008; Kaplan, 
MM & Bertagna, P 1955; Marrie, Thomas J. & Raoult 2015; Parker, NR, Barralet & Bell 2006; Roest et al. 
2013). Pet animals are also reservoirs of C. burnetii (European Food Safety Authority & European Centre for 
Disease Prevention and Control 2014; Georgiev et al. 2013; Tissot-Dupont & Raoult 2008; Wilson et al. 2010). 
In addition, wild animal species as reservoirs that are known to be infected with C. burnetii is evidenced (Baca 
& Paretsky 1983; CDC 2015; Kaplan, M & Bertagna, P 1955; World Health Assembly 1950). 
1.2.3. Transmission Route 
Humans are considered as accidental hosts (European Food Safety Authority & European Centre for Disease 
Prevention and Control 2014) and mostly infected by inhaling infectious aerosols originating from birth 
products of parturient animals (Aguirre Errasti et al. 1984; Anderson et al. 2005; CDC 2015; Marrie, Thomas J. 
& Raoult 2015; Tissot-Dupont et al. 2004; Tissot-Dupont & Raoult 2008). The placenta of infected animals 
such as sheep may contain up to 109 infectious C. burnetii doses per gram of tissue during late gestation 
(Hartwell et al. 1951; Marrie, Thomas J. & Raoult 2015; Welsh et al. 1958). The possibility of other 
transmission mechanisms to humans as have been documented (CDC 2015). For instance, evidence of 
transmission via orally ingesting unpasteurized dairy products (Bernard et al. 2012; European Food Safety 
Authority & European Centre for Disease Prevention and Control 2014; Porter et al. 2011; Tissot-Dupont & 
Raoult 2008) and direct contact with products of infected animals, and the possibility of infection as a result of 
tick bites exist (Bernard et al. 2012; Porter et al. 2011).  Moreover, evidence of transmission through laboratory 
serological products has been reported (Hogema et al. 2012). The capability of extracellular survivorship 
bestow the organism to remain infectious in donated serological products (Hogema et al. 2012; Kersh, Priestley 
& Massung 2013).  
1.2.4. Sources of infection for humans  
Dairy goat farms, human contact with sheep, cattle and goat herds, movement of sheep and goats from farms to 
slaughter houses, their birth products, and manures are important sources for infection with C. burnetii (CDC 
2015; Marrie, Thomas J. & Raoult 2015). Q fever has been associated with sheep and goat grazing areas (CDC 
 35  
2015; Marrie, Thomas J. & Raoult 2015), which reflects the high infectivity and environmental survivorship of 
C. burnetii (Kersh, G. J. et al. 2013) enabling it to travel for miles once windborne (CDC 2011).   
1.2.5. Risk Factors 
Proximity to and contact with infected farm animals 
Several risk factors for Q fever disease in humans are established and the main predictor of infection with C. 
burnetii are closeness to contaminated farm animals or their birth products (Georgiev et al. 2013). In Australia, 
exposure to native and parturient domestic animals is shown to be risk factors (Department of Health 
(Australia) 2015). Production systems and management related farming factors were also found to be predictors 
of the possibility and frequency of outbreaks in a given area (Georgiev et al. 2013). For instance, in Germany 
several sheep grazing related Q fever outbreaks took place (Gilsdorf et al. 2008; Hellenbrand, Breuer & 
Petersen 2001; Porten et al. 2006). In Croatia, investigation of the importance of wind in the spread of C. 
burnetii from the source of infection (sheep on the pastures) to the factory found Q fever epidemic among 
employees (Medic et al. 2005). The outbreak of Q fever in Italy associated to transportation of sheep during the 
lambing season (Manfredi Selvaggi et al. 1996) and the Swiss Alpine valley outbreak of human Q fever 
(Dupuis et al. 1987) demonstrated the role of farming related factors in the transmission and sustainment of Q 
fever infection.  
Distance from the source 
The possibility of infection with C. burnetii was found to strongly depend on the distance from the source 
(Brooke et al. 2015). Being resident within 500 m of herds of gestating ewes was shown to be a risk factor for 
infection with C. burnetii in Jena, Germany (Gilsdorf et al. 2008). The study confirmed higher risk of (OR = 
14.7, 95% CI: 5.4 - 40.2, p < 0.001) Q fever in people living within 60 m of the grazing land compared to living 
500 m outside of the grazing land  (Boden et al. 2014). Another investigation of a large Q fever outbreak in 
Germany in 2005, found an 11.8% attack rate (AR) of people living within 50 m of the meadow (Gilsdorf et al. 
2008). It decreased the further the residence was from the meadow, falling to 1.3% at 350–400 m distance (50 
m vs >350–400 m) (RR = 8.7, 95% CI: 4.5 - 17.1) (Gilsdorf et al. 2008).  
An investigation of the risk factors based on the 2007-2010 largest ever epidemics in the Netherlands, the risk 
of Q fever infection was shown to be associated with closeness to contaminated farms (Bart et al. 2014; 
Schimmer et al. 2010). The incidence Q fever diminished with the further the distances from affected farms and 
dairy goat farms with clinical symptoms indicated the highest incidence (Commandeur et al. 2014; Schimmer 
et al. 2010).  
Wind 
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Tissot-Dupont et al. (2004) demonstrated the importance of wind in C. burnetii transmission (Tissot-Dupont et 
al. 2004). Higher incidence of Q fever infection found to be related to repeated frequency of air bellowing from 
the infection source (Tissot-Dupont et al. 2004). Hyperendemicity have been associated with wind coming 
from sheep-grazing area (Tissot-Dupont et al. 2004) and the highest cases of Q fever occurred in April and May 
(Tissot-Dupont et al. 2004). Incidence in urban areas was due to exposure to aerosolization of contaminated 
farm materials transported by road (Dupuis et al. 1987; Salmon et al. 1982).  
Prospective and retrospective studies on Q fever outbreaks that occurred in England, during 2007, found 
corroborative evidence of Q fever cases in humans as a result of wind blowing from nearby sheep farms 
affected by C. burnetii (Wallensten et al. 2010).  
Manufacturing plant-related incidence 
Evidence of manufacturing plant-related incidence and outbreaks of Q fever due to aerosolization of C. burnetii 
and proximity to affected sources have been reported (CDC 1997; van Woerden et al. 2004). Risk factor 
investigation based on the outbreak that occurred in Rollshausen, Germany in 1996, found a high attack rate 
(25%) among Rollshausen residents (CDC 1997). In addition, the study conducted on a waste-processing plant 
in Bilbao, Spain, conducted on a waste-processing plant demonstrated an increased odds of Q fever among staff 
who never wore respiratory mask compared to those who did (Alonso et al. 2015).  
Slaughtering Houses 
Slaughtering houses as risk factors of Q fever infection has been documented extensively. For instance, a case 
control study indicated increased risk of Q fever incidence with the extent of exposure to the slaughterhouse 
(Armengaud et al. 1997). A slaughterhouse and cutting plant related risk of Q fever infection that is associated 
with closeness to sheep lairage was evidenced (Wilson et al. 2010). 
Educational Centres (colleges, universities)  
In Israel, school based retrospective study related to Q fever outbreak which started two weeks earlier in June 
2005 identified 144 (88%) out of the 164 serologically tested individuals as having C. burnetii infection 
(Amitai et al. 2010). Frequent use of school canteen by staff and students was shown to be a risk factor for 
being infected with C. burnetii (King et al. 2011). 
Age and Sex 
Age and sex were also indicated to be risk factors of Q fever. The susceptibility of males to develop Q-fever 
decreases with age, while in females, middle-aged women appear to have the lowest risk (Brooke et al. 2015). 
Case control study showed strong association with age < 40 (OR=4.6, 95% CI: 1.1-40.3) and male sex 
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(OR=15.2, 95% CI: 2.5-91.2)  (Armengaud et al. 1997). Men are 5.2 (95% CI: 1.1–24.0) times as likely to be a 
confirmed case (Wilson et al. 2010). Retrospective study showed a strong association with age less than 40 
years old and the odds of Q fever increases in males (Armengaud et al. 1997; Wilson et al. 2010).  
Many studies and countries report that mostly adult males are affected but in certain regions (such as studies 
from the African continent), children can be more affected. For instance, a seroprevalence of 8.3% (66/796) 
antibodies against Coxiella burnetii (Q fever) in children in the Gambia, West Africa, is found with the highest 
prevalence being in the age group 1–4 years (van der Hoek et al. 2013). In addition, positive Coxiella burnetii  
phase II IgG responses were observed in 16.9% (37) among 219 randomly selected children living in 9 rural 
villages of the Ashanti region, Ghana (Kobbe et al. 2008). 
The burden of Q fever in children was evidenced in a recent study that indicated between 6-70% evidence of 
previous Q fever infection (Reller & Dumler 2015). An investigation on the seroprevalence of C. burnetii 
found 29 of 447 samples positive in South West Queensland (Parker, N, Robson & Bell 2010). Children, 
especially in rural settings were at increased risk of exposure to birth products of cattle, sheep and goats (Reller 
& Dumler 2015). Moreover, under diagnosis and under ascertainment in children may play a role in lowering 
the magnitude of Q fever in children (Hackert et al. 2015). However, vaccination for Q fever is not available to 
children aged under 15 years old (NHMRC 2015) though the need for vaccinating children who are at greater 
risk was indicated (Barralet & Parker 2004).  
Summary of the risk factors of infection with C. burnetii are presented in Table 1.1. 
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Table 1. 1 Summary of the main risk factors of infection with C. burnetii, the associated risk estimates and major related studies.  
Risk factors and characteristics Risk estimates 
Proximity to and contact with infected farm animals: 
 closeness to contaminated farm animals or their birth 
products 
 production systems and management related farming 
factors  
References: (Bart et al. 2014; Boden et al. 2014; Commandeur 
et al. 2014; Dupuis et al. 1987; Georgiev et al. 2013; Gilsdorf et 
al. 2008; Hellenbrand, Breuer & Petersen 2001; Porten et al. 
2006; Schimmer et al. 2010) 
- living within 60 m of grazing land compared to living 500 m outside of the grazing 
land [OR = 14.7, 95% CI: 5.4 - 40.2] (Boden et al. 2014) 
-11.8% attack rate (AR) for people living within 50 m of meadow and 1.3% AR at 
350–400 m distance of meadow [RR = 8.7, 95% CI: 4.5 - 17.1] (Gilsdorf et al. 2008)  
-having been near a sheep stable or pasture than those without this exposure (AR: 36% 
versus 19%; RR = 1.9; 95% CI = 1.2-3.1) and walking near sheep farm (AR: 33% 
versus 18%; RR=1.8; 95% CI=1.1-2.9) (CDC 1997) 
 exposure to native and parturient domestic animals References: (Department of Health (Australia) 2015) 
 outdoor (time spent outside in the affected area) activity 
 ‘lamb-viewing days’ at a sheep farm open to the public 
-OR =2.5, 95% CI: 1.3–4.7 (Boden et al. 2014) 
-OR = 43, 95% CI (9–200) (Whelan et al. 2012) 
References: (Boden et al. 2014; Whelan et al. 2012) 
Wind blowing from nearby contaminated farms and 
transportation of farm materials: 
 wind blowing from the source of infection such as 
sheep-grazing area 
-employees exposed to north wind, had a significantly higher possibility of acquiring 
Q fever than did those working in sections protected from the wind (OR=12,24; 95% 
CI: 1.26-2.59) (Medic et al. 2005) 
References: (Dupuis et al. 1987; Medic et al. 2005; Salmon et al. 1982; Tissot-Dupont 
et al. 2004) 
 transportation of sheep during lambing season 
 incidence in urban areas due to exposure to 
aerosolization of contaminated farm materials 
transported by road 
References: (Dupuis et al. 1987; Manfredi Selvaggi et al. 1996; Salmon et al. 1982; 
Wallensten et al. 2010) 
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Slaughtering Houses: 
 slaughterhouse and cutting plant related risk of Q fever 
infection 
 
References: (Armengaud et al. 1997; Wilson et al. 2010) 
-exposure to slaughterhouse (low exposure: OR=3.0; moderate: OR=4.7; high: 
OR=15.0) and high level of exposure to slaughterhouse site (OR=6.8, 95% CI: 1.1-
40.3)  (Armengaud et al. 1997) 
-passing through the stores [OR = 3.2, 95% CI: 1.7–6.3) and walkway [OR = 2.1, 95% 
CI: 1.0–4.3) (Wilson et al. 2010) 
Manufacturing plant-related incidence,  
Cardboard manufacturing plant,  
Waste-Sorting Plant in Bilbao  
 
 
References: (Alonso et al. 2015; CDC 1997; van Woerden et al. 
2004) 
-employees in the factory’s offices are at greatest risk for infection (OR = 3.46; 95% 
CI: 1.38–9.06) (van Woerden et al. 2004) 
-spending most of  working day at the waste processing areas of the plant (those 
ascribed to the receipt, sorting and biological treatment areas): highest attack rate at 
the receipt area (66.6%) and the second highest at the sorting 62.5% (Alonso et al. 
2015) 
-25% attack rate (CDC 1997) 
-never wearing respiratory mask [OR=2.8, 95% CI: 1.1–7.1] 
Educational Centres (colleges, universities): 
 Frequent use of school canteen by staff and students 
 
References: (Amitai et al. 2010; King et al. 2011) 
-Being a student (OR, 11.09; 95% CI, 3.07–40.07), 
-boarding at school (OR, 13.9; 95% CI, 4.45–43.45),  
-dining regularly at the school dining room (OR, 8.57; 95% CI, 2.05–35.79) (Amitai et 
al. 2010) 
Age and Sex: 
 Older age groups are generally at increased risk of Q 
fever  
 Generally, higher odds of Q fever in males 
-age < 40 (OR=4.6, 95% CI: 1.1-40.3) and  
-male sex (OR=15.2, 95% CI: 2.5-91.2)  (Armengaud et al. 1997) 
-men are 5.2 (95% CI: 1.1–24.0) times as likely to be a confirmed case (Wilson et al. 
2010) 
References: (Armengaud et al. 1997; Brooke et al. 2015; Wilson et al. 2010) 
 
 40  
1.2.6. Dose response  
Onset of Q fever disease associated with even low doses of C. burnetii is established based on a dose response 
model in human. Experimental studies indicated that even one micro-organism is sufficient to infect man 
(World Health Organization (WHO) 2004). According to WHO estimate of the assumed human infective doses 
(assumed 50% human infective dose, ID50, is the dose that would cause overt disease in 50% of exposed 
individuals) for Q fever is 100 organisms (World Health Organization (WHO) 2004).  Brooke et al. (2013) 
demonstrated the high infectivity of the organism in humans using a hierarchical Bayesian framework with a 
dose response relational model (Brooke et al. 2013).  
1.2.7. Persons at risk for Q fever  
Mainly, people at risk of Q fever includes abattoir workers, meat or dairy processing workers, dairy farmers, 
individuals who have contact with dairy products, veterinarians, and researchers working closely with animals 
infected by C. burnetii (CDC 1997, 2015; Maurin & Raoult 1999; Sawyer, Fishbein & McDade 1987).  This 
has motivated some countries to undertake vaccination programmes for workers at risk of contracting the 
disease (Khalili et al. 2014; Schimmer et al. 2014).   
1.2.8. Control and Prevention  
Various control and prevention strategies have been forwarded and implemented. Improving the accuracy of 
the Q fever diagnostic techniques, methods to improve handling of laboratory animals, strategies to minimize 
potential transmission from infected farms settings to humans and actions to reduce the extent and frequency of 
human exposure were some of the actions implemented to curve the impact of Q fever (Georgiev et al. 2013; 
Raoult & Marrie 1995).  
In effect, vaccinating people at increased risk of Q fever infection remains the primary strategy in the control of 
Q fever (CDC 1997; Raoult & Marrie 1995).  Other effective strategy in the control of the epidemic was 
demonstrated by Hogerwer, et al. (2011) in The Netherlands through vaccination of goats and sheep which 
reduces the prevalence and bacterial load in vaccinated animals compared with unvaccinated animals. These 
effects were most pronounced in animals during their first pregnancy (Eibach et al. 2013; Hogerwerf et al. 
2011). Results indicate that vaccination may reduce bacterial load in the environment and human exposure to 
C. burnetii (Dijkstra et al. 2012; Hogerwerf et al. 2011), and hygiene measures and culling of pregnant animals 
on infected farms shwon to be effective (Dijkstra et al. 2012). In combination with a rise in the human 
population with antibodies against C. burnetii, the 2007-2010 epidemic ended after vaccination of the complete 
Dutch dairy goat population (Slok et al. 2015). In addition, prevention through the vaccination of livestock 
(Eibach et al. 2013; Hogerwerf et al. 2011) and removing of pregnant animals from affected farms (Dijkstra et 
al. 2012) have been demosntrated. 
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Multisectoral approach with good communication among stakeholders in areas where there are close proximity 
between animal farming and human residency is recommend in the prevention and control of Q fever (CDC 
1997).  
1.3. Treatment 
Acute Q fever is treated with doxycycline, which is the recommended first-line therapy (Angelakis & Raoult 
2010; CDC 1997; Kovacova & Kazar 2002; Raoult & Marrie 1995). Fluoroquinolones, cotrimoxazole and 
rifampin as treatment options in case of allergy to tetracyclines or contraindication have been indicated 
(Angelakis & Raoult 2010). 
Chronic Q fever is more challenging to treat.  Two to three years extended treatment with doxycycline and 
hydroxychloroquine is considered to be optimal treatment of chronic disease (CDC 1997) (Angelakis & Raoult 
2010).  
1.4. Laboratory Diagnosis 
Serology, culture, molecular methods and micro array techniques are used for the diagnosis of Q fever (Maurin 
& Raoult 1999). Among these techniques, serology remains the test of choice for Q fever (Maurin & Raoult 
1999).  
1.4.1. Serology 
The broad array of clinical presentations entails serologic confirmation for clinical Q fever diagnosis (Blaauw 
et al. 2012; Dupont, Thirion & Raoult 1994); the reference standard for diagnosing Q fever (Wegdam-Blans, 
Kampschreur, et al. 2012).  
Serology involves detection of specific antibodies produced by host following infection with C. burnetii. 
Various serological techniques are available in the laboratory diagnosis of Q fever such as Micro-
Immunofluorescence Test (Micro-IFT), Indirect Immunofluorescent Assay (IFA), Enzyme linked 
Immunosorbent Assays (ELISA) and Complement Fixation Tests (CFT) (Dupont, Thirion & Raoult 1994; 
Herremans, T. et al. 2013; Wegdam-Blans, Wielders, et al. 2012).  
The complement fixation test (CFT) is the traditional technique for the detection of C. burnetii (Field, P. R. et 
al. 2002). It is considered to have low sensitivity but high specificity (Field, P. R. et al. 2002; Peter et al. 1985). 
However, Devine et al. showed 97% sensitivity (for both IgM and IgA) and 100% specificity (Devine, Doyle & 
Lambkin 1997). 
IFA provides higher sensitivity (98%) being the most specific (100%) for the diagnosis of Q fever (Slaba, 
Skultety & Toman 2005) and hence is consider to be the gold standard for the diagnosis (Dupont, Thirion & 
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Raoult 1994; Fournier, PE, Marrie, TJ & Raoult, D 1998; Herremans, T. et al. 2013; Maurin & Raoult 1999).  
Micro-immunofluorescence has also been used to diagnose acute Q fever and shown to be highly sensitive and 
specific, (Kazar et al. 1981; Nguyen et al. 1996). 
Enzyme-linked immunosorbent assays are considered to be particularly useful during pre-vaccination screening 
for C. burnetii immunity (Field, P. R. et al. 2002) because the sensitivity is higher than the CFT (Maurin & 
Raoult 1999).  
1.4.2. Culture methods 
Because of its higher virulence factor, C. burnetii and since numerous cases of laboratory-acquired infections 
have been reported, culture methods are used in highly specialized laboratories (Angelakis & Raoult 2010; 
Fournier, PE, Marrie, TJ & Raoult, D 1998; Hervé 2007; Maurin & Raoult 1999). 
1.4.3. Molecular methods 
The need for rapid diagnostics pave the way to the development of numerous PCR-based assays (Angelakis & 
Raoult 2010; Musso & La Scola 2013; Schneeberger et al. 2010).  Real-time PCR with serum samples is 
valuable for early diagnosis of acute Q fever before seroconversion takes place (Pradeep et al. 2017; Wielders 
et al. 2013). 
1.5. Coxiella burnetii in Australia 
1.5.1. Q fever notification in Australia 
Q fever has been a notifiable disease in Australia since 1952 (Bond et al. 2016; Communicable Diseases 
Network Australia (CDNA) 2016; Hall R & Department of Health (Australia) 1993; McGuinness, Denholm & 
Leder 2013). The maximum notification was reported during 1965-66 with 17.9 per 100 000 population per 
year nationwide (Hall R & Department of Health (Australia) 1993). 
A review of reported cases in Australia showed a range from 202 to 860 reports per year (2.5 to 4.9 per 100,000 
population per year (Milton et al. 2012)) (Garner et al. 1997) with 2600 cases reported over the period 1991-94 
(Garner et al. 1997).   
In 2015, 605 cases were notified (2.6 per 100,000 population per year) across Australia from which 517 
(85.45%) of the cases were from NSW (43.31%, n = 262) and QLD (42.15%, n = 255) of notified cases 
(Australian Government Department of Health 2016).  
Number of notifications of Q fever per 100,000 population received from State and Territory health authorities 
in the period of 1991 to 2015 and year-to-date notifications for 2016 is shown in Figure 1.2. 
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Figure 1. 2 Q fever notifications rate per 100,000 population, 1991 to 2018 and year-to-date notifications, 
received from State and Territory health. 
Source: Data are obtained from Australian Government Department Health [URL: 
http://www9.health.gov.au/cda/source/rpt_2.cfm, http://www9.health.gov.au/cda/source/rpt_2.cfm Date of 
Access: 11/04/2019] 
Note: Population data used for years above 2018 is from year 2018 
1.5.2. Reservoirs  
The importance of domestic ruminants as the primary drivers for the transmission of the pathogen is well 
recognized (Queensland Health 2010). Growing evidences from retrospective and prospective studies confirm 
that close contact to infected domestic ruminants as source of infection with the agent (Bond et al. 2016; 
O'Connor, Tribe & Givney 2015). A case series (2005–2013) study also indicated that close proximity to 
infected animals as potential source of infection (Graves & Islam 2016).  
Cat as source of infection for the pathogen was seen (Kopecny et al. 2013).  A recent seroprevalence study 
found out higher prevalence (35/376, 9.3%) among cattery-confined breeding cats (Shapiro, AJ et al. 2015).  
This is important because a recent survey regarding zoonoses indicated that 64.5% of respondents did not 
consider themselves at risk of being infected from pet animals showing a lower level of awareness of the 
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possibility of infection from these animals (Steele & Mor 2015).  In addition, there is evidence of infection in 
other animal species such as horses, dogs (Tozer, S. J. et al. 2014), wild animals and their ticks, and (Cooper et 
al. 2013) marsupials (Potter et al. 2011).  
1.5.3. People at risk of Q fever in Australia 
In Australia, meat and livestock workers, veterinarians, and farmers who have close proximity with affected 
animals and their products are greater risk of infection with the pathogen (Garner et al. 1997; Marrie, Thomas J. 
& Raoult 2015; Queensland Health 2010). Various groups of individuals who have close contact including 
visitors and contractors to meat processing industries and affected farms have been identified to be at risk of 
being infected with C. burnetii (Milton et al. 2012; NNDSS Annual Report Writing Group 2015; Queensland 
Health 2010). 
1.5.4. Prevention and control: Q fever vaccine (Q-VAX®) 
A registered vaccine to prevent Q fever (Q-VAX®) has been commercially available in Australia since 1989.  
Q-VAX® (Seqirus, Australia) is a formalin-inactivated whole cell C. burnetti vaccine (“Q-VAX®”) that is safe 
and provides complete and long lasting immunity (Garner et al. 1997; Maurin & Raoult 1999; Parker, NR, 
Barralet & Bell 2006). However, it vaccination during incubation period does not halt progression to W fever, 
nor does it confer life-long protection (Morrissey, Cotton & Ball 2014; NHMRC 2015).  
Before the vaccine is administered, previous exposure to C. burnetti or the presence of immunity should be 
ruled out using two parallel screening tests: serology and skin tests (Milton et al. 2012). This is because of the 
associated adverse reactions in individuals exposed to the infectious agent. (Marmion, BP et al. 1984; 
Marmion, BP et al. 1990). Inoculation site oedema is frequently reported reaction to administering the vaccine 
in immune individuals (Gidding et al. 2009).  
The National Q Fever Management Program (NQFMP) in Australia 
Application of Q fever vaccines is indicated at least for professionally exposed groups of the population 
(Kovacova & Kazar 2002). In Australia, the primary protective measure against Q fever is through targeted 
immunisation; recommending and providing vaccination to the at risk group (Gidding et al. 2009; Parker, NR, 
Barralet & Bell 2006). Government funding for Q fever vaccination was provided from 1991 to 2007, with the 
national program (NQFMP) implemented from 2001-2006.   
There were four important periods in the implementation of the vaccination program (Department of Health 
(Australia), 2015):   
 Period 1 (1991 - 1999): when vaccination was provided to workers in in a small number of abattoirs;  
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 Period 2 (2000 - 2006): when vaccination coverage expanded to include other abattoirs in a number of  
states;  
 Period 3 (2007 - 2011): the time of the NQFMP; and  
 Period 4 (post 2011): when individuals have to cover the cost of both pre-vaccination screening and 
vaccination costs.  
Funding was provided for screening and vaccination at no costs to individuals considered to be greater risk of 
Q fever (Gidding et al. 2009; Milton et al. 2012).  Funding for the NQFMP ended in 2006-2007 but separate 
government funding has been provided to the vaccine manufacturer to help cover costs of its manufacture but 
not the cost of testing and vaccination for members of the community (Milton et al. 2012). 
Q fever vaccination uptake  
Vaccine uptake ranging from 43% (in farmers) - 100% (amongst abattoir workers) was reported (Gidding et al. 
2009; Lowbridge et al. 2012). However, the uptake of the vaccine by meat processing plants lacks uniformity 
and does not conform to the current vaccination protocol. For instance, a survey of all accredited abattoirs in 
Queensland was undertaken to ascertain the number that conducted Q fever vaccination programs and only ten 
of the 30 (33.33%) abattoirs had vaccination programs (Bell, Patel & Sheridan 1997). In addition, very few 
meat processors in South Australia offer a Q fever immunisation program for their workers (Milazzo, A., 
Featherstone & Hall 2005). 
This is important because the Q fever vaccination program has been responsible for a significant decline in the 
incidence of notified cases.  Before the implementation of the NQFMP, between 500 and 800 annual cases of Q 
fever were recorded (Queensland Health 2010). After the introduction of the Q fever vaccination programs the 
incidence of Q fever reduced to 2.8 cases per 100,000 persons per year (Graves & Islam 2016; Lowbridge et al. 
2012).  Indeed, There has been an approximately 50% decline in the reported and admitted cases of Q fever 
between 2002 and 2006 when the NQFMP was expanded with  the highest decline being among adult males 
(Gidding et al. 2009).  
The effectiveness of the Q fever vaccine (Q-VAX®) 
Early follow up studies have shown the safety and effectiveness of Q-VAX® ranging from 83–100% (Chiu & 
Durrheim 2007). For instance, a retrospective cohort study during the period 1985 to 1990 indicated 100% 
protective efficacy of Q-VAX® (Seqirus Australia) for at least five years (Ackland, Worswick & Marmion 
1994). Another clinical trial conducted during the period 1981-8 indicated the effectiveness of the vaccine in 
providing immunity for at least five years (Marmion, BP et al. 1990). Furthermore, an experimental follow-up 
study has shown higher odds of Q fever incidence in unvaccinated workers (Shapiro, RA et al. 1990). 
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Moreover, the highly effective nature of Q-VAX® is indicated in a meta-analysis (Chiu & Durrheim 2007; 
Gefenaite et al. 2011).  
Up to 93% effectiveness of the Q fever vaccine was shown in systematic review and meta-analysis (O'Neill, 
Sargeant & Poljak 2014).  
1.5.5. Occupational epidemiology of Q fever in Australia  
In Australia, various reports indicated that Q fever to be an occupational diseases and higher incidences were 
reported in workers who are in close proximate with affected animals and their products (Garner et al. 1997; 
Marrie, Thomas J. & Raoult 2015). A strong association with the meat industry is confirmed (Garner et al. 
1997). And this is in accordance with study that has shown that abattoir workers are notable at-risk group for Q 
fever (Bell, Patel & Sheridan 1997). Other occupational groups as well as non-occupational animal exposures 
appear to be accounting for an increasing proportion of notifications (NHMRC 2015). 
In a review of notification from 1993 – 2007 in New South Wales, a significant decline in the proportion of 
notifications occurred in the occupational group reported as ‘Abattoir/Meat’ worker though a significant 
increase occurred in the ‘Farmer/Livestock’ category.  
Several studies evidenced the Q fever associated epidemiologic transition in the occupation. For instance, 
evidence of shift in the occupation category affected by the Q fever disease has been demonstrated in NSW 
which showed increase in the role of exposure to other wildlife or feral animals (Irwin, Massey & Durrheim 
2009). Similar changes in the epidemiology of Q fever have also been evidenced from The Netherlands study 
based on the outbreaks occurred from 2007-2010 which was associated with intensive farming of dairy goats 
and dairy sheep. In addition, from 2000-2010, 60% of cases reported to CDC occurred in those without 
reported exposure to livestock (Reller & Dumler 2015). 
Moreover, though children are less frequently symptomatic than adults following infection, a review of 46 
published articles from seroepidemiological studies on paediatric cases only showed that children are 
frequently exposed to Coxiella burnetii (Dijkstra et al. 2012; Maltezou & Raoult 2002). In the medical 
literature, 42 case reports described 140 childhood Q fever cases, four outbreaks, and thirty six national and/or 
regional studies reported seroprevalences varying between 0 and 70 % (Slok et al. 2015). Increasing 
notifications in children may reflect increased awareness that Q fever is not confined to adults with 
occupational exposures. 
1.5.6. Economic burden of Q fever in Australia 
Q fever associated morbidity costs Australia an estimated A$ 1 million and 1,700 weeks of work-associated 
time every year (Bell, Patel & Sheridan 1997; Garner et al. 1997). Cost estimation of vaccination for Q fever in 
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previous studies was obtained from workers’ compensation insurance claims that resulted in permanent 
disability for work, or temporary disability where five or more working days were paid for total incapacity 
(Bell, Patel & Sheridan 1997; Garner et al. 1997). Moreover, an individual client may incur an estimated cost 
(the cost of vaccine and screening) ranging from $380 to $480 for the complete vaccination for Q fever 
[http://www.qfever.com.au/vaccine.html http://www.qfever.com.au/ ] (Bell, Patel & Sheridan 1997; Garner et 
al. 1997). 
1.6. Significance 
The transition in the epidemiology of Q fever with regard to reservoirs, exposures, age structure, occupation 
and geographic distribution has been shown with evidence that cases have been reported across a broad range 
of demographic groups, including children (Barralet & Parker 2004; Reller & Dumler 2015; Tozer, Sarah Jane 
2015).  
In Australia, the burden of Q fever notification continued to remain high despite the availability of effective Q 
fever vaccine (Q – Vax) (Garner et al. 1997; Marrie, Thomas J. & Raoult 2015).  It has been shown that 
improving vaccination coverage and involving those stakeholders associated with the meat processing plants 
will result in substaintial reduction in the incidence of Q fever (Bell, Patel & Sheridan 1997; Bond et al. 2016). 
Nevertheless, program implementation on Q fever vaccination has not been fully implemented among target 
groups.  This is evidenced by the persistence of Q fever in abattoir workers (Gilroy et al. 2001; Greig et al. 
2005). 
There is anecdotal and published evidence of Q fever in vaccinated and immune people (Bond et al. 2017; 
Lowbridge et al. 2012). Therefore, it is important to explore the vaccine failure rate and the longevity of the 
immunity in those who received the vaccine. This project was intended to estimate the vaccine failure rate and 
longevity of immunity in those who received the vaccine and the factors that are associated with failure rate and 
length of immunity in those who were previously vaccinated. In addition, it assessed the accuracy of the pre-
vaccination screening tests. Finally, it estimated the rate of Q fever notification and associated hospitalization 
and the factors associated with both notification and hospitalization rates.  
The current project is innovative in terms of approach in that it combines Notifiable Conditions System 
(NOCS), Queensland Hospital Admission Patient Data Collection (QHAPDC), and Q fever Vaccination 
Registry data to assess the burden of Q fever in terms of notification and hospitalisation in those who were 
previously vaccinated for Q fever. 
1.7. Research Questions, Hypotheses and Objectives 
Based on the review of the current knowledge on Q fever vaccine, the following hypotheses and research 
questions have been developed. 
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Research questions: 
I. What are the general characteristics of the notified and hospitalized Q fever cases? 
II. How many cases of Q fever have been reported and hospitalized in vaccinated or “test-positive” 
individuals? 
III. What are the factors (demographic factors) that are associated with vaccine failure rate? 
IV. What is the duration of immunity since vaccination with Q Vax? 
V. What are the factors that are associated with longevity of vaccine immunity? 
VI. Is there any association between test results (derived from the Register) and Q fever notifications in 
both vaccinated and non-vaccinated individuals recorded on the Register? 
Research hypotheses: 
I. That test results (serology and skin tests) and pre-screening information (on exposure to Coxiella 
burnetii) obtained from the Q fever Vaccination Register are associated with Q fever vaccine failure.  
That is, there is higher incidence of Q fever notifications among abattoir workers with negative test 
results for serology and skin tests and negative exposure during pre-screening information than in 
vaccinated abattoir workers.  
II. There is association between vaccination status and Q fever notifications and hospitalizations. 
III. There is association between time since vaccination (derived from the Register) and occurrence of 
confirmed Q fever infection (notification data) as an indication of possible duration of vaccine 
immunity? 
Research Objectives: 
In order to test the above hypotheses, the proposed study has the following objectives: 
I. Describe notifications, hospitalization and Q fever vaccination registry data.  
II. Determine the rate of notification and hospitalization, and identification of any associated factors.  
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III. Determine rate of Q fever notification and hospitalization (as proximate for vaccine failure rate) in 
vaccinated and unvaccinated individuals and identify factors associated with Q fever vaccine failure 
rate. 
IV. Determine the duration of vaccine immunity among vaccinated individuals and identify factors that are 
associated with duration of immunity of Q-VAX®.  
V. Evaluate the diagnostic accuracy of the Q fever screening tests and determination of the extent of 
exposure to Q fever using Bayesian latent class model (BLCM).   
VI. Identify high risk groups based on the notification characteristics on abattoir exposure using multiple 
correspondence analyses.  
1.8. Ethical and Public Health Act (PHA) 2005 approvals 
This project was completed with approval from the Medical Research Ethics Committee, University of 
Queensland (protocol number: 2016000696).  Data from NOCS and QHAPDC databases was obtained with 
approval under the Public Health Act (2005) (PHA). Data from the Q Fever Vaccination Register was obtained 
with permission from the Register Technical Advisory Committee. 
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Abstract 
Coxiella burnetii, the causative agent of Q fever, is an occupational hazard for those who live and work in rural 
settings and those who are in contact with animals, especially abattoir and slaughterhouse workers. Australia is 
the only country to register a vaccine to prevent Q fever (Q-VAX®, Seqirus, Australia) that is used in high risk 
populations. Seroprevalence studies conducted to determine the burden of Q fever (C. burnetii infection) in 
different settings have demonstrated high levels of heterogeneity with estimates of the percent positive ranging 
from 30% to 70%. There is a need for a more systematic evaluation of the findings of these studies in order to 
provide summary estimates of the seroprevalence in different settings.   
We searched for published articles using PubMed, MEDLINE-EMBASE, and Scopus databases using search 
terms obtained from an initial review of published reports of recent Q fever outbreaks.  Data on the 
seroprevalence of C. burnetii infection (Q fever) was extracted from the selected studies and a random effects 
meta-analysis was performed with stratification by outbreak status, year, country and serological techniques 
used. Results were visualised with a forest plot with 95% CI and measures of heterogeneity (I2) for the random 
effects model.  
A total of 19 articles met the search criteria and were included. The reported seroprevalence rate ranged from 
4.7% to 91.7% among abattoir and slaughterhouse workers. No inter-group heterogeneity between outbreak 
and non-outbreak situations was observed (p = 0.956). The pooled estimate of seropositivity for C. burnetii 
infection in people working in abattoirs and slaughterhouses was 26% (95% CI: 18-35%) regardless of the 
evidence of an “outbreak”, the time of year or country. Seropositivity for C burnetii was independent of a 
person’s age and years of occupational experience. Within abattoirs and slaughterhouses, slaughtering of cattle, 
sheep and goats are the most important risk factors associated with seropositivity and for those who showed 
over symptoms upon infection. 
We recommend that vaccination programmes are directed towards people employed in the meat processing 
industry to mitigate the significant health and economic impacts of Q fever.  
Keywords:  Q fever, Coxiella burnetii, abattoir, slaughterhouse, butcher, meta-analysis 
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Background  
Q fever (Q stands for query), caused by the highly pathogenic bacteria called Coxiella burnetii, is a zoonotic 
disease (European Food Safety Authority & European Centre for Disease Prevention and Control 2014) and has 
worldwide distribution (Maurin & Raoult 1999). Since its discovery and description in Australia in 1937 
(Derrick 1983; Dyer 1949) there have been several Q fever outbreaks reported internationally and the disease is 
considered endemic in most regions of the world (Dupont, Thirion & Raoult 1994; Kaplan, M & Bertagna, P 
1955; Maurin & Raoult 1999; World Health Assembly 1950). The Netherlands is the country, which 
experienced the highest ever reported Q fever outbreak (Roest et al. 2011). Intensive farming of dairy goats and 
dairy sheep was the main reason for the outbreaks that occurred in The Netherlands (Reller & Dumler 2015). 
Domestic ruminants and pets and in Australia, native marsupials, are the main reservoirs of infection (Bond et 
al. 2016; Cooper et al. 2011; Shapiro, AJ et al. 2015; Tozer, S. J. et al. 2014).  Transmission to humans occurs 
mainly through aerosolization of contaminated materials from parturient animals (European Food Safety 
Authority & European Centre for Disease Prevention and Control 2014). Humans are considered accidental 
hosts (European Food Safety Authority & European Centre for Disease Prevention and Control 2014; Maurin 
& Raoult 1999). The seroprevalence of the pathogen reported to be between 30% and 70% in people working 
in high-risk occupations such as farmers, veterinarians and abattoir workers (Aitken et al. 1987).   
Prevention of Q fever in Australia is through targeted immunization especially in those working in, or 
associated with the meat industry using the locally produced Q-VAX® vaccine (Seqirus, Australia), which has 
high efficacy in adults (Marmion, BP et al. 1984; Marmion, BP et al. 1990). Q-VAX® is reported to provide up 
to 93% immune protection (O'Neill, Sargeant & Poljak 2014) with long-lived immune responses to infection 
with C. burnetii (Kersh, G.J. et al. 2013). However, the incidence of Q fever in people working in the red meat 
industry remains relatively high. Therefore, the current review provides information on the variability of the 
prevalence of Q fever exposure and risk factors for exposure in this occupational group.  
Materials and Methods 
Systematic articles search published in referred journals was conducted using various methods (see details in 
Tables 2.1 – 2.3 and supporting files 1 – 2 and Figure 2.4): an online search of PubMed, MEDLINE-EMBASE, 
and Scopus databases was conducted using the terms Q fever, Coxiella burnetii, seroprevalence, sero-
epidemiology, serology, incidence, prevalence, abattoir, abattoir workers, slaughterhouse, slaughterhouse 
workers, and butcher and meat workers. Further key words were then obtained from an initial review of reports 
of outbreak investigations in various countries.  
One reviewer individually screened all study titles identified through database searches. An initial review of 
abstracts was performed to identify articles for a more detailed full text review.  The final articles included in 
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this review and meta-analysis were selected based on the following criteria for inclusion: 1) if the full text or 
abstract of the article is available, 2) articles that are published in a peer-reviewed journals and archived in 
English, 3) original articles, that is, excluding review article or meta-analysis, 4) articles that contained reported 
prevalence estimates from statistical analyses, and 5) articles that were conducted on people working in the 
meat industry (slaughterhouse and abattoir workers, and butchers). Meta-analysis was conducted on the 
seroprevalence of C. burnetii infection among abattoir and slaughterhouse workers with 19 studies, which fulfil 
the inclusion criteria in the study. Detailed characteristics of the studies are summarized in Table 2.1. 
Articles with extreme reported seroprevalence rates, that is, 0.0% and 100%, have been included in order to 
minimize the publication bias especially for positive findings. The prevalence of exposure was selected as the 
outcome variable in each of the various sub-groups. Odds and risk ratios were also extracted as measures of the 
strength of association between Q fever and exposures to different risk factors. Initial data extraction was done 
using Microsoft Excel and compiled data was imported to Stata version 13 (StataCorp 2013).  
Stratification based on serological test type and whether the study reported findings of an outbreak 
investigation was performed to determine the presence of heterogeneity in terms of the seroprevalence and 
potential reporting bias. Both fixed and random effects meta-analysis was conducted using the Stata package 
metaprop (Nyaga, Arbyn & Aerts 2014) (see supporting File 2). A forest plot with error bars to indicate the 
95% confidence interval around each of the [true] prevalence estimates was constructed and Higgin's I2 was 
used to quantify the extent of heterogeneity in the seroprevalence estimates, across studies (Higgins, JP & 
Thompson 2002; Higgins, JPT et al. 2003). 
Results 
Around 7,110 articles were identified in the initial searches of PubMed (2864), MEDLINE - EMBASE (2246) 
and Scopus (2000) databases. After removing duplicate articles, the title and abstracts of 4,685 articles were 
reviewed to identify a total of 185 research articles that met our initial selection criteria.  After the final screen 
19 seroprevalence studies were included that met the criteria for inclusion in the meta-analysis. Details on the 
characteristics of included studies are provided in Table 2.1.  
Reported seroprevalence rates ranging from 4.7% to 91.7% among abattoir and slaughterhouse workers have 
been reported (Abebe 1990; Adesiyun et al. 2011; Aflatoonian et al. 2014; Berktaş et al. 2011; Esmaeili et al. 
2016; Gilroy et al. 2001; Htwe et al. 1993; Khalili et al. 2014; Marrie, T. J. & Fraser 1985; Perez-Trallero et al. 
1995). The magnitude ranged from 4.7% in Trinidad (Adesiyun et al. 2011) to 43.0% among abattoirs in 
Australia (Abebe 1990; Adesiyun et al. 2011; Gilroy et al. 2001), and 7.8% in Iran – 91.7% in Spain among 
slaughterhouse workers (Aflatoonian et al. 2014; Berktaş et al. 2011; Khalili et al. 2014; Perez-Trallero et al. 
1995). 
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The outputs of meta-analysis using random effects model on the seroprevalence of C. burnetii among abattoirs 
and slaughterhouse workers stratified by outbreak status, year, country and serological techniques are shown in 
Figures 2.1-2.3. These figures show individual study specific estimated percentages along with 95% exact CIs, 
sub-group and overall pooled estimate with 95% CIs and the I 2 statistic that measures of the extent of variation 
(as a percentage) in the prevalence estimates that is due to variation at the individual level study.  
The result of the meta-analysis shown in Figure 2.1 indicates the absence of inter-group heterogeneity on the 
seroprevalence of C. burnetii (p = 0.932, I2=97.33%), both during outbreak and non-outbreak situations, and 
hence the pooled seroprevalence estimate of 26% (95%, CI: 17-35%).  However, the seroprevalence estimates 
showed significant intra-group heterogeneity for the three serological tests with I 2 exceeding 94% (p <0.001) 
for both outbreak and non-outbreak situations.  
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Figure 2. 1 Forest plot of seroprevalence of C. burnetii among abattoirs and slaughterhouse workers in 19 
included studies stratified by outbreak status.  
Note: CFT = Complement Fixation Test, IFA = Immunofluorescence Assay, and ELISA = Enzyme-Linked 
Immunosorbent Assay. Also, ES(95% CI) refers to the seroprevalence point estimate (ES) with 95% CI. P=p-
value and I2 describes the proportion of total variation attributable to heterogeneity. 
 
Table 2. 1 Table Mixed-effects meta-regression model results on the seroprevalence of Q fever in abattoir and 
slaughterhouses.  
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Source of 
variation 
Category  
Estimate 
 
SE 
 
Z 
 
P-value 
95% CI  
I2 
 
R2 Lower Upper 
Outbreak  Intercept 0.27 0.09 3.05 0.00 0.10 0.45 99.06% 0.02% 
Outbreak 0.01 0.11 0.08 0.94 -0.21 0.23 
Diagnosis 
method 
Intercept 0.18 0.12 1.57 0.12 -0.05 0.41 98.90% 26.86% 
CFT 0.01 0.14 0.06 0.96 -0.26 0.27 
ELISA 0.22 0.16 1.40 0.16 -0.09 0.52 
IFA 0.30 0.17 1.78 0.08 -0.03 0.62 
Mixed-Effects Model (k = 19; tau^2 (estimated amount of residual heterogeneity) estimator: ML (Maximum 
Likelihood)). I^2 (residual heterogeneity / unaccounted variability). R^2 (amount of heterogeneity accounted 
for).  
There was significant heterogeneity from year to year between 1962 and 2016 both during outbreak (I2 = 
94.88%, p-value = 0.000) and non-outbreak situations (I2 = 97.69%, p-value = 0.000) (Figure 2.2). 
Stratification of the seroprevalences based on year of occurrence did not have a significant effect on the 
seroprevalence estimates or the overall pooled estimate (26%, 95% CI:  17% - 35%), p-value (0.932).  
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Figure 2. 2 Forest plot of the seroprevalence of C. burnetii among abattoirs and slaughterhouse workers 
stratified by year.  
Note that ES(95% CI) refers to the seroprevalence point estimate (ES) with 95% CI. P=p-value and I2 
describes the proportion of total variation attributable to heterogeneity. 
There was significant heterogeneity in the seroprevalence of C. burnetii infection when results were stratified 
by country both during outbreak (I2 = 94.88%, p-value = 0.000) and non-outbreak situations (I2 = 97.69%, p-
value = 0.000) (Figure 2.3). Stratification of the seroprevalences based on the country of occurrence did not 
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have a significant effect on the seroprevalence estimates or the overall pooled estimate (26%, 95% CI:  17% - 
35%), p-value (0.932). 
 
Figure 2. 3 Forest plot of the seroprevalence of C. burnetii among abattoirs and slaughterhouse workers 
stratified by country.  
Note that ES(95% CI) refers to the seroprevalence point estimate (ES) with 95% CI. P=p-value and I2 
describes the proportion of total variation attributable to heterogeneity. 
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Discussion 
Estimates of the seroprevalence studies showed that Q fever is endemic in meat processing industries such as 
abattoirs and slaughterhouses.  The result of the meta-analysis indicated that, the seroprevalence of C. burnetii 
infection remained relatively constant regardless of outbreak status, year and country of occurrence. A strong 
association with the meat industry is confirmed (Garner et al. 1997). This is in accordance with studies that 
have shown that abattoir workers are notable at-risk group for Q fever that are considered to be fully immune to 
the disease (Bell, Patel & Sheridan 1997).  
The overall seroprevalence of C. burnetii (26%) determined in this meta-analysis falls within the range of 
values (30-70%) reported in studies of high-risk groups elsewhere (Aitken et al. 1987). Gilroy et al (2001) 
indicated that up to sixty-eight (66%) of employees in abattoirs are considered susceptible to primary infection 
with C. burnetii (Gilroy et al. 2001). Furthermore, Perez-Trallero et al. showed that more than 86% of 
slaughterhouse workers in one study had evidence of previous infection by C. burnetii using skin testing and 
serology (Perez-Trallero et al. 1995). 
The presence of higher prevalence of Q fever among abattoir workers and those who had minimal contact with 
animals is an indication of presence of pre-existing immunity rather than recent infection (Adesiyun et al. 2011; 
Gilroy et al. 2001). Seroprevalence of C. burnetii in these workers found to be independent of the age, sex, 
race, years of occupational experience or the types of duties performed in the abattoir or in the offices by the 
workers (Adesiyun et al. 2011; Esmaeili et al. 2016; Khalili et al. 2014). Reports of work experience in studies 
conducted among slaughterhouse workers in Spain was shown to be 20± 8 years (mean ± SD) ranging from 4 
to 40 years (Perez-Trallero et al. 1995). Also, in a seroprevalence study in Iran conducted among butchers and 
slaughterhouse workers, the median (minimum, maximum) age and work experience of participants were 33.5 
(18, 86) and 8 (1, 44) years, respectively (Esmaeili et al. 2016). In the study, age (≤ 33.5 years versus > 33.5 
years) and work history (≤ 8 years versus > 8 years) (OR = 1.64, 95% CI: .081, 3.32) showed no association 
with seropositivity for C. burnetii (OR = 1.43, 95% CI: 0.76, 2.86) (Esmaeili et al. 2016). An another serologic 
survey for C. burnetii phase II antibodies among slaughterhouse workers in Kerman, southeast of Iran indicated 
68% positive rate of IgG antibody in the slaughterhouse workers. In the study, there was no significant 
correlation between years of occupational experience and the titers of IgG phase II antibodies. Seropositive 
cases were higher in 31 to 40 years old group, but there were no significant differences in age among the four 
groups (20-30, 31-40, 41-50 and >50) and occupational experience (in years: 1-5, 6-10, 11-20, and >20) 
(Khalili et al. 2014). Consistent evidence was also documented from in a serosurvey among livestock and 
abattoir workers in Trinidad showing that the age, sex and race of workers not to be significantly associated 
with the occurrence of acute Q-fever (P>0.05) (Adesiyun et al. 2011). 
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In addition, the absence of association between seropositivity for C. burnetii and the type of activity within 
abattoirs and slaughterhouses have also been reported (Esmaeili et al. 2016). However, the results of two 
studies (Wilson et al (2010); Marrie and Fraser (1985)) suggest that being male (6.4, 95% CI: 1.8–23.4) has 
increased odds of positive test for C. burnetii (Marrie, T. J. & Fraser 1985; Wilson et al. 2010).  
The greatest risk of infection was associated with working in areas where cattle, sheep and swine are 
slaughtered (Donaghy, Prempeh & Macdonald 2006; McKelvie 1980). Marrie and Fraser (1985) showed that 
slaughtering cattle (working on the kill floor) was a significant risk factor for positive antibody titers among 
slaughterhouse workers (Marrie, T. J. & Fraser 1985). Furthermore, A previous study by Perez-Trallero et al., 
(1995) reported 19.25 higher [OR = 19.25; 95% CI: (5.34, 102.74] odds of Q fever infection for those working 
in slaughterhouses (Perez-Trallero et al. 1995). 
In addition, people who work in other occupations in rural settings and that have contact with animals, 
especially the operators of the livestock industry (veterinarians, tanners, and wool carders) are also at higher 
risk of seropositivity (Khalili et al. 2014; Schimmer et al. 2014).  
One published case control study confirmed the increased odds of Q fever infection associated with increased 
extent of closeness to a slaughterhouse (Armengaud et al. 1997). In addition, another study confirmed presence 
of strong association between Q fever incidence and the degree of closeness to meat processing plant industry 
(Garner et al. 1997). This is in accordance with studies that have shown that abattoir workers are a notable at-
risk group for Q fever (Bell, Patel & Sheridan 1997).  Scottish co-located slaughterhouse and cutting plant 
supported the hypothesis of that places where cattle or sheep rested on their way to slaughterhouses as potential 
source of infection with C. burnetii. Up to three fold odds of being infected as a result of passing through 
walkway by the sheep lairage was reported. (Wilson et al. 2010). Bell, et al (1997) indicated the importance of 
vaccinating workers and work related visitors to abattoirs and slaughterhouses (Bell, Patel & Sheridan 1997).  
Supportive evidence of higher odds of infection with the agent in unvaccinated workers was also evidenced 
from an experimental study (Shapiro, RA et al. 1990). Moreover, Greig et al. (2005) also showed presence of 
higher risk of Q fever among abattoir workers and the need for vaccinating new employees (Greig et al. 2005).  
In summary, the seroprevalence associated with C. burnetii infection ranging from 4.7% to 91.7% among 
abattoir and slaughterhouse workers was reported. From the random effects meta-analysis, seropositivity for C. 
burnetii in abattoirs and slaughterhouses can be expected in more than a quarter of workers (26%; 95% CI: 
17%-35%) regardless of evidence of an outbreak. In addition, seropositivity for C. burnetii is independent of 
age and years of occupational experience in meat abattoir and slaughterhouses but significantly associated with 
activities related to slaughtering of cattle, sheep and goats. Vaccination 10 days prior to exposure to 
environments where C. burnetii may be present was shown to be an effective prevention mechanism.  
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Vaccination programmes for workers in high-risk industries is highly recommended for mitigating the 
incidence of Q fever, and subsequent chronic sufferings and work day offs among abattoir and slaughterhouse 
workers. These results suggest that personal protective equipment, such as fine dust masks (N95), should be 
considered as an adjunct to compulsory Q fever vaccination to protect workers in high-risk occupations. 
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Table 2. 2 Characteristics of studies that included abattoir and slaughterhouse workers. 
 
Author (Year) Outbreak Country Setting Size (n) Seropositive Prevalence (%) Lab Method 
Gilroy (2001) Yes Australia Abattoir 68 29 43 CFT 
Abebe (1990) No Ethiopia Abattoir 465 30 6.5 CFT 
Adesiyun (2011) No Trinidad Abattoir 85 4 4.7 ELISA 
Khalili (2014) No Iran Slaughterhouse 75 51 68 ELISA 
Marrie (1985) No Canada Slaughterhouse 96 12 12.5 CFT 
Esmaeili (2016) No Iran Slaughterhouse 190 43 22.5 ELISA 
Aflatoonian (2014) No Iran Slaughterhouse 64 5 7.8 ELISA 
Perez-Trallero (1995) No Spain Slaughterhouse 36 33 91.7 IFA 
Berktaş (2011) No Turkey Slaughterhouse 41 27 65.9 ELISA 
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Table 2. 3 Characteristics of studies that included abattoir and slaughterhouse workers (continued). 
 
Author (Year) Outbreak Country Setting Size (n) Seropositive Prevalence (%) Lab Method 
Htwe (1993) No Japan Abattoir 107 12 11.2 IFA 
CDC (1986) Yes USA Abattoir 42 19 45.2 CFT 
Beech (1962) Yes Australia Abattoir 516 50 9.7 CFT 
Schnurrenberger (1966) No USA Abattoir 2,091 104 5 CFT 
Schonell (1966) No UK Abattoir 96 21 28.1 CFT 
Riemann (1975) No Brazil Abattoir 144 42 29 Agglutination 
McKelvie (1980) Yes Australia Abattoir 139 22 15.8 CFT 
CDNANZ (1998) Yes Australia Abattoir 100 18 18 CFT 
Donaghy (2006) Yes UK Abattoir 228 49 21.5 NA 
Wilson (2010) Yes UK Slaughterhouse 179 75 41.9 IFA 
Berktaş (2011) No Turkey Butcher house 77 33 42.9 ELISA 
Note: CFT = Complement Fixation Test, IFA = Immunofluorescence Assay, and ELISA = Enzyme-Linked Immunosorbent Assay. NA refers to Not 
Available.  
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Table 2. 4 PubMed Search Strategy: Articles search history and strategy for abattoirs and slaughterhouse 
workers. 
 
Search Query Items found 
#12 Search (((q fever) OR coxiella burnetii)) AND (((((((seroprevalence) OR 
seroepidemiology) OR serology) OR serological) OR prevalence) OR incidence) 
OR epidemiology) 
2864 
#11 Search ((((((seroprevalence) OR seroepidemiology) OR serology) OR serological) 
OR prevalence) OR incidence) OR epidemiology 
2745738 
#10 Search (q fever) OR coxiella burnetii 5865 
#9 Search epidemiology 1970371 
#8 Search incidence 2343722 
#7 Search prevalence 2189454 
#6 Search serological 56243 
#5 Search serology 194892 
#4 Search seroepidemiology 1336 
#3 Search seroprevalence 25616 
#2 Search coxiella burnetii 3157 
#1 Search q fever 4994 
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Table 2. 5 MEDLIN-EMBASE search history: Articles search history and strategy for abattoirs and 
slaughterhouse workers. 
 
No. Query Results 
#11 'q fever'/exp OR 'coxiella burnetii'/exp AND ('seroprevalence'/exp OR 
'seroepidemiology'/exp OR 'serology'/exp OR 'prevalence'/exp OR 'incidence'/exp 
OR 'epidemiology'/exp) 
2,246 
#10 'seroprevalence'/exp OR 'seroepidemiology'/exp OR 'serology'/exp OR 
'prevalence'/exp OR 'incidence'/exp OR 'epidemiology'/exp 
2,687,691 
#9 'q fever'/exp OR 'coxiella burnetii'/exp 6,631 
#8 'epidemiology'/exp 2,514,169 
#7 'incidence'/exp 313,776 
#6 'prevalence'/exp 520,913 
#5 'serology'/exp 202,792 
#4 'seroepidemiology'/exp 2,906 
#3 'seroprevalence'/exp 15,639 
#2 'coxiella burnetii'/exp 3,640 
#1 'q fever'/exp 5,152 
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File 1. Scopus Search Strategy [from Health and Life Sciences Subject Areas]. Articles search history 
and strategy for abattoirs and slaughterhouse workers. 
( TITLE-ABS-KEY ( q  fever )  OR  TITLE-ABS-KEY ( coxiella  burnetii )  AND  TITLE-ABS-
KEY ( seroprevalence )  OR  TITLE-ABS-KEY ( seroepidemiology )  OR  TITLE-ABS-
KEY ( serology )  OR  TITLE-ABS-KEY ( serological )  OR  TITLE-ABS-KEY ( prevalence )  OR  
TITLE-ABS-KEY ( incidence )  OR  TITLE-ABS-KEY ( epidemiology ) )  AND  
SUBJAREA ( mult  OR  agri  OR  bioc  OR  immu  OR  neur  OR  phar  OR  mult  OR  medi  OR  
nurs  OR  vete  OR  dent  OR  heal )  
File 2. Metaprop Stata Package for Running the Meta-Analysis 
Details on Stata Package metaprop is described elsewhere (Nyaga, Arbyn & Aerts 2014). 
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Diagram showing the result of the systematic search  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 4 Search strategy decision tree 
A total of 7110 articles were found from PubMed (2864), MEDLINE - EMBASE (2246) and Scopus 
(2000) databases. See Tables 2.2 and 2.3, supporting Files 1 and 2, and Figure 2.4 for detailed search 
histories and strategies. After removing duplicated articles, 4685 articles were found and further 
refinement using title and abstract skimming, a total of 185 researches have retained. Finally, a total 
of 19 studies which fulfil the eligibility criteria were included in the meta-analysis.  
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CHAPTER 3: Q fever vaccine failure rate, duration of immunity and associated demographic factors 
in Queensland, Australia, 1991-2016 
Background 
Q fever is an acute febrile illness that may be associated with chronic sequelae such as endocarditis 
and chronic fatigue syndrome (CFS) (Angelakis & Raoult 2010; Chiu & Durrheim 2007; Gunaratnam 
et al. 2014; Hartzell et al. 2008; Marrie, Thomas J. & Raoult 2015; Parker, NR, Barralet & Bell 2006; 
Raoult, Marrie & Mege 2005). It is most common in occupational groups exposed to livestock 
through husbandry and meat processing environments (Irwin, Massey & Durrheim 2009) where 
infection with C. burnetii occurs via aerosols (Aguirre Errasti et al. 1984; Anderson et al. 2005; 
Tissot-Dupont et al. 2004; Tissot-Dupont & Raoult 2008).   
In Australia, prevention from Q fever infection is through vaccination of groups at high risk of Q 
fever (Gidding et al. 2009; Parker, NR, Barralet & Bell 2006) especially in those working in the meat 
industry using Q fever vaccine (Q-VAX®) (Seqirus Australia), which has been shown to be effective 
and provide long lasting immunity (Maurin & Raoult 1999). Vaccine protective efficacy has been 
shown to last for at least 5 years and a range of 83–100% protective efficacy has been demonstrated 
(Chiu & Durrheim 2007).  
The use of Q-VAX® requires the demonstration that an individual has not been previously exposed to 
C. burnetii prior to administration (Gilroy et al. 2001; Marmion, B et al. 2005) to avoid the associated 
with risk of severe local adverse reactions at the vaccine site (Marmion, BP et al. 1984; Marmion, BP 
et al. 1990).  Therefore, current Q fever vaccination protocols require pre-vaccination screening to 
rule out previous immunity as a result of exposure to C. burnetii (Gidding et al. 2009). This typically 
involves consultation with a suitably trained medical practitioner, an intradermal skin test and a 
serological assay to detect anti-C. burnetii antibodies, which requires a minimum of two visits 
conducted seven days apart.   
The incidence of Q fever remains high in people working in high risk industries such as abattoirs, 
which are considered to be fully protected thorough vaccination (Garner et al. 1997; Greig et al. 
2005). The higher incidence in abattoirs could be due to variable vaccine coverage or presence of 
abattoir workers not adhering to the vaccination protocol, which requires the to wait 2 weeks after 
vaccination before entering the workforce. For instance, a sequential analysis in Queensland abattoirs 
showed that there were new cases of Q fever among workers who were not vaccinated (Shapiro, RA 
et al. 1990) confirming presence of unvaccinated workers in abattoirs.  In addition, recent studies have 
reported evidence of vaccine failure.  An analysis of 1,912 notified cases of Q fever in NSW between 
2001 and 2010 showed that 3.52% cases were vaccinated prior to illness (Lowbridge et al. 2012). 
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Furthermore, a recent case series from Victoria, Australia between 1994-2013, confirmed a number of 
vaccine failures (Bond et al. 2017). 
Therefore, the current study sought to estimate the incidence rate of Q fever in vaccinated individuals. 
In addition, the study estimated the length of duration of immunity until first onset of Q fever in 
vaccinated individuals and identified the associated demographic factors. Thereby estimating the Q 
fever vaccine failure rate and duration of immunity it could confer to vaccinated individuals in high-
risk working environment.  
Methods 
Study design 
In order to address the research objectives, a retrospective cohort study with record review based on a 
linked data from three large databases containing information on Q fever was conducted.  Databases 
included the Queensland Health Notifiable Conditions Systems (NOCS), Queensland Hospital 
Admission Patient Data Collection (QHAPDC) and Q fever Vaccination Registry. A retrospective 
cohort study design was formulated within the linked data in order to estimate the duration (in years) 
from vaccination to first onset of Q fever (a proxy to estimate the longevity of immunity of the Q 
fever vaccine) and identify associated factors. Incident Q fever cases (defined as those notified and 
admitted Q fever cases) in vaccinated and unvaccinated individuals were compared. Within the cohort 
study, a nested case-control (NCC) design was used to overcome the rare event effect that would 
occur in our data set from the Q fever Vaccination Register.   
The rare event effect occurs in retrospective cohort studies that focus on rare events in a large cohort, 
such as an infectious disease case, where causal relationships are likely to be weakened by the large 
number of negative events.  This approach has shown to be useful for studies involving populations 
that are defined by specific characteristics, especially disease or vaccination registers, or in a large 
cohort that has been followed prospectively (e.g., an occupational group) (Schoenbach & Rosamond 
2000). Nested case-control design has been used in large epidemiologic studies to investigate the 
temporal relationship of diseases with environmental exposures or biological precursors has been 
evidenced (Ernster 1994; Liu, Lu & Tseng 2010). 
Accordingly, cases were defined as those notified and admitted cases linked to the Q fever 
vaccination registry and the rest of the individuals in the registry that were not notified or admitted 
were considered as controls. A total of 303 linked records were identified from 153,706 Q fever 
vaccination records, 6,218 notified cases and 1,112 admitted cases (see Figure 3.1). They included 
256 notified and 47 hospitalised (not in NOCS) cases of Q fever.  A total of 197 linked cases were 
excluded leaving 106 cases for further analysis.  Cases were excluded as follows: 14 cases that were 
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screening test negative and unvaccinated for which a start date could not be defined, 5 cases with 
onset dates within 14 days of vaccination and 178 cases with an onset date prior to the screening and 
vaccination dates that provided negative date differences.  
Using the principle of sampling for a nested case control design, a total of 424 control samples (4 
controls per case) were randomly drawn from the unlinked (uninfected) records from the Q fever 
Register (see Figures 3.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 1 Diagram showing the linked Q fever data and the flow of sample selection for the study 
from the three databases containing information on Q fever: NOCS, QHAPDC and Q fever 
Vaccination Registry, 1991-2016, Queensland, Australia.  
Vaccinated (N= 133,819) Unvaccinated (N= 19,887) 
Queensland (N = 81,738) 
Q fever Registry, NOCS 
and QHAPDC Linked  
(N = 303) 
 
 
 
A total of 197 linked cases were excluded. The 
197 cases excluded were those with missing pre-
screening test dates (14 cases), onset date within 
14 days (5 cases) of vaccination, individuals who 
were vaccinated after they have been notified or 
admitted because of confirmed Q fever infection 
and individuals without epidemiological 
exposure, with negative screening blood and skin 
tests and who were not vaccinated (178 cases). In 
all cases, exclusion was because of non-
adherence to vaccination protocol.  
 
A total of 106 Q fever 
cases were included  
(n = 106, 18 females and 
88 males) 
Total study size with 1:4 
cases to control 
(n = 530) 
Australian Q fever Registry (N = 153,706) 
(38,004 Females and 115,702 Males) 
 
Q fever cases: 
NOCS (N= 6,218) 
QHAPDC (N = 1,113) 
 
NOCS (N= 256) 
QHAPDC (N= 47) 
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The following working definitions were used in the study:  
Population: Individuals in an occupational group defined in the Q Fever Register for whom Q fever 
vaccination is recommended. These include individuals who work in, or are contractors or visitors to a 
meat processing plant, who work with livestock or wildlife, and others who are considered to have 
contact with a meat processing plant and could be at risk of infection.  
Exposed cohort: Individuals in the Q fever Register who were screening test (serological and/or 
intradermal skin test) – negative and subsequently vaccinated with Q-VAX®.  
Unexposed cohort: Individuals in the Q fever register who were screening test-positive and as a result 
were not vaccinated.  
Outcome (Q fever [A78]): notification of or hospitalization due to Q fever. This definition excludes 
cases of Q fever in individuals who received the vaccine before 15 days as this not considered to be 
vaccine failure (Marmion, BP et al. 1984). 
Based on the definitions above, we considered four possible alternative outcomes:  
1. Vaccinated and subsequently hospitalized due to or notified as a case of Q fever 
2. Vaccinated and not hospitalized due to or notified as a case of Q fever  
3. Unvaccinated and subsequently hospitalized due to or notified as a case of Q fever, and  
4. Unvaccinated and neither hospitalized due to nor notified as a case of Q fever.  
Follow-up 
Follow-up of for all vaccinated and unvaccinated individuals, respectively, began on the day they 
were vaccinated or screened positive for Q fever until December 31, 2016 for NOCs and December 
2015 for QHAPDC. 
Entry to study date 
The entry to study date was considered as either the date of vaccination or date of the screening test in 
individuals shown to be positive on one or more screening tests.  
End of study date 
We assumed right censoring with December 31, 2016 defined as the end of study date. Two outcomes 
are available: 1) duration (in days) from Q fever vaccination or screening test dates to the notification 
of or hospitalization due to Q fever within end of study date (coded as Infected) and 2) duration (in 
days) of staying free from infection when at the study end date (was coded as Uninfected).  
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The duration from date of vaccination or screening test was computed using the difference between 
the onset date recorded in NOCS or the date of hospitalization due to Q fever.  
Primary outcome: the length of duration in years from entry to onset of Q fever or admission to 
hospital due to Q fever.   
Cohort (Open Cohort) Characterization:  
We assumed individuals in the Q fever Register to represent an open cohort since individuals enter to 
the study at variable times based on the vaccination date and screening test-positive dates.  
Censoring Mechanism: 
We assumed right censoring as we have defined end of study as December 31, 2016 as the last time of 
observation and we do know the outcomes of those vaccinated individuals who have not been notified 
under NOCS. Similarly, end of study for QHAPDC is defined as December 31, 2015.  
Denominator 
Follow up time (person time in years) was defined as the sum of years free of Q fever from the date of 
vaccination for those eligible for vaccination and date of positive screening test result for those 
unvaccinated individuals considered immune to C. burnetii.  
Statistical Analysis  
Q-VAX® Failure Rate 
Incidence rate of Q fever was calculated as the sum of new Q fever confirmed cases (notified or 
hospitalized) divided by the total person-years of observation of individuals. The daily Q fever 
incidence rate was computed as the sum of new Q fever cases divided by the total person-days of 
observation of individuals.   
Based on Figure 3.1, the following analyses were performed:  
Analysis approach 1: Compare duration (in years) from vaccination to first onset of Q fever between 
vaccinated indivuduals (n=71,543) and unvaccinated individuals who are screening to be immune for 
Q fever (n=10,195). 
Analysis approach 2: Assess the relationship between demographic factors and vaccination with the 
duration (in years) from vaccination to first onset of Q fever between Q fever infected cases (n=106) 
and uninfected individuals (n=81,632) – full cohort analysis.  
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Since incidence of Q fever in vaccinated indviduals is rare event as is eveident from analysis approach 
1 and 2, a nested case control was emplyed in order to assess the relationship between demographic 
and vaccination with duration (in years) from vaccination to first onset of Q fever.  
Analysis approach 3: Assess the relationship between demographic factors and vaccination with the 
duration (in years) from vaccination to first onset of Q fever between Q fever infected cases (n=106 
controls) and random sample of uninfected individuals (n=424 controls) – a nested case-control 
analysis.  
The Kaplan Meier (KM) life table approach was used to estimate the probability of remaining free 
from Q fever for vaccinated and unvaccinated individuals. Univariate and multivariable Cox 
Proportional Hazard models were fitted to estimate the protective efficacy of the Q-VAX® accounting 
for potential confounding demographic factors.  
Log rank tests were run to compare the distributions of duration (in years) that an individual remained 
free of Q fever infection between vaccinated and unvaccinated individuals. In addition, log rank tests 
were also used to compare the distribution of duration (in years) of Q fever free survival time based 
on their demographic characteristics such as gender, age and occupation groups. We treated 
vaccination as a time-dependent covariate. Univariate and multivariable cox regression models were 
fitted to estimate the protective efficacy of the Q-VAX® accounting for potential confounding 
demographic factors.  
The Cox Proportional Hazard model was represented using the following model formula: 
 ikki XXtt   110 exp)()(  
where, λ0(t) = baseline hazard, β1,…, βk = regression coefficients, Xi1,…, Xik = predictors/factors for 
the ith individual. The hazard ratio (HR) is then: HR= λ(t)/ λ0(t).  
The Cox Proportional Hazard assumption of proportionality of hazard over time was checked using 
the Schoenfeld residuals for each predictor and globally by creating an interaction with log 
transformed time. In addition, plots of the log cumulative hazard function and the Cox-Snell residuals 
against the log transformed time were plotted for graphical assessment of the proportionality of the 
hazard. Also, the proportionality assumption for each of the predictors was checked by assessing the 
significance of the interaction between the log-transformed survival time and the scaled Schoenfeld 
residuals. A plot of the resulting log transformed survival time and the scaled the Schoenfeld residuals 
should be approximately parallel. A global test of proportionality was also assessed.  
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Data management and analysis was done using the statistical package R version 3.3.3 and Rstudio 
which is an integrated development environment (IDE) for R (R Core Team 2017). The R package 
survival is used to run the Cox Proportional hazard model.  
This project was completed with approval from the Medical Research Ethics Committee, University 
of Queensland (protocol number: 2016000696).  Data from NOCS and QHAPDC databases was 
obtained with approval under the Public Health Act (2005) (PHA). Data from the Q Fever 
Vaccination Register was obtained with permission from the Register Technical Advisory Committee. 
Results 
Data on a total of 153,706 individuals from QLD including 38,004 (24.73%) females and 115,702 
(75.27%) males were recorded in the Q fever Vaccination Register between 1991 and 31 December 
2016. Screening tests (serological and skin tests) resulted in 19,460 (12.66%) positive test results with 
134,246 (87.34%) negative results (Table 3.1). A total of 133,819 (87.06%) were vaccinated, while 
19, 887 (12.94%) individuals were not vaccinated.  
A total of 106 (30 vaccinated and 76 unvaccinated) linked Q fever cases from NOCS, QHAPDC and 
the Q fever Registry were considered as cases in the analysis. Eighty three percent of the cases were 
males (88/106) and 17% (18/106) of the cases were females.  Nearly, one third (36/106) of the cases 
were in the age range 25-34 years and 26% (28/106) are in the age range 35-44 years. Eighty five 
percent (90/106) of the cases were employed in a meat processing facility, 7% (7/106) worked with 
livestock or wildlife and 4% (4/106) were contractors and visitors to a meat processing facility. 
Approximately, seventy four percent (78/106) had a positive pre-vaccination screening test result and 
26% (26/106) had a negative result at the time of study entry. More than a quarter of the cases (28%, 
30/106) were vaccinated for Q fever while 72% (76/106) were not vaccinated with Q-VAX® (Table 
3.1).  
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Table 3. 1 Demographic and Q fever vaccination information for individuals from Queensland 
recorded in the Q fever Vaccination Register (1991-2016). Table cells represent counts along with 
percent in brackects.  
Variable Variable categories Uninfected (%) Infected (%) Total 
Sex Female 18,342 (22) 18 (17) 18,360 
Male 63,290 (78) 88 (83) 63,378 
Age 14-24 31,849 (39) 19 (18) 31,868 
25-34 25,000 (31) 38 (36) 25,038 
35-44 13,367 (16) 28 (26) 13,395 
45-54 7,933 (10) 16 (15) 7,949 
55+ 3,482 (4) 5 (5) 3,487 
Job Others 10,027 (12) 5 (5) 10,032 
Contractor or visitor 6,186 (8) 4 (4) 6,190 
Meat workers 59,058 (72) 90 (85) 59,148 
Livestock workers 6,361 (8) 7 (7) 6,368 
GP’s Interpretation of 
Test Results 
Negative 71,299 (87) 28 (26) 71,327 
Positive 10,333 (13) 78 (74) 10,411 
Vaccination Status Unvaccinated 10,119 (12) 76 (72) 10,195 
Vaccinated 71,513 (88) 30 (28) 71,543 
Meat workers = Work in a meat processing plant 
Livestock workers = Work with livestock or wildlife.  
Note: 214 individuals with positive screening test results were vaccinated for Q fever. 
Incidence of Q fever in vaccinated and unvaccinated individuals 
Within the at risk population studied, the overall incidence rate was 16.58 [95% CI: 13.57, 20.05] per 
100,000 person years of follow up. The incidence rates for vaccinated and unvaccinated individuals 
were 5.40 [95% CI: 3.65, 7.72] and 89.50 [95% CI: 70.50, 112.00] per 100,000 person years of follow 
up, respectively. The incidence rates for vaccinated and unvaccinated workers in a meat processing 
plant were 6.57 [95% CI: [4.33, 9.56] and 99.35 [95% CI: 76.34, 127.11] per 100,000 person years of 
follow up, respectively (Table 3.2).  
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Table 3. 2 Annual incidence of Q fever in vaccinated and unvaccinated individuals from Queensland 
recorded in the Q fever Vaccination Register per 100,000 person years of follow up (1991-2016). 
Q fever Status Vaccination 
Status 
Person –Years  Incidence Rate Per 100,000 Person-Years  
[95% CI] 
Cases (n = 30) Vaccinated 554466.60 5.40 [3.65, 7.72] 
Cases (n =76) Unvaccinated 84940.80 89.50 [70.50, 112.00] 
Total (n = 106) Total 639407.40 16.58 [13.57, 20.05] 
Meat workers (n = 51759 vaccinated and n = 7389 unvaccinated) 
Cases (n = 27) Vaccinated 410727.30 6.57 [4.33, 9.56] 
Cases (n =63) Unvaccinated 63411.30 99.35 [76.34, 127.11] 
Total (n = 90) Total 474138.60 18.98 [15.26, 23.33] 
 
Duration (in years) from vaccination to first onset of Q fever (as proxy for longivity of 
immunity) 
From the cohort analysis, the probability of surviving free of Q fever beyond 20 years was 98.9% and 
99.9% for unvaccinated and vaccinated individuals, respectively. As it can be seen from Table 3.3, 46 
(43.40%) of the incident Q fever infections occurred during the first half of the follow up time (in 
years) (Table 3.3).  
Table 3. 3 Life table for estimating duration (in years) from vaccination to first onset of Q fever at 0.5, 
1, 5, 10, 15 and 20 years of follow up for vaccinated and unvaccinated individuals 
Time (t) 
(Years) 
 
Number at risk 
 
Number of event 
Probability of surviving beyond time t  
Unvaccinated Vaccinated 
0.5 80609 46 0.997 1.000 
1.0 77837 13 0.996 1.000 
5.0 54893 34 0.993 1.000 
10.0 28124 9 0.992 1.000 
15.0 3295 2 0.991 0.999 
20.0 632 2 0.988 0.999 
Note: the unvaccinated cohort were pre-vaccination screening positive and hence presumed to be 
immune, and surviving = free from Q fever. Analysis results of the full cohort Q fever Vaccination 
Register data from 1991-2016, Queensland, Australia. 
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Demographic and vaccination factors associated with Q fever free duration (in years) 
There was a statistically significant association between age, the occupation group “Meat workers” 
and vaccination status with the duration between vaccinations to first onset of Q fever (Table 4). The 
highest hazards for Q fever occurrence were observed in individuals aged between 25-34 and 35-44 
compared to the reference age group (15-24 years old). Compared to the reference group, the model-
derived hazard ratio for 25-34 years old and above was 2.06 (95% CI: 1.18, 3.58), for 35-44 was 2.21 
(95% CI: 1.22, 4.01) and for 45-54 years old was 2.20 (95% CI: 1.11, 4.35) (Table 3.4).  
When we see the role of job on the occurrence of Q fever, the hazard for workers in a meat processing 
plant was 2.76 times higher compared to other workers (HR = 2.76, 95% CI: 1.11-6.85). Comparing 
the occurrence of Q fever in vaccinated and unvaccinated individuals, the hazard for vaccinated 
individuals was 93% [HR =0.07, 95%CI: 0.04-0.10] lower compared to unvaccinated individuals (see 
Table 3.4).  
Table 3. 4 Cox proportional hazard model results on demographic and vaccination factors associated 
with the duration (in years) from vaccination to first onset of Q fever, 1991-1999, Queensland, 
Australia (Full Cohort Data) 
Variable Variable Category β Exp(β) SE(β) Z Pr(>|z|) LL UL 
Sex Female(Ref)        
 Male 0.09 1.10 0.26 0.35 0.72 0.66 1.83 
Age 15-24(Ref)        
25-34 0.72 2.06 0.28 2.55 0.01 1.18 3.58 
35-44 0.79 2.21 0.30 2.62 0.01 1.22 4.01 
45-54 0.79 2.20 0.35 2.26 0.02 1.11 4.35 
55+ 0.41 1.50 0.52 0.79 0.43 0.55 4.12 
Job Others(Ref)        
Contractor or visitor 0.11 1.12 0.67 0.17 0.87 0.30 4.17 
Meat workers 1.01 2.76 0.46 2.19 0.03 1.11 6.85 
Livestock workers 0.51 1.66 0.59 0.86 0.39 0.52 5.28 
Vaccination 
Status 
Unvaccinated(Ref)        
Vaccinated -2.73 0.07 0.22 -12.27 < 0.001 0.04 0.10 
β = Cox Regression Coefficient, Exp(β) = Hazard Rate, SE(B) = Standard Error (B), Ref = Reference 
category, n= 81737, number of events= 106, Meat workers = Work in a meat processing plant, 
Livestock workers = Work with livestock or wildlife 
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Socio demographics of Cases and Controls: Nested Case-Control 
With a ratio of 1:4 cases to controls, a total of 424 controls using risk set sampling were used in the 
study (incidence density, 4 controls from the risk set were selected at the same time when a case is 
diagnosed with Q fever). Characteristics of the 106 cases have been described in the result section on 
page 73.  
Among the controls, 79% (333/424) were males and most of them were in the age range 14-24 years 
(29%, 121/424) and in the range 25-34 years (24%, 103/424). Most of the controls (74%, 314/424) 
were workers in a meat processing plant while 8% (34/424) worked with livestock or wildlife and 6% 
(26/424) were reported as a contractor or visitor to a meat processing plant. More than three fourths 
(79%, 335/424) of the controls had a negative screening test result and 21% (89/424) had positive 
screening test results. Eighty five percent of the controls (80%, 338/424) were vaccinated for Q fever 
while 20% (86/424) were unvaccinated with Q-VAX® (Table 3.5).
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TABLE 3. 5 Column percentages of the demographics characteristic of cases and controls for the 
duration of the study between January 1, 1991 and December 31, 2016 
 
Variable 
 
Categories 
Cases Controls  
Total (%) Count (%) Count (%) 
Gender Female        18(17) 91(21) 109 
Male          88(83) 333(79) 421 
Age 14-24         19(18) 121(29) 140 
25-34         35(33) 103(24) 138 
35-44          24(23) 88(21) 112 
45-54          14(13) 45(11) 59 
55+            14(13) 67(16) 81 
Job Others                               5(5) 50(12) 55 
Contractor or visitor  4(4) 26(6) 30 
Meat workers     90(85) 314(74) 404 
Livestock or wildlife workers     7(7) 34(8) 41 
Screening Test Negative           78(74) 89(21) 167 
Positive              28(26) 335(79) 363 
Vaccination Not vaccinated             76(72) 86(20) 162 
Vaccinated            30(28) 338(80) 368 
Meat workers = Work in a meat processing plant, Livestock workers = Work with livestock or wildlife, 
Contractor or visitor = Contractor or visitor to a meat processing plant.  
The life table showed that vaccinated individuals had more than 90% probability of Q fever free time 
exceeding 20 years (Table 3.6).  
Table 3.6 Life/Risk Table for individuals at 0.5, 1, 5, 10, 15 and 20 follow up years after vaccination 
with Q-VAX® and individuals unvaccinated in Queensland (1991-2016).  
   Survival Probability 
Time in Years Number at Risk Number of Events  Unvaccinated Vaccinated 
0.5 484 46 0.792 0.967 
1.0 471 13 0.736 0.957 
5.0 415 34 0.591 0.928 
10.0 317 9 0.551 0.919 
15.0 124 2 0.540 0.916 
20.0 57 2 0.520 0.911 
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Kaplan Meier (KM) survival curves and log rank test 
The Kaplan Meier survival curves for the age, sex and job did not show significant differences in the 
duration of immunity. There were no significant differences in the distribution of duration of 
immunity based on the demographics of the study participants (Table 3.7). The duration of immunity 
was significantly greater in vaccinated compared to unvaccinated/pre-immune individuals.  Similarly, 
statistically significant difference in the duration of immunity between screening test positive and 
negative results was observed. That is screening test positive individuals had lower duration of 
immunity than those test negative and hence vaccinated individuals. The KM survival curves in 
Figure 3.2 shows the presence of large differences in the longevity of immunity between vaccinated 
and unvaccinated individuals.  
Table 3.7 Log Rank test for comparing the distribution of Q fever infection free survival times 
Variable Category N Observed Expected χ2 DF P-value 
Gender Female 106 18 21.1 0.6 1 0.455 
Male 424 88 84.9 
Age  14-24 182 19 37.5 9.3 4 0.054 
25-34 170 38 33.7 
35-44 101 28 20.3 
45-54 56 16 10.5 
55+ 21 5 4.4 
Job Others 33 5 11.88 6.8 3 0.077 
Contract or visitor  53 4 6.47 
Meat workers 401 90 78.97 
Livestock workers 43 7 8.67 
Vaccination Unvaccinated 138 76 22.4 165 1 <0.001 
Vaccinated 392 30 83.6    
N = total sample size, χ2 = Chi-square, DF = Degrees of Freedom, Meat workers = Work in a meat 
processing plant, Livestock workers = Work with livestock or wildlife, Contractor or visitor  = 
Contractor or visitor to a meat processing plant 
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Figure 3. 2 Kaplan Meier survival curves showing the distribution of Q fever infection free survival 
time for vaccination status, gender, age and job variables for at risk population studied between 
January 1, 1991 – 31 December 31, 2016, Queensland, Australia.  
 
In a multivariate analysis, vaccination was found to be statistically significant. The hazard for 
vaccinated individuals was 91% [HR =0.09, 95% CI: 0.05-0.16] lower compared to unvaccinated 
individuals. In addition, meat workers were at greater risk of Q fever (HR= 3.48, 95% CI: 1.09, 
11.14). That is, meat workers 3.48 times at greater risk of Q fever compared to other workers. 
Table 3.8 presents the adjusted multivariable Cox PHM for the duration (in years) from vaccination to 
first onset of Q fever. 
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Table 3.8 Cox proportional hazard model results on demographic and vaccination factors associated 
with the duration (in years) from vaccination to first onset of Q fever, 1991-1999, Queensland, 
Australia (Nested Case-Control) 
       95% CI 
Variable Category Β Exp(β) SE(β) Z P(>|z|) LL UL 
Sex Female (Ref)        
Male -0.06 0.95 0.36 0.15 0.878 0.46 1.93 
Age 15–24 (Ref)        
25-34 0.73 2.08 0.39 1.90 0.057  0.98 4.44 
35-44 0.34 1.41 0.42 0.82 0.412 0.62 3.17 
45-54 0.68 1.97 0.49 1.37 0.171 0.75 5.16 
55+ 0.25 1.28 0.46 0.54 0.590 0.52 3.15 
Job Others (Ref)        
Contractor  0.66 1.93 0.86 0.77 0.441 0.36 10.34 
Meat workers 1.25 3.48 0.59 2.10 0.036 1.09 11.14 
Livestock 
workers 
0.70 2.01 0.72 0.97 0.332 0.49 8.29 
Vaccination Unvaccinated 
(Ref) 
       
 Vaccinated -2.38 0.09 0.29 -8.11 <0.001 0.05 0.16 
β = Cox Regression Coefficient, Exp(β) = Hazard Rate, SE(B) = Standard Error (B), Ref = Reference 
Category, n = 530, number of events = 106, Meat workers = Work in a meat processing plant, 
Livestock workers = Work with livestock or wildlife 
Proportionality assumption and model adequacy for the Cox PHM 
The cox proportional assumption, proportionality of hazard over time, was checked using the 
Schoenfeld residuals for each predictor and globally by creating interaction term with log transformed 
time. There was no evidence of time-varying effects, for the fitted model. See Table 3.9.  
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Table 3.9 Table of correlation coefficients between transformed survival time and the scaled 
Schoenfeld residuals, a chi-square, and the two-sided p-value 
Variables Categories Rho (ρ) χ2 P-Value 
Age 14-24 (Ref)    
25-34                        -0.04353 0.20032 0.654 
35-44                         0.03558 0.14490 0.703 
45-54                        -0.09058 0.92754 0.336 
55+                           -0.03271 0.13146 0.717 
Vaccination Vaccinated               -0.10649 1.35601 0.244 
Job Contractor or visitor             0.00409 0.00186 0.966 
Work in a meat processing plant  -0.10905 1.25704 0.262 
Work with livestock or wildlife  -0.10765 1.22947 0.268 
Global                                   5.99176 0.648 
Note: The column rho is the Pearson product-moment correlation between the scaled Schoenfeld 
residuals and log(time) for each covariate.  A p-value less than 0.05 indicates a violation of the 
proportionality assumption. 
In addition, Figure 3.3 presents plots of the log cumulative hazard function and the Cox-Snell 
residuals against the log transformed time. The log cumulative hazard functions, plot (3.4A.), 
appeared to be parallel showing that the proportionality assumption of the proportional hazard 
assumption was met. Moreover, the cumulative hazard function for the Cox-Snell residuals, plot 
(3.4B.), showed better fitted model to the data.  
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Figure 3. 3 Plots of the log cumulative hazard function against log (time) and the cumulative hazard 
function plot for the Cox-Snell residuals.  
Discussion 
Interpretation of the findings of this study requires the understanding that the at risk population 
consisted of workers in a meat processor and livestock industries, contractors and visitors to abattoirs, 
and others that had contacts directly or indirectly with abattoirs and livestock industries. Of 153,706 
individuals who sought vaccination services (i.e. were recorded in the Q fever vaccination registry) 
between 1991 and December 31, 2016 in Australia, 19,460 (12.66%) had positive screening test 
results and 134,246 (87.34%) had negative results.  The positivity rate is similar to the sero-
prevalence rate in the general population from among residents of the Hunter New England Region of 
NSW (Islam et al. 2011).  In the study, seroprevalence ranging between 6% and 12% (Islam et al. 
2011) was reported within the local government areas (LGAs) studied. 
The use of a nested case control design for this study was used to overcome the rare event effect that 
would occur in our data set from the Q fever Vaccination Register.  The rare event effect occurs in 
retrospective cohort studies that focus on rare events in a large cohort, such as an infectious disease 
case, where causal relationships are likely to be weakened by the large number of negative events 
(Checkoway, Pearce & Kriebel 2007; Johansen et al. 2017).  This approach has shown to be useful for 
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studies involving populations that are defined by specific characteristics, especially disease or 
vaccination registers, or in a large cohort that has been followed prospectively (e.g., an occupational 
group) (Schoenbach & Rosamond 2000). The usefulness of nested case-control design has been 
demonstrated in large epidemiologic studies to investigate the temporal effect of predisposing factors 
for rare events (Ernster 1994; Liu, Lu & Tseng 2010): the relationship between serum cholesterol and 
large bowel cancer (Sidney, Friedman & Hiatt 1986), the relationship between serum organochlorines 
and breast cancer and (Krieger et al. 1994), aspirin use and the associated risk reduction in colon 
cancer (Thun, Namboodiri & Heath 1991).  
The usefulness of the case-control approach to analyse a cohort with time-dependent covariate is also 
illustrated empirically and the gain in relative statistical efficiency in using 4 controls per case was 
indicated (Essebag et al. 2005; Liu, Lu & Tseng 2010). Growing evidence shows that similar results 
can be obtained using case-control analyses as full cohort analysis using cox regression (Essebag et al. 
2005; Liu, Lu & Tseng 2010; Richardson 2004). Moreover, the application of the Cox proportional 
hazard model for case-cohort studies, another variant of case control study design which combines the 
advantage of cohort and case control studies, has been evidenced in a review of published studies 
(Sharp et al. 2014).  
The significantly lower incidence rate in vaccinated individuals compared to unvaccinated individuals 
is substantial evidence that Q-VAX® is a highly effective vaccine.  The incidence of Q fever in 
unvaccinated individuals is similar to the rates observed in an experimental study among abattoirs in 
Queensland during the1980’s that reported the occurrence of Q fever in unvaccinated workers to be 
higher (15/102=14.01%) than vaccinated individuals (none of them develop Q fever) (Shapiro, RA et 
al. 1990).  This suggests that those individuals classified as immune and not vaccinated have a similar 
risk of Q fever as an in-tested and un-vaccinated control group.  This raises the need to determine the 
accuracy of the screening tests used to identify pre-existing immunity (see Chapter 4).  
The overall incidence rate among vaccinated and unvaccinated individuals in this study was 
significantly lower (18.98 [15.26, 23.33]) compared to the results reported by Greig et al. (2005b) that 
reported 45.0 per 1,000 (95% CI: 42.3-47.6) average annual risk of infection among abattoir workers 
over the first 10 years of exposure. This difference may be due to the difference in time periods, study 
design, and populations studied.  For instance, the rate of Q fever infection among individuals who 
underwent pre-vaccination screening, the annual risk of infection was calculated by (exp(rate)-1) 
(Greig et al. 2005). In addition, the study by Greig et al. (2005) did not include data on vaccination 
status of individuals so it is possible that a higher proposition were not immune (Greig et al. 2005).  
This is possible because a recent small study showed that only 25% (2/8) of Q fever cases from one 
abattoir had previously received Q fever vaccination (Lord et al. 2016).  The immune status (i.e. pre-
vaccination screening results) of individuals in this study was not documented.  This is interesting 
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because it is also possible that the current estimate of incidence is an under-representation of the true 
incidence because it is derived from surveillance data, which is known to under-estimate true 
prevalence (Dahlgren, F. Scott, Haberling & McQuiston 2015). 
The results of this study confirmed the presence of unvaccinated (and non-immune) abattoir workers 
and the lack of adhere to vaccination protocols, such as individuals who were being tested after being 
notified as Q fever.  These findings corroborate the results of other studies (Bell, Patel & Sheridan 
1997; Gilroy et al. 2001; Greig et al. 2005).  The use of Q-VAX® is hindered by the need to test for 
evidence of immunity prior to vaccination that requires two visits to a medical practitioner 7 days 
apart.  In addition, a vaccinated individual must be excluded from a high-risk workplace until 2 weeks 
after vaccination to ensure they are immune.   
This is the first study that has been able to empirically calculate the efficacy and duration of immunity 
of Q-VAX®.  The observation that there is more than 93% probability of staying free of Q fever 
infection for more than 20 years following vaccination is evidence of the high efficacy of Q-VAX® 
and confirms the results of previous studies that did not have access to data from the Q fever 
Vaccination registry (Kersh, G.J. et al. 2013).  In addition, the hazard of Q fever infection in 
vaccinated individuals was 0.10 (95% CI: 0.05, 0.16) compared to unvaccinated individuals (i.e., 
vaccinated individuals were 90% less likely to be infected with Q fever) is consistent with study by 
O’Neill, et al. (2014) which showed Q-VAX® to be highly efficacious providing 93% protection 
(O'Neill, Sargeant & Poljak 2014).  These efficacy estimates are also in keeping with a systematic 
review that determine that vaccine efficacy ranged between 83–100% (Chiu & Durrheim 2007). 
Early follow up studies also confirmed the efficacy of Q-VAX®.  However, these were a short 
duration (5 year) retrospective cohort study (Ackland, Worswick & Marmion 1994), a clinical trial (7 
years) (Marmion, BP et al. 1990) and a shorter experimental study (Shapiro, RA et al. 1990). Whilst 
these studies confirmed the efficacy of the vaccination, they were unable to provide population level 
estimates of the efficacy and duration of immunity.  Furthermore, a review indicated vaccine efficacy 
ranging from 83–100% (Chiu and Durrheim, 2007b). 
Conclusion 
The Q fever vaccine is highly effective and provided more than 90% protective efficacy in individuals 
who had no Q fever exposure upon pre vaccination assessment and who were vaccinated with Q-
VAX®. The incidence of Q fever infection in vaccinated individuals was 5.4 per 100,000 person years 
of follow up. Significant incidence of Q fever was observed in those individuals who were classified 
as positive in pre-screening tests and were considered to have had prior Q fever exposure. In this 
group, the incidence was as high as 89.50 per 100,000 person years of follow up. The overall hazard 
in the study population was 16.58 per 100,000 person years of follow up. The hazard was quite 
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significant in those who worked in the meat processing plants and whose ages fall within the age 
range 45-54 years.  
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CHAPTER 4: Diagnostic accuracy of the Q fever screening tests and determination of the extent of 
exposure to Q fever using Bayesian latent class analysis (BLCA) 
 
Background 
Vaccination with Q-VAX® to prevent Q fever is recommended for people working in high risk 
occupations (livestock industries) or who have exposure to high-risk animal species (wildlife carers).  
Before Q-VAX® can be administered the immune-status of an individual must be determined because 
pre-existing immunity is associated with hypersensitivity reactions to the vaccine (Gidding et al. 
2009; Marmion, BP et al. 1984; Marmion, BP et al. 1990; Schoffelen et al. 2014). 
Although there has been a considerable reduction in the burden of Q fever among high risk groups 
since the introduction of Q-VAX® the reported incidence in Queensland and NSW remains high 
(Lowbridge et al. 2012).  In addition, the incidence of Q fever in unvaccinated individuals (who are 
considered to be immune as a result of the pre-vaccination test) (Marmion, BP et al. 1984; Shapiro, 
RA et al. 1990) suggests that the accuracy of the screening protocol may be less than optimal. Indeed, 
the lack of data on the accuracy (sensitivity and specificity) of pre-vaccination screening tests 
(serology and skin) has been noted in the Australian immunisation handbook (Department of Health 
(Australia) 2015).   
Vaccination for Q fever with Q-VAX® requires mandatory skin and serological tests conducted in 
parallel for ruling out prior exposure to Q fever (Department of Health (Australia) 2015).  The 
protocol specifies that only those individuals who are negative in both tests (i.e. no prior immunity) 
should receive vaccination.  Whilst this approach will improve the confidence in negative result (i.e. 
that no prior immunity exists), it will lead to a number of individuals who are falsely classified as 
immune (i.e. positive in 1 or more test) because testing in parallel increase the false-positive rate 
(Zhou, McClish & Obuchowski 2009).   
There is no agreed reference, or gold-standard test for C. burnetii that can be used to estimate the 
sensitivity and specificity of screening tests.  Bayesian latent class analysis (BLCA) is an approach 
that is increasingly used to determine the accuracy of diagnostic tests in the absence of a gold standard 
test (Agarwal et al. 2013; Bauman et al. 2016; Dendukuri et al. 2012; Girardi et al. 2009; Gonçalves et 
al. 2012; Hartnack et al. 2014; Martinez, E. Z. et al. 2008; Pan-ngum et al. 2013; Pereira et al. 2012; 
Singer et al. 1998).  It is based on the concept of ‘latent variable’; a single unobservable binary 
random variable that classifies individuals into two groups with different prevalence (Girardi et al. 
2009; Qu, Tan & Kutner 1996).  Therefore, this study was designed to determine the accuracy of pre-
vaccination screening tests using BLCA using data from the Q fever vaccination registry that included 
a dichotomous classification of immunity using serological and skin test results.   
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Methods 
Full description of the BLCA and derivation of some of the formula used are provided in Appendix 
4.1.  A brief summary of the method is as follows: 
In order to assess the sensitivity and specify of the serological methods and the skin test used in the 
pre-vaccination test for Q fever, latent class analysis (LCA) was performed (Bermingham et al. 2015; 
Collins & Huynh 2014; Dendukuri & Joseph 2001; Dendukuri et al. 2012; Engel, Backer & Buist 
2010; Hui, S. L. & Walter 1980; Hui, Siu L & Zhou 1998; Menten, Boelaert & Lesaffre 2008; Qu, 
Tan & Kutner 1996) using a Bayesian implementation. Models were constructed and run using R with 
code adapted from (Lewis & Torgerson 2012; Menten, Boelaert & Lesaffre 2008; Tang et al. 2014). 
Each model run included initiations with three chains, each with 10,000 iterations (first 5,000 
discarded), n.thin = 5, n.sims = 3000 iterations saved. Convergence of the chains was assessed using 
the potential scale reduction factor (Rhat), which reaches 1 at convergence.  Model fit was checked 
using deviance information criteria (DIC), which is an estimate of expected predictive error (lower 
deviance is better). 
Rationale and assumption for the diagnostic accuracy study: 
Although Q-VAX® vaccine can help prevent Q fever among people who are at risk of C. burnetii 
infection, administering the vaccine to people who have previously been exposed to this pathogen has 
the potential to induce serious hypersensitivity reactions. To help prevent such reactions from 
occurring, serological and skin tests are conducted to rule out previous immunity for Q fever. 
Therefore, GP are required to interpret the results of pre-vaccination screening and verify the 
following: 
1. Confirm that the potential vaccinees have a negative history of Q fever and Q fever 
vaccination, 
2. Always conduct the recommended pre-vaccination screens, including a blood test and a 
separate skin test, and 
3. Administer the vaccine if a patient has both a negative blood test AND a negative skin 
test (NHMRC 2015). 
Intuitively, within the pre-vaccination screening process, individuals with all tests positive (pattern: 
+Ve, +Ve) are highly likely to be have had the exposure, and those individuals with both tests 
negative (pattern: -Ve, -Ve) are likely to have had no Q fever exposure. For a subject with an 
intermediate pattern, for example, +Ve, -Ve, the situation is less clear. In this situation, the individual 
will be considered sensitised and the decision is do not vaccinate. And, as there were few intermediate 
screening test results, individuals with intermediate results were excluded in this analysis.  
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Furthermore, the individual may show a false positive result on serological test, or false negative 
results on skin test. The probability that an individual with such a pattern of outcomes is truly have the 
exposure will depend on the accuracy of the two tests. If we knew that serological test is highly 
specific, then it would be less likely that the result for serological test will be false positive result. 
Similarly, if we knew that serological test and skin test lack sensitivity, the probability of false 
negative results on serological test and skin test would increase (see Appendix 4.1; Figure 4.1.1). 
Therefore, the basic assumption is that the results of the screening tests are measures, that are subject 
to error, of an underlying true but unknown latent variable; the true Q fever exposure status.  
Our assumption was none of the tests are reference standard and the screening accuracy of the tests 
have not been determined. Moreover, in using a diagnostic test which is not a reference test, getting a 
positive test result for a given individual lead to the concern that how likely the individual is truly 
positive; the predictive positive value of the test (PPV) (Lewis & Torgerson 2012). The PPV depends 
on the underlying true prevalence of disease within the population from which the particular subject 
comes from, the extent of exposure in the environment and frequency of contact to exposure, and 
individual susceptibility to diseases, etc. Therefore, Bayesian latent class analysis (LCMA) is 
performed to estimate the screening tests sensitivities and specificities. 
BLCA for conditionally independent and dependent tests situations were considered in the analysis. 
However, since CFT is based on detection of antibodies and the skin test based on intradermal 
hypersensitivity dependency between the two screening tests was not warranted. And hence, this 
study presents the final analysis results based on the assumption of conditionally independent tests. 
Moreover, various assumptions on the target population were considered in the BLCA. These include 
homogeneous population, heterogeneous populations (such as meat workers, livestock workers, 
visitors/or contractors, and others). 
In order to assess the effect of the prior information on the sensitivity and specificity of the tests, 
sensitivity analysis was conducted using the sensitivity and specificity of ELISA and IFA. The results 
of the sensitivity analysis are summarized in Table 4.9 on page 100. 
This project was completed with approval from the Medical Research Ethics Committee, University 
of Queensland (protocol number: 2016000696).  Data from NOCS and QHAPDC databases was 
obtained with approval under the Public Health Act (2005) (PHA). Data from the Q Fever 
Vaccination Register was obtained with permission from the Register Technical Advisory Committee. 
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Results 
Socio Demographics of Q fever Pre Screening Test and Vaccination Services Users  
More than three quarters (77.5%) of the Q fever pre-screening and vaccination services users were 
male. A total of 39.0% and 31.0% of the service users were, respectively, in the ages 15-24 and 25-34 
years old. The majority (73.0%) of the individuals recorded in the vaccine register were workers from 
abattoirs and the remainder were workers from livestock and wildlife industries, contractors and 
others (Figure 4.1). Of the total individuals recorded in the vaccine register who underwent 
serological and skin test 94.0% had negative serological test results while 90.0% had negative skin 
test results (Table 4.1).  
Table 4. 1 Socio demographics of Q fever pre-screening test service users, 1991-2016, Queensland, 
Australia. 
Variable Name Variable Category Count(n) Percent(n/N) 
Sex Female 17871 22.5 
Male 61543 77.5 
Age 
Mean=30.28    
SD=11.43     
15-24 31073 39 
25-34 24500 31 
35-44 12974 16 
45-54 7614 10 
55-64 2836 4 
65+ 417 1 
Job Others 9773 12 
Contractor or visitor 6042 8 
Work in a meat processing plant 57700 73 
Work with livestock or wildlife 5899 7 
Serological Test Negative 74529 94 
Positive 4885 6 
Skin Test Negative 71390 90 
Positive 8024 10 
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Figure 4.1 Distribution of age, sex and job of the Q fever vaccination service users, 1991-2016, 
Queensland, Australia. 
The age group, sex and employment classification of individuals tested for pre-existing immunity 
using serology and skin tests, and the general practitioners (GPs) interpretation are presented in Table 
4.2.  In general, more males than females were positive in both tests and classified as immune by GPs.  
The proportion of test positive and immune individuals increased with increasing age group.  The 
highest proportion of test-positive and immune individuals was in those working with livestock or 
wildlife followed by works in abattoirs (meat processing plants).   
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Figure 4.2 The distribution of serology and skin test results, and the general practitioner (GP) 
interpretation, 1991-2016, Queensland, Australia 
Of the total serology results, 4.0% (738) of females and 7.0% (4147) of males had positive test results.  
The proportion of positive serology results increased with increasing age, and the maximum positive 
serology test result (14.0%) was observed in the age range 65 years old and above. The highest 
proportion of positive skin test result was observed in those livestock or wildlife workers (13.0%) 
followed by contractors and visitors (11.0%) (Table 4.2).  
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Table 4. 2 The distribution of Q fever serology and skin test results, and the general practitioners 
(GP)  interpretation, 1991-2016, Queensland, Australia 
Variable 
Name          
Variable Category Test 
Result 
Serology Skin GP 
N (%) N (%) N (%) 
Sex Female Negative 17133(96) 16728(94) 16400(92) 
Positive 738(4) 1143(6) 1471(8) 
Male Negative 57396(93) 54662(89) 53259(87) 
Positive 4147(7) 6881(11) 8284(13) 
Age 15-24 Negative 30077(97) 29039(93) 28617(92) 
Positive 996(3) 2034(7) 2456(8) 
25-34 Negative 23046(94) 22084(90) 21573(88) 
Positive 1454(6) 2416(10) 2927(12) 
35-44 Negative 11784(91) 11119(86) 10720(83) 
Positive 1190(9) 1855(14) 2254(17) 
45-54 Negative 6806(89) 6462(85) 6198(81) 
Positive 808(11) 1152(15) 1416(19) 
55-64 Negative 2456(87) 2341(83) 2227(79) 
Positive 380(13) 495(17) 609(21) 
65+ Negative 360(86) 345(83) 324(78) 
Positive 57(14) 72(17) 93(22) 
Job Others Negative 9368(96) 9023(92) 8854(91) 
Positive 405(4) 750(8) 919(9) 
Contractor or visitor Negative 5737(95) 5361(89) 5243(87) 
Positive 305(5) 681(11) 799(13) 
Meat workers Negative 54034(94) 51850(90) 50589(88) 
Positive 3666(6) 5850(10) 7111(12) 
Livestock or wildlife workers Negative 5390(91) 5156(87) 4973(84) 
Positive 509(9) 743(13) 926(16) 
 
Six percent (6.0%) of females and 11.0% of males had positive skin test results. Positive skin test 
results increased with increasing age, and the maximum positive skin test result (17.0%) was observed 
in the age range 54-64 and 65 years old and above. The highest proportion of positive skin test result 
was observed in those livestock or wildlife workers (13.0%) followed by contractors and visitors 
(11.0%). General practitioners’ interpretation of test results described 8.0% of females and 13.0% of 
males as positive. General practitioners’ interpretation of test results as positive increased with 
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increase in age from 8.0% in the age range 15-24 years old to 22.0% in those aged 65 years old and 
above. The distribution of general practitioners’ interpretation of test results for the occupation groups 
also showed that the highest proportion of positive test result to be in those livestock or wildlife 
workers (16.0%) followed by contractors and visitors (13.0%) (see Table 4.2).  
Pre-vaccination screening tests agreement 
Only 40.2% of the time, serological and skin tests provide pairwise positive test results and 97.7% of 
the time the two tests provide pairwise negative test results. Approximately 99.0% of the time, health 
workers’ interpretation was positive if either the serological or skin test result was positive. However, 
health workers’ interpretation of test results as negative was 97.6% if the result of the skin test was 
negative and it was only 93.5% for a negative serological test result. When we see misclassification of 
test results by health workers, they would interpret as positive 2.5% of negative serological test results 
and 6.6% of a negative skin test result (see Table 4.3). 
Table 4. 3 Cross-tabulation of serology and skin test results, and general practitioners (GPs) 
interpretation, 1991-2016, Queensland, Australia. 
 Serology Test Result GPs Interpretation 
Positive 
(%) 
Negative 
(%) 
Positive 
(%) 
Negative 
(%) 
Positive 
(%) 
Negative 
(%) 
Skin Test 
Result 
Positive 3224 
(40.18) 
4800 
(59.82) 
8008   
(99.80) 
16      
(0.20) 
  
Negative 1661 
(2.33) 
69729 
(97.67) 
1747     
(2.45) 
69643 
(97.55) 
  
Serology 
Test Result 
Positive     4873 
(99.75) 
12  
(0.25) 
Negative     4882 
(6.55) 
69647 
(93.45) 
Note: This table presents aggregated data of serology and skin test results for individuals recorded in 
the vaccination register cross-classified in a contingency table.  
There was moderate agreement (0.46) between the results of the serology and skin tests using Cohen’s 
kappa and the Bayesian approach. The agreement between skin test and serology results and GPs 
interpretation of the test results were high (0.88) and moderate (0.63) respectively (Table 4.4).  
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Table 4. 4 Cohen’s Kappa estimates for serology and skin test results, and the general practitioners 
(GPs) interpretation, 1991-2016, Queensland, Australia 
  
 
Bayesian Approach 
Classical Approach (Fleiss, Cohen and Everitt 
weight similarities (Fleiss, Levin & Paik 2004; 
Hallgren 2012)) 
Serological Test GPs Interpretation 
Serological 
Test  
GPs 
Interpretation 
 
LL 
 
Estimate 
 
UL 
 
LL 
 
Estimate 
 
UL 
Skin Test  0.46 0.89 0.4
5 
0.46   0.47 0.88      0.89   0.89 
Serologica
l Test 
 0.64    0.63 0.64 0.65 
 
 
Table 4. 5 Serology and skin test results for the 4 sub populations Bayesian latent class model 
Job Category (++)=(11) (+-)=(10) (-+)=(01) (--)=(00)  
Workers in a meat processing plant 2446 (41.81) 1220 (2.35) 3404 (58.19) 50630 (97.65) 
Livestock or wildlife workers  330 (44.41) 179 (3.47) 413 (55.59) 4977 (96.53) 
Contractors or visitors  201 (29.52) 104 (1.94) 480 (70.48) 5257 (98.06) 
Others 247 (32.93) 158 (1.75) 503 (67.07) 8865 (98.25) 
Note: Table 4.5 presents the cross-tabulated data from the serology and skin test results of individuals 
recorded in the vaccination register stratified by employment classification. The order of appearance 
of test results: Serological Test Result, Skin Test result (Hence, 11 = number of individuals with both 
serological and skin test results positive) and 1 line for each subpopulation.  
Sensitivity, Specificity, PPV, NPV and the estimated true Q fever exposure (immunity) 
prevalence 
The results of the BLCA are summarised in Table 4.6.  The posterior means of the sensitivity of 
serology and skin tests, respectively, were found to be 67.3% and 77.0%. The posterior means of the 
specificity of serological and skin test, respectively, were found to be 99.0% and 95.6%. The mean 
posterior predictive positive values for serological and skin tests were, respectively, 85.0% and 
59.7%. The mean posterior predictive negative values for serological and skin tests were, respectively, 
97.2% and 98.0%. There was no significant difference in the posterior estimates of the mean 
sensitivity and NPV of serology and skin tests (i.e. overlapping CIs).   
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The posterior of the mean specificity and PPV were significantly higher for serology compared to the 
skin test (i.e. non-overlapping CIs). The posterior mean of the true latent Q fever prevalence was 
7.9%.  
Table 4. 6 The prevalence of Q fever exposure, sensitivity (Se), specificity (Sp), negative predictive 
value (NPV), positive predictive value (PPV) of serological and skin tests, and the credible intervals 
(CI), 1991-2016, Queensland, Australia 
   95% CI   
Parameter Mean SD LL UL Rhat n.eff 
Sp1 0.990 0.003 0.984 0.997 1.010 270 
Sp2 0.956 0.007 0.945 0.971 1.007 3000 
npv1 0.972 0.009 0.952 0.987 1.005 3000 
npv2 0.980 0.006 0.968 0.989 1.004 520 
ppv1 0.850 0.051 0.758 0.952 1.009 280 
ppv2 0.597 0.066 0.490 0.744 1.005 3000 
Pr 0.079 0.010 0.062 0.100 1.003 1500 
Se1 0.673 0.071 0.536 0.805 1.006 3000 
Se2 0.770 0.043 0.690 0.856 1.008 290 
deviance  78585.567 2.476 78582.787 78592.055 1.000 1 
Sp1 = Specificity of Serological Test, Sp2 = Specificity of Skin Test, Se1 = Sensitivity of Serological 
Test, Se2 = Sensitivity of Skin Test, npv1 = Negative Predictive Value of Serological Test, npv2 = 
Negative Predictive Value of Skin Test, ppv1 = Positive Predictive Value of Serological Test, ppv1 = 
Positive Predictive Value of Skin Test, pr = Prevalence of the Latent True Q fever Exposure, Mean = 
Vector of Posterior Mean, SD = Vector of Posterior SD, 2.5% = 2.5th Percentile of the Posterior 
Means, 25% = 25th Percentile of the Posterior Means, 50% = 50th Percentile of the Posterior Means, 
75% = 75th Percentile of the Posterior Means, 97.5% = 97.5th Percentile of the Posterior Means. For 
each parameter, n.eff is a crude measure of effective sample size, and Rhat is the potential scale 
reduction factor (at convergence, Rhat=1). SD = Standard Deviation, CI = Credible Interval. 
Estimated sensitivity and specificity of serology and skin test to detect prior exposure to Coxiella 
burnetii assuming homogenous test accuracy for the four employment categories of workers in 
meat processing plants. 
The results of the BCLA using data stratified by employment category assuming the accuracy of the 
tests vary in workers in each employment category in meat processing plants are presented in Table 
4.7.  The result shows that there were small but not significant differences in sensitivities, 
specificities, and the prevalence of Q fever exposure among the four populations. And the results are 
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similar to that of the analysis presented in Table 4.7 that assumes homogenous population. Moreover, 
there were small but not significant differences in the posterior means of the extent of the true latent Q 
fever exposure prevalence in the four job categories was observed (i.e., overlapping CIs) (see Table 
4.7).  
Table 4. 7 The Sensitivity, specificity, negative predictive value (NPV), positive predictive value 
(PPV) of serology and skin tests, and the estimated prevalence of Q fever exposure among workers in 
a meat processing plant, 1991-2016, Queensland, Australia.  
   95% CI   
Parameters Mean SD LL UL Rhat n.eff 
Se1 0.646 0.051 0.552 0.751 1.062 37 
Se2 0.734 0.026 0.686 0.787 1.010 240 
Sp1 0.993 0.002 0.988 0.997 1.011 210 
Sp2 0.958 0.005 0.949 0.969 1.062 38 
npv1C 0.969 0.008 0.950 0.983 1.067 36 
npv1L 0.951 0.011 0.929 0.971 1.063 38 
npv1M 0.966 0.007 0.950 0.980 1.066 36 
npv1O 0.980 0.005 0.969 0.989 1.068 36 
npv2C 0.976 0.005 0.966 0.984 1.046 53 
npv2L 0.962 0.006 0.950 0.974 1.031 77 
npv2M 0.974 0.004 0.965 0.982 1.036 66 
npv2O 0.984 0.003 0.978 0.990 1.041 62 
ppv1C 0.887 0.035 0.816 0.955 1.015 150 
ppv1L 0.927 0.023 0.878 0.970 1.010 230 
ppv1M 0.896 0.032 0.831 0.957 1.011 200 
ppv1O 0.834 0.050 0.736 0.932 1.013 180 
ppv2C 0.606 0.060 0.492 0.727 1.059 39 
ppv2L 0.712 0.043 0.630 0.799 1.056 41 
ppv2M 0.628 0.049 0.537 0.729 1.061 38 
ppv2O 0.497 0.058 0.396 0.625 1.062 38 
pr[1] 0.088 0.008 0.073 0.104 1.059 39 
pr[2] 0.124 0.011 0.103 0.146 1.045 50 
pr[3] 0.081 0.011 0.062 0.104 1.055 41 
pr[4] 0.053 0.007 0.042 0.067 1.053 44 
deviance    154.875 3.726 149.408 163.573 1.001 3000 
Analysis History: 3 chains, each with 10000 iterations (first 5000 discarded), n.thin = 5, n.sims = 
3000 iterations saved. For each parameter, n.eff is a crude measure of effective sample size, and Rhat 
is the potential scale reduction factor (at convergence, Rhat=1). For each parameter, n.eff is a crude 
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measure of effective sample size, and Rhat is the potential scale reduction factor (at convergence, 
Rhat=1). 
DIC info (using the rule, pD = var(deviance)/2), pD = 7.0 and DIC = 161.9 
DIC is an estimate of expected predictive error (lower deviance is better). 
Sp1 = Specificity of Serological Test, Sp2 = Specificity of Skin Test, Se1 = Sensitivity of Serological 
Test, Se2 = Sensitivity of Skin Test, npv1 = Negative Predictive Value of Serological Test, npv2 = 
Negative Predictive Value of Skin Test, ppv1 = Positive Predictive Value of Serological Test, ppv1 = 
Positive Predictive Value of Skin Test, pi[1:4] = Prevalence of the Latent True Q fever Exposure, 
se.par2 = sensitivity of parallel tests, sp.par2 = specificity of parallel tests,  
Respectively, ppv1C, ppv1L, ppv1M, ppv1O = positive predicted value of serological test for 
contractor, livestock, meat and other workers.  
Respectively, ppv2C, ppv2L, ppv2M, ppv2O = positive predicted value of skin test for contractor, 
livestock, meat and other workers.  
Respectively, npv1C, npv1L, npv1M, npv1O = negative predicted value of serological test for 
contractor, livestock, meat and other workers.  
Respectively, npv2C, npv2L, npv2M, npv2O = negative predicted value of skin test for contractor, 
livestock, meat and other workers.  
LRNT1 = likelihood ratio test for negative test results for serological test, LRNT2 = likelihood ratio 
test for negative test results for skin test, LRPT1 likelihood ratio test for positive test results for 
serological test, LRPT2 = likelihood ratio test for positive test results for skin test, Mean = Vector of 
Posterior Mean, SD = Vector of Posterior SD, 2.5% = 2.5th Percentile of the Posterior Means, 25% = 
25th Percentile of the Posterior Means, 50% = 50th Percentile of the Posterior Means, 75% = 75th 
Percentile of the Posterior Means, 97.5% = 97.5th Percentile of the Posterior Means, CI = Credible 
Interval. 
Estimated sensitivity and specificity of serology and skin test to detect prior exposure to Coxiella 
burnetii assuming test performance is heterogeneous in each of the four employment categories 
of workers in meat processing plants  
The results of the BCLA using data stratified by employment category assuming the accuracy of the 
tests is not constant in each of the four employment categories of workers in meat processing plants 
are presented in Table 4.8.  Again, the results showed that there were small but not significant 
differences in the sensitivities and specificities of each test, in each employment category.  
In addition, there were small but not significant differences in the posterior means of the extent of the 
true latent Q fever exposure prevalence in the four job categories was observed (i.e., overlapping CIs) 
(see Table 4.8).  
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Table 4. 8 The sensitivity, specificity, negative predictive value (NPV), positive predictive value 
(PPV) of serological and skin tests, and the estimated prevalence of Q fever exposure among workers 
in a meat processing plant, 1991-2016, Queensland, Australia 
   95% CI   
Parameters Mean SD LL UL Rhat n.eff 
Se1Contractor 0.650 0.084 0.481 0.801 1.001 2400 
Se1Livestock 0.664 0.073 0.526 0.806 1.002 1800 
Se1Meat 0.678 0.075 0.532 0.819 1.007 300 
Se1Others 0.669 0.077 0.513 0.814 1.003 2900 
Se2Contractor 0.759 0.047 0.671 0.854 1.003 900 
Se2Livestock 0.754 0.049 0.667 0.853 1.001 3000 
Se2Meat 0.769 0.043 0.694 0.860 1.036 65 
Se2Others 0.744 0.055 0.640 0.849 1.001 2500 
Sp1Contractor 0.991 0.003 0.985 0.997 1.001 2000 
Sp1Livestock 0.985 0.006 0.974 0.995 1.001 3000 
Sp1Meat 0.990 0.003 0.984 0.997 1.033 68 
Sp1Others 0.991 0.003 0.986 0.997 1.002 1200 
Sp2Contractor 0.934 0.008 0.921 0.953 1.001 2200 
Sp2Livestock 0.953 0.011 0.935 0.976 1.002 1700 
Sp2Meat 0.958 0.008 0.946 0.976 1.010 310 
Sp2Others 0.959 0.005 0.950 0.970 1.002 3000 
piContractor 0.067 0.011 0.050 0.093 1.001 3000 
piLivestock 0.111 0.015 0.085 0.144 1.001 3000 
piMeat 0.082 0.011 0.064 0.104 1.023 110 
piOthers 0.051 0.008 0.038 0.068 1.003 1500 
deviance 107.075 5.036 99.264 118.739 1.001 2700 
Analysis History: 3 chains, each with 10000 iterations (first 5000 discarded), n.thin = 5, n.sims = 
3000 iterations saved, mu.vect sd.vect   2.5%     25%     50%     75%   97.5% Rhat n.eff . For each 
parameter, n.eff is a crude measure of effective sample size, and Rhat is the potential scale reduction 
factor (at convergence, Rhat=1). 
DIC info (using the rule, pD = var(deviance)/2) 
pD = 13.2 and DIC = 120.6 
DIC is an estimate of expected predictive error (lower deviance is better). 
Se1Contractor = Sensitivity of Serological Test for Contractors,  
Se1Meat = Sensitivity of Serological Test for Meat Workers,  
Se1Livestock = Sensitivity of Serological Test for Livestock Workers,  
Se1Others = Sensitivity of Serological Test for Other Workers,  
Se2Contractor = Sensitivity of Skin Test for Contractors,  
Se2Meat = Sensitivity of Skin Test for Meat Workers,  
Se2Livestock = Sensitivity of Skin Test for Livestock Workers,  
Se2Others = Sensitivity of Skin Test for Other Workers,  
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Sp1Contractor = Specificity of Serological Test for Contractors,  
Sp1Meat = Specificity of Serological Test for Meat Workers,  
Sp1Livestock = Specificity of Serological Test for Livestock Workers,  
Sp1Others = Specificity of Serological Test for Other Workers,  
Sp2Contractor = Specificity of Skin Test for Contractors,  
Sp2Meat = Specificity of Skin Test for Meat Workers,  
Sp2Livestock = Specificity of Skin Test for Livestock Workers,  
Sp2Others = Specificity of Skin Test for Other Workers,  
pContractor = Prevalence of the Latent True Q fever Exposure among Contractor Workers,  
pLivestock = Prevalence of the Latent True Q fever Exposure among Livestock Workers,  
pMeat = Prevalence of the Latent True Q fever Exposure among Meat Workers,  
pOther = Prevalence of the Latent True Q fever Exposure among Other Workers,  
se.parContractor = sensitivity of parallel tests among contractor workers,  
se.parLivestock = sensitivity of parallel tests among livestock workers 
se.parMeat = sensitivity of parallel tests among meat workers 
se.parOther = sensitivity of parallel tests among other workers 
sp.parContractor = Specificity of parallel tests among contractor workers 
sp.parLivestock = Specificity of parallel tests among livestock workers 
sp.parMeat = Specificity of parallel tests among meat workers 
sp.parOthers = Specificity of parallel tests among other workers 
Mean = Vector of Posterior Mean, SD = Vector of Posterior SD, 2.5% = 2.5th Percentile of the 
Posterior Means, 25% = 25th Percentile of the Posterior Means, 50% = 50th Percentile of the Posterior 
Means, 75% = 75th Percentile of the Posterior Means, 97.5% = 97.5th Percentile of the Posterior 
Means. CI = Credible Interval. 
 
Sensitivity analysis using different informative priors of the sensitivity and specificity of ELISA 
The results of the BCLA using informative priors of the sensitivity and specificity of are presented in 
Table 4.9. The sensitivity analysis results showed that there were small but not marked differences in 
the sensitivities and specificities of each test in using informative priors on the sensitivity and 
specificity of ELISA (see Table 4.9).  
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Table 4. 9 The sensitivity, specificity, negative predictive value (NPV), positive predictive value 
(PPV) of serology and skin tests, and the estimated prevalence of Q fever exposure among workers in 
a meat processing plant, 1991-2016, Queensland, Australia 
   95% CI   
Parameter Mean SD LL UL Rhat n.eff 
Sp1 0.990 0.003 0.983 0.996 1.005 3000 
Sp2 0.955 0.007 0.943 0.970 1.011 260 
npv1 0.974 0.009 0.953 0.989 1.013 240 
npv2 0.981 0.006 0.968 0.991 1.007 1000 
ppv1 0.844 0.053 0.742 0.947 1.005 3000 
ppv2 0.586 0.067 0.476 0.728 1.009 290 
Pr 0.077 0.010 0.059 0.099 1.013 360 
Se1 0.686 0.075 0.546 0.831 1.009 280 
Se2 0.775 0.046 0.693 0.871 1.005 3000 
Deviance 78585.648 2.541 78582.796 78592.009 1.000 1 
Sp1 = Specificity of Serological Test, Sp2 = Specificity of Skin Test, Se1 = Sensitivity of Serological 
Test, Se2 = Sensitivity of Skin Test, npv1 = Negative Predictive Value of Serological Test, npv2 = 
Negative Predictive Value of Skin Test, ppv1 = Positive Predictive Value of Serological Test, ppv1 = 
Positive Predictive Value of Skin Test, pr = Prevalence of the Latent True Q fever Exposure, Mean = 
Vector of Posterior Mean, SD = Vector of Posterior SD, 2.5% = 2.5th Percentile of the Posterior 
Means, 25% = 25th Percentile of the Posterior Means, 50% = 50th Percentile of the Posterior Means, 
75% = 75th Percentile of the Posterior Means, 97.5% = 97.5th Percentile of the Posterior Means. For 
each parameter, n.eff is a crude measure of effective sample size, and Rhat is the potential scale 
reduction factor (at convergence, Rhat=1), CI = Credible Interval 
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Discussion 
The use of BLCA to determine the accuracy of multiple diagnostic tests has been confirmed in studies 
in animal and human health (Agarwal et al. 2013; Bauman et al. 2016; Dendukuri et al. 2012; Girardi 
et al. 2009; Gonçalves et al. 2012; Hartnack et al. 2014; Martinez, E. Z. et al. 2008; Pan-ngum et al. 
2013; Pereira et al. 2012; Singer et al. 1998).  It has been extensively applied to improve diagnosis of 
infectious (Gardner, Greiner & Dubey 2010; Girardi et al. 2009; Limmathurotsakul et al. 2010; 
Limmathurotsakul et al. 2012; Pereira et al. 2012; Schumacher et al. 2016) and chronic (Agarwal et 
al. 2013; Martinez, E. Z. et al. 2008) diseases in the absence of gold standard test.  Lewis and 
Torgerson (2012) demonstrated the benefit of using BLCA to account for diagnostic errors due to 
misclassification in the absence of accurate reference test in multiple infectious disease case studies. 
The impact of misclassification is compounded with multiple diagnostic tests are used together (Lewis 
& Torgerson 2012).  
The application of BLCA in this study was necessary because there is no gold standard test for C. 
burnetii infection and there is evidence that individuals classified as “immune” before vaccination are 
still at risk of infection (see chapter 3).  
The over-representation of young males and employees of meat processing plants in the vaccination 
register was expected because the register was established with funding from the AMPC on behalf of 
the meat processing companies (source: https://www.qfever.org/).  In addition, the majority of 
workers in meat processing plants are male (Greig et al. 2005) less than 40 years of age.  The next 
largest demographic group in the register are livestock and wildlife industries that include workers on 
livestock enterprises (farms) and wildlife carers.  These employment categories are identified in the 
Australian Immunisation Handbook (Australian Technical Advisory Group on Immunisation 
(ATAGI) 2018; NHMRC 2015) because they are the next highest risk category.  Indeed, a descriptive 
study of Q fever cases notified in NSW between 2001 and 2010 reported that agricultural related 
professions as the most commonly reported (52.0%) while only 10.0% constitute those workers 
associated with meat processing industries (10.0%) (Lowbridge et al. 2012).  The lower rate of Q 
fever in meat processing employees reflects the high rate of vaccine coverage in that sector. 
The Australian Immunisation Handbook recommends a number of serology techniques to screen for 
prior immunity to C. burnetii including, Indirect Immunofluorescent Assay (IFA), Enzyme-linked 
Immunosorbent Assays (ELISA) and Complement Fixation Tests (CFT) (Australian Technical 
Advisory Group on Immunisation (ATAGI) 2018; NHMRC 2015). Each is different in terms of the 
test basis and interpretation.  None have been properly validated for use as screening tests to confirm 
the presence of protective antibodies.  This study was limited because data on the specific test used 
was not available.  
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The moderate agreement between serological and skin test was not unexpected given the tests are 
conditionally independent and based on very different immunological mechanisms. Serological tests 
aim to detect antibodies to C. burnetii whilst the skin test detects cell-mediated immunity.  These 
methods detect different arms of the immune response and therefore can’t be expected to provide 
results that are highly correlated.  However, this may increase their usefulness when used in 
combination.   
High agreement between the skin test result and GP classification compared to serological tests 
requires careful interpretation because it forms an important part of the overall classification of 
immune status.  Similar results were described by Greig et al. (2005) who showed ‘fair’ (kappa, κ = 
0.52) agreement between results of tests for immunity (Greig et al. 2005). The overall test agreement 
was higher than the findings from a previous similar study in Victoria in which 7.0% of persons 
screened were positive on both tests while the concordance of both negative screening test results was 
75% (Greig et al. 2005). 
This high level of agreement is also reflected in the higher proportion of individuals recorded in the 
register that were skin –test positive (10%) compared to serologically positive (6%).  Given the use of 
the tests in parallel to determine prior immune status the high agreement of the skin test with the GP 
classification compared to serology would suggest that it is the dominant factor in the classification 
protocol.  Moreover, the overall sensitivity and specificity of this parallel testing protocol is similar to 
that of the skin test on its own, which confers a significantly lower PPV compared to the results from 
using serological tests on their own.   This is a concern given serological tests are the most specific 
and provide an acceptably high PPV that allows greater confidence that a positive test results is most 
likely from an individual with circulating antibodies to C. burnetii.  This is important because the 
results of Chapter 3 showed that mis-classification of pre-existing immunity is a significant risk factor 
for subsequent Q fever notification. Furthermore, serological tests are less complicated to perform and 
are not time bound like the skin test that requires two visits to a medical practitioner 7 days apart 
(Australian Technical Advisory Group on Immunisation (ATAGI) 2018; NHMRC 2015).   
The lower sensitivity observed for serology could be due to the fact that a significant proportion of 
test results are likely to have been generated using the Complement Fixation Test (CFT), which was 
the first serological method for detecting antibodies to C. burnetii.  The repeatability of the CFT may 
be poor because it is subjectively assessed and not standardized between laboratories (Field, P. R. et 
al. 2002). It is also considered to have low sensitivity but high specificity for diagnosis of Q fever 
(Field, P. R. et al. 2002; Peter et al. 1985).  Peter et al. (1985) estimated that it had a 27.0% sensitivity 
and 89.0% specificity during the first week after onset of symptoms, and 61-67% sensitivity and 94-
99.0% specificity between 4th and 6th weeks after onset. 
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The higher sensitivity of ELISA has been described as being more sensitive than both CFT and IFA 
(Maurin & Raoult 1999; Uhaa et al. 1994; Waag et al. 1995). Its capability in detecting both anti-
phase I and II antibodies (detection of Immunoglobulin M) makes ELISA useful in early diagnosis of 
primary Q fever infection and detection of antibodies to confirm pre-existing immunity makes ELISA 
useful in early diagnosis of primary Q fever infection (Döller, Döller & Gerth 1984; Field et al. 2000). 
A more recent investigation of by Wegdam-Blans, et al. (2012) demonstrated that the three 
serological tests to be equally effective in diagnosing acute Q fever within 3 months of start of 
symptoms. However, in follow-up sera, their demonstration showed that more IgG antibodies can be 
detected by IFAT than by ELISA or CFT, making IFAT more suitable for pre-vaccination screening 
programs (Wegdam-Blans, Wielders, et al. 2012). 
This study was not able to explore the relative accuracy of ELISA compared to CFT because the data 
were not available in the Q fever register.  This is an important future study because it is possible that 
the use of ELISA may provide greater sensitivity with high specificity and thus would further improve 
the PPV.   
Misclassification by complement fixation (CF) and skin was shown in previous studies among 
occupationally exposed groups (mainly abattoir workers). For instance, in the study by Casolin 
(1999), of 829 individuals tested, seropositivity was observed in 35 (4.2%) while the skin test showed 
positivity result for Q fever in 51 (6.2%) individuals. In the same study, very low (29.4%) 
seropositivity agreement was observed in those skin test positives (Casolin 1999). In addition, in the 
seroprevalence study by Hutson (2000) using EIA / CF, out of 979 individuals tested, a total of 208 
(21.2%) found to be seropositive while 345 (35.2%) were positive for skin test. Around half (47.8%) 
of the agreement was observed in those skin test positives (Hutson, Deaker & Newland 2000). 
Moreover, in the seroprevalence study by Taylor (2001) using CFT, out of 265 individuals tested, a 
total of 25 (9.4%) found to be seropositive while 42 (15.2%) were positive for skin test. A total of 18 
(42.9%) seropositivity agreements were observed in those skin test positives (Taylor, Hunter & Tan 
2001).  
It is interesting to note that the estimated extent of the true latent Q fever exposure was 7.9%, which is 
consistent with the seropositivity (11-11.7%) observed in a previous studies (Greig et al. 2005).  This 
means that up to 92% of new employees in work places with higher risk of Q fever are not immune 
and remain susceptible to C. burnetii infection.  This re-emphasises the importance of maintaining 
high coverage of vaccination in these populations.  
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Conclusions 
This is the first Australian study to estimate the accuracy of tests to detect immunity to C. burnetii in 
occupationally exposed groups such as abattoir workers. The study confirmed previous findings of 
moderate agreement between screening tests (46.0%) and the low predictive value of history of 
vaccination/exposure (immunity). In addition, the false negative rate was high (33.0% for serological 
test and 23.0% for skin test). The finding that the skin test had poor positive predictive values strongly 
suggests that its usefulness as a screening test for immunity is limited because it is likely to lead to 
mis-classification that leaves individuals at risk of infection.  The need for vaccination in high risk 
occupational settings was confirmed by the observation that up to 92.0% of individuals had no 
evidence of immunity to C. burnetii.  Further follow up research is needed to explore the rate of 
adverse reactions to Q-VAX® and to explore the feasibility of removing the use of the skin test from 
the pre-vaccination screening protocols.   
The results of this study support changes to the Q fever vaccination protocol to require only 
serological testing to confirm the presence of prior immunity to C. burnetii.   
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CHAPTER 5: Factors associated with the incidence of Q fever infection: demographic and 
vaccination status factors 
 
Background 
The incidence of Q fever has declined since the introduction of the Q fever vaccination Q-VAX® and 
its use in a National Q fever Management Program (NQFMP) (Lowbridge et al. 2012).  However, Q 
fever is still relatively prevalent in high risk occupational sectors such as abattoirs especially in New 
South Wales (NSW) and Queensland (Sloan-Gardner et al. 2016). Q fever notifications have 
increased significantly since the end of the NQFMP in 2006 (Sloan-Gardner et al. 2016). 
People who work in close contact with livestock and meat processing industries are traditionally 
considered at increased risk of Q fever (Garner et al. 1997; Marrie, Thomas J. & Raoult 2015).  In 
particular, people residing in rural areas, occupations related to agriculture including shearers, 
graziers, and farmers, and occupations associated with animal slaughtering and working in abattoirs 
(Lowbridge et al. 2012).   
Hence, Q fever is considered an occupational hazard for this group of people.    
There is evidence of a shift occupation in the risk of Q fever in Australia from a review of notification 
from 1993 – 2007 in NSW that showed a significant increase in the proportion of notified cases 
among ‘Farmer/Livestock’ occupation category while significant drop in the proportion of notified 
cases among ‘Abattoir/Meat’ occupation category (Irwin, Massey & Durrheim 2009). There are also 
suggestions that the vaccination policy needs to be revisited to direct vaccination uptake to more 
directly combat risks and the need for more finely tuned vaccination policy was indicated (Massey, P. 
D., Irwin, M. & Durrheim, D. N. 2009).  
There is also anecdotal and published evidence of the incidence of Q fever in people who have been 
vaccinated (Bond et al. 2017; Lowbridge et al. 2012).  Indeed, the results of an analysis of vaccine 
efficacy (Chapter 3) showed a significant number of notified cases of Q fever in vaccinated and 
unvaccinated/pre-immune individuals working in the abattoir industry.  There is a dearth of data on 
risk factors on the incidence of Q fever in vaccinated and unvaccinated individuals. Therefore, we 
designed a case control study within the linked notification, admission and vaccination registry data in 
order to identify socio demographic and vaccination factors.  
Objective 
Assess the relationship between demographic and vaccination factors with the incident Q fever 
infection  
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Identify factors associated with the incidence of Q fever (Q fever notification and hospitalization) in 
vaccinated and unvaccinated individuals.  
Method 
A case-control study design was formulated (refer to Chapter 3 for details of the data sources and 
linkage) witin the linked Q fever data in order to assess the factors associated with incidence of Q 
fever. A total of 81, 738 individuals sought vaccination services for Q fever in Queensland, Australia, 
1991-2016. Majorty of the service users (87.5%, 71,543/81,738) were vaccinated while 12.5% 
(10,195/81,738) were not vaccinated. Of the vaccinated individuals, there were 30 incident cases of Q 
fever, and among the unvaccinated individuals, 76 incident cases were recorded making a total of 106 
incident cases of Q fever within the linked Q fever data. Accordingly, a total of 81,632 (71,513 
vaccinated and 10,119 unvaccinated) individuals who sought vaccination during 1991-2016 remained 
free of Q fever. From the Q fever free individuals, with 4:1 controls to cases ratio, a total of 424 
control samples (4 controls per case) were randomly drawn from the unlinked (uninfected) records in 
the Q fever Register using the principle of survivor sampling (Figures 5.1).  
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 1 Digram showing the incident cases of Q fever in vaccinated and unvaccinated individuals, 
1991-2016, Queensland, Australia.  
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Within the case control framework, we assessed factors associated with the incidence of Q fever. We 
used a case-control study design with data stratified on a dichotomous Q fever status in which notified 
cases (from NOCS) and admitted patients (from QHAPDC) were defined as cases.  Sampling was 
performed by including all “linked cases” and a random sample of four controls per case from the 
unlinked individuals (who remained uninfected with Q fever) from the registry.  Vaccination outcome 
for cases and controls was predicated on pre-vaccination skin and serological test results. An 
individual was vaccinated if both tests are interpreted by a medical practitioner as negative.  
In order to assess the relationship between demographic factors, serological test result, skin test result 
and vaccination with incident Q fever infection, a multivariable logistic regression model was fitted to 
a dataset consisting of Q fever cases (n=106),  and a random sample of uninfected individuals (n=424 
controls).   The aim was to assess the relationhips between demographic and vaccination status and 
the incidence of Q fever infection. Analyses were conducted using univariate and multivariable binary 
logistic regressions. Odds ratios along with 95% confidence intervals were used to assess the strength 
and statistical significances of the observed associations, respectively.  
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 (Kleinbaum 1994). 
The parameters in the model were estimated using the Maximum Likelihood Estimate (MLE). The 
competing models were compared by score test, Likelihood Ratio (LR) test, and Wald’s test. Validity 
of the model was checked through the LR test of Omnibus test of model coefficients, the -2 log 
likelihood statistics, the Hosmer and Lemeshow test, and the validation of predicted probabilities. The 
full model (constant plus explanatory variables) represented a significantly better fit to the data than 
the null model and the model was deemed to provide an adequate fit to the data. 
This project was completed with approval from the Medical Research Ethics Committee, University 
of Queensland (protocol number: 2016000696).  Data from NOCS and QHAPDC databases was 
obtained with approval under the Public Health Act (2005) (PHA). Data from the Q Fever 
Vaccination Register was obtained with permission from the Register Technical Advisory Committee. 
Results 
Demographics characteristics of cases and controls 
The demographic characteristics of the cases and controls are presented in Table 5.1.   Using a ration 
1: 4 cases to controls ratio, a total of 424 controls using survivor sampling were included in the study. 
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Among the controls, 79.0% were males and most of them were in the age range 14-24 years (33.0%) 
and in the range 25-34 years (29.0%). The majority of the controls (73.0%) were workers in a meat 
processing plant while 8.0% worked with livestock or wildlife and 7.0% were recorded as contractor 
or visitor to a meat processing plant. Among cases, 30(28.0%) were vaccinated for Q fever and 76 
(72.0%) were unvaccinated, and in the controls, 62(15.0%) were vaccinated for Q fever and 362 
(85.0%) were unvaccinated. 
Table 5. 1 Column percentages of the demographics characteristic of cases and controls for the 
duration of the study between January 1, 1991 and December 31, 2016,  
   Cases Controls 
Variable Categories Total (%) Count (%) Count (%) 
Gender Female        106 (20) 18  (17) 88  (21) 
Male          424 (80) 88  (83) 336 (79) 
Age 14-24         182 (30) 19  (18) 163  (38) 
25-34         170 (30) 38 (36) 132 (71) 
35-44          95 (18) 28 (26) 73 (17) 
45-54          46 (10) 16 (15) 30 (9) 
55+            21 (12) 5 (5) 16 (4) 
Job Others                               53 (10) 5  (5) 48 (11) 
Contractor or visitor                 33 (6) 4 (4) 29 (7) 
Meat workers     401 (76) 90 (85) 311 (73) 
Livestock workers      43 (8) 7 (7) 36  (8) 
Screening Test Negative           388 (73) 28 (26) 360 (85) 
Positive              142 (27) 78 (74) 64 (15) 
Vaccination Unvaccinated             138 (26) 76 (72) 62 (15) 
Vaccinated            392 (74) 30 (28) 362 (85) 
Contractor or visitor = Contractor or visitor to a meat processing, Meat workers = Work in a meat 
processing plant, Livestock workers = Work with livestock or wildlife 
Multivariable Logistic Regression Model Results on the Incidence of Q fever Infections 
Compared to the reference age 15-24 years old, the odds of Q fever were significantly higher in all 
age groups above 24 years of age (Table 5.2).  The odds of Q fever were not significantly different 
between the age groups older than the reference group.  The odds of Q fever infection among workers 
in the meat processing plant was higher than other workers (OR=13.32; 95% CI: 2.21, 262.14).  The 
odds of Q fever in vaccinated workers was significantly lower compared to unvaccinated workers 
(OR=0.09; 95% CI: 0.02, 0.34).  
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Table 5. 2 Multivariable logistic regression model results on the incidence of Q fever, 1991-2016, 
Queensland, Australia 
Variable 
name 
     Variable Category                                                Estimate Std.
Error 
Z 
value 
Pr(>|z|) Odds 
Ratio 
Lower 
Bound 
Upper 
Bound 
Intercept Null -3.35 1.33 -2.52 0.01 0.04 0.00 0.36 
Age 15-24 (Ref)        
25-34 1.16 0.40 2.87 <0.001 3.18 1.48 7.22 
35-44 1.28 0.44 2.88 <0.001 3.60 1.53 8.79 
45-54 1.55 0.54 2.85 <0.001 4.69 1.61 13.67 
55-64 1.61 0.77 2.08 0.04 5.01 1.02 21.90 
Sex Female (Ref)        
 Male -0.08 0.37 -0.21 0.83 0.93 0.46 1.94 
Job Others (Ref)        
Contractor or visitor  1.19 1.22 0.98 0.33 3.30 0.40 72.17 
Meat workers  2.59 1.11 2.33 0.02 13.32 2.21 262.14 
Livestock workers 1.75 1.23 1.43 0.15 5.76 0.69 127.67 
Serological Positive (Ref)        
 Negative -0.46 0.47 -0.99 0.33 0.63 0.25 1.58 
Skin Positive (Ref)        
 Negative 0.50 0.58 0.87 0.39 1.66 0.53 5.23 
Vaccination Vaccinated -2.40 0.68 -3.56 <0.001 0.09 0.02 0.34 
Ref = Reference Category, n= 106 cases and n= 424 controls, Contractor or visitor = Contractor or 
visitor to a meat processing, Meat workers = Work in a meat processing plant, Livestock workers  = 
Work with livestock or wildlife 
Predicted probabilities on the Incidence of Q fever Infections 
The predicted probability of the incidence of Q fever infection for a male abattoir worker 25-34 years 
old with negative serological and skin test results, and hence vaccinated, was 12.0% while for female 
meat worker with similar characteristics, it was 13.0%. Similarly, the predicted probabilities of the 
incidence of Q fever infection for a male and female abattoir worker 25-34 years old with positive 
serological and skin test results, and hence unvaccinated, was 44.0% and 55.0% higher compared to 
vaccinated abattoir workers (Table 5.3).  
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Table 5. 3 Predicted probabilities of the incidence of Q fever infection, 1991-2016, Queensland, 
Australia 
Age Sex Job Serology Test Skin Test Vaccination Predicted 
probability 
25-34 Male Meat worker Negative Negative Vaccinated 0.12 
25-34 Female Meat worker Negative Negative Vaccinated 0.13 
25-34 Male Meat worker Positive Positive Unvaccinated 1.44 
25-34 Female Meat worker Positive Positive Unvaccinated 1.55 
25-34 Male Livestock worker Negative Negative Vaccinated 0.05 
25-34 Female Livestock worker Negative Negative Vaccinated 0.06 
25-34 Male Livestock worker Positive Positive Unvaccinated 0.62 
25-34 Female Livestock worker Positive Positive Unvaccinated 0.67 
 
Goodness of fit test for the logistic regression 
The Goodness of fit test table indicated adeqauacy of the Logistic regression model (p-value > 0.05) 
(see Table 5.4).  
Table 5.4 Model goodness of fit summary table for the multivariable logistic regression model of the 
incidence of Q fever infection, 1991-2016, Queensland, Australia. 
Model Statistics Logistic 
Model Deviance (Residual Deviance) 323.77 
Residual degrees of freedom 482 
Chi Square  534.181 
P-value 1.00 
 
Receiver Operating Characteristics (ROC) Curve and Area under the Curve (AUC):  
The performance of the model is shown in Figure 5.1. The area under the curve (AUC) of the receiver 
operating characteristics (ROC) curve is a common model performance measurement used to measure 
the classification accuracy of a logistic regression model (Seshan, Gönen & Begg 2013). 
The ROC curve shows the adequacy of the fitted logistic regression model as the curve is away from 
the 45o diagonal line (Figure 5.1). Accordingly, the predictive ability of the model for the incidence of 
Q fever infection was found to be 85.7% (i.e. AUC). 
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Figure 5. 2 ROC curve for predictive performance of the multivariable logistic regression model for 
the incidence of Q fever infection, 1991-2016, Queensland, Australia. 
Discussion 
The observation that there was no significant difference in the association between Q fever and gender 
of individuals in the study population is at odds with the majority of previous published studies.  The 
higher risk of Q fever in males has been identified in a range of studies from different parts of the 
world.  There is strong evidence in previous reports in association with contact with farms and/or 
livestock in (Snedeker & Sikora 2014) and using seroprevalence as an indicator of risk in south west 
Queensland (Parker, N, Robson & Bell 2010). A recent study in Germany also indicated that an 
attributable risk (AR) greater in males [RR = 1.4, 95% CI: 1.1–1.8] (Gilsdorf et al. 2008). Moreover, a 
more recent prospective cohort study from Australia, showed lower risk of (52.0% less likely) Q fever 
in females (HR = 0.48, 95% CI: 0.26–0.88) (Karki et al. 2015). 
In the current study, one possible reason for the lack of statistical significant between genders is that 
the population under study was drawn from the Q fever register that contains individuals that are 
considered immune for Q fever either through previous Q fever exposure or vaccination. The register 
is voluntary and is most heavily populated by meat industry workers who are predominantly adult 
males (source: http://www.health.gov.au/internet/publications/publishing.nsf/Content/cda-
cdi31suppl.htm~cda-cdi31suppl-3.htm~cda-cdi31suppl-3l.htm). The Australian Q Fever Register is 
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owned and funded by Australian Meat Processing Corporation (AMPIC). It is a database to store 
information about the Q fever immune status of people who have agreed to be part of the register. The 
Register is designed to store information on anybody who is at risk of being exposed to Q fever and 
who has agreed to be part of the Register. [https://www.qfever.org/]. It consecutively enrols people 
working in high risk industries avoid getting the disease. A relatively itinerant workforce that does not 
require high levels of skills and education so those registered are not representative of the general 
population.  This bias was managed by ensuring the results of the study were not extrapolated beyond 
the population of registered individuals, or something similar. Therefore, the underlying dataset used 
in these analyses may therefore not be representative of the broader population.     
A total of 39.0% and 31.0% of the individuals recorded in the register were in the ages 15-24 and 25-
34 years old, respectively. This is a younger demographic than a recent study of notified Q fever cases 
in NSW conducted from 2001 to 2010 that found the majority of (75.0% of all notifications) cases 
were men, aged between 40 and 59 years (Lowbridge et al. 2012).  That study showed similar risks 
associated with adults and occupational contact with livestock as a wide range of studies around the 
world (these includes farmers, veterinarians, abattoirs, school students and teachers, inseminators and 
hoof trimmers) (Abe et al. 2001; Alkan et al. 1973; Amitai et al. 2010; Berktaş et al. 2011; Bernard et 
al. 2012; Bosnjak et al. 2010; Cetinkaya et al. 2000; Dal Pozzo et al. 2016; de Rooij et al. 2012; 
Dorko, Kalinova & Pilipcinec 2008; Dorko et al. 2011; Fenga et al. 2015; Valencia et al. 2000; Van 
den Brom et al. 2013; Whitney et al. 2009).  
The observation of the significantly increased odds f Q fever in age groups older than 25 years most 
likely reflects their participation in the workforce and hence higher cumulative risk.  However, the 
results did not demonstrate a significant difference between the older age groups, which is at odds 
with other studies. For instance, the Australian prospective cohort study by Karki et al. (2015) found 
that people aged from 45 to 54 years were less likely to have Q fever compared to  younger age 
groups [HR = 0.39, 95% CI: 0.16 - 0.96] (Karki et al. 2015). In addition, Whelan et al. (2012) showed 
that people 40 - 59 and ≥ 60 years were more likely to have Q fever compared to people < 40 years of 
age [Matched OR = 5.4, 95% CI: 1.9–15.3; OR = 3.8, 95% CI: 1.3 –10.6, respectively] Whelan et al. 
(2012). The results suggest that there is a cumulative risk once in the workforce, i.e. as the risk of Q 
fever increase with age. The lack of difference in odds of Q fever between older age groups in the 
current study may suggest that the population represented by the Register has a more homogenous 
risk compared to the general population.  This is not unexpected because the Register is biased 
towards individuals working within the meat-processing sector.   
The higher odds of Q fever infection among workers in meat processing plants compared to livestock 
workers agrees with published studies using notified cases only. The odds of Q fever infection among 
workers in a meat processing plant in this study was 13.32 [OR=13.32, 95% CI: 2.21, 262.14] times 
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higher than other types of workers. Similar finding that showed the increased odds of Q fever 
infection with increased level of exposure within abattoirs was evidence. In that study, the abattoir 
associated risk of Q fever was shown to be 45.0 per 1,000 (95% CI: 42.3 - 47.6) (Greig et al. 2005).  
In addition, the predicted probability table also shows that livestock workers have a lower probability 
of Q fever infection compared to abattoir workers when compared with other workers such as visitors 
or contractor workers.  This confirms that the overall risk of exposure is lower in livestock workers 
compared to meat workers, despite the emphasis on Q fever vaccination in the latter group.   
Although the findings of this study reflects the characteristics of the population that is covered by the 
Q fever vaccination register, the current finding is in accordance with the findings that Q fever is 
mainly occupational hazard affecting people who work and have close contact with infected animals 
and their products within the livestock and meat industries (Garner et al. 1997; Marrie, Thomas J. & 
Raoult 2015). Bell et al. (1997) has also shown that abattoir workers are notable at-risk group for Q 
fever who should be fully protected from this occupational disease (Bell, Patel & Sheridan 1997). 
Similar changes in the epidemiology of Q fever have also been reported elsewhere (Reller & Dumler 
2015), associated with a hypothesized increase over time in the relative importance of non-abattoir 
contact with livestock, wildlife or feral animals amongst notified cases (Irwin, Massey & Durrheim 
2009).  
This study found out that vaccinated workers to be 91.0% [OR=0.09, 95% CI: 0.02, 0.34] less likely 
to be infected with Q fever than unvaccinated workers. Evidence that unvaccinated individuals are at 
increased risk of Q fever is also documented. For instance, this finding is in line with an experimental 
study conducted in three Queensland abattoirs that showed occurrence of Q fever cases in 
unvaccinated workers (Shapiro, RA et al. 1990). Additional evidence has been provided in several 
previous studies on the effectiveness of the Q fever vaccine. For instance, up to 93.0% protective 
efficacy among abattoir workers was evidenced from a met-analysis (RR = 0.07; 95% CI: 0.02 – 0.22) 
(O'Neill, Sargeant & Poljak 2014). Moreover, in the early study of the vaccine by Marmion et al. 
(1984), around 2.5% (34 cases in 1349) incident cases of Q fever were reported in unvaccinated 
workers (Marmion, BP et al. 1984). A relatively recent study with 8 years follow up indicated a 
seroconversion ranging from 80.0% to 82.0% after vaccination with Q-VAX® (Marmion, BP et al. 
1990). About 83–100% vaccine efficacy has also been reported from a review (Chiu & Durrheim 
2007).  Therefore, this result support the previous observations that vaccination is protective and that 
classification as pre-immune and unvaccinated is a risk factor.  
Despite the fact that our analysis results of the linked data were consistent with that of the existing 
literature the lack of completeness of the enhanced Q fever exposure enhanced data restricted our 
analysis for further evaluation of the role of other Q fever exposure information on the incidence of Q 
fever. Evidence of poor record on the notified cases of Q fever was also shown from a descriptive 
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analysis of Q fever notifications in NSW that showed only 34.0% of records had Q fever vaccination 
status of the notifications recorded and only 55.0% information recorded on occupation (Lowbridge et 
al. 2012). The relative lack of data prevents a confident assessment of causal risk factors.  
Conclusion 
The results of this chapter support the previous observations that vaccination is protective and that 
classification as pre-immune and unvaccinated is a risk factor for Q fever.  Hence, the value of 
vaccinating workers in the meat processing plant was supported and that risk-based Q fever screening 
and vaccination should be enhanced in order to further reduce the incidence of Q fever.  
 117 
 
CHAPTER 6: Rate of Q fever notification and hospitalization, and identification of associated 
factors.  
Background 
Q fever caused by infection with Coxiella burnetii is a zoonotic disease (European Food Safety 
Authority & European Centre for Disease Prevention and Control 2014; Irwin, Massey & Durrheim 
2009; Maurin & Raoult 1999) that is primarily an occupational risk for people working in the 
livestock industry (Khalili et al. 2014; Schimmer et al. 2014).  The largest proportions of reported 
cases of Q fever occur in Queensland (QLD) and New South Wales (NSW) (Garner et al. 1997; 
Gidding et al. 2009; Graves & Islam 2016). The incidence of Q fever has declined since the 
introduction of the Q fever vaccination Q-VAX® and its use in the government-funded National Q 
fever Management Program (NQFMP) (Lowbridge et al. 2012).  However, Q fever is still relatively 
prevalent in high-risk occupational sectors such as abattoirs (Bell, Patel & Sheridan 1997; Garner et 
al. 1997; Khalili et al. 2014; Schimmer et al. 2014) and there is concern that its epidemiology is 
changing with cases occurring in previously unknown risk groups (Irwin, Massey & Durrheim 2009; 
NHMRC 2015). 
A number of demographic and geographic factors have been associated with the occurrence and Q 
fever in Australia.  They largely reflect the gender and age bias in the livestock sector (males>females 
and 25-50 years of age (Garner et al. 1997; Hopper et al. 2016; Marrie, Thomas J. & Raoult 2015), 
and the geographical distribution associated with livestock production and meat processing enterprises 
(outer regional/remote vs inner regional/urban (Karki et al. 2015). 
However, there have been no studies that explored the effectiveness of public health interventions for 
Q fever such as the NQFMP-supported vaccination program and outreach performed by public health 
units that are geographically based.   
There were four important periods in the implementation of the vaccination program (Department of 
Health (Australia), 2015):   
 Period 1 (1991 - 1999): when vaccination was provided to workers in in a small number of 
abattoirs;  
 Period 2 (2000 - 2006): when vaccination coverage expanded to include other abattoirs in a 
number of  states;  
 Period 3 (2007 - 2011): the time of the NQFMP; and  
 Period 4 (post 2011): when individuals have to cover the cost of both pre-vaccination 
screening and vaccination costs.  
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Therefore, this study investigated the associations between the incidence of Q fever and associated 
hospital admission, and demographic factors, geographic location (public health unit area) and 
vaccination program period.  
Objectives 
I. Describe notifications, hospitalization and Q fever vaccination registry data.  
II. Determine the rate of notification and hospitalization, and identification associated with 
demographic factors, PHU location and vaccination program period.  
Methods 
Data 
In order to address the research objectives, Q fever notification (Queensland Health Notifiable 
Conditions Systems - NOCS) data from 1991 to 2016, and Q fever admission data (Queensland 
Hospital Admission Patient Data Collection - QHAPDC) from 2001 to 2015 were used. In addition, 
the estimated residence population of Queensland obtained from the Australian Bureau of Statistics 
which served as the denominator: http://www.abs.gov.au/ausstats/abs@.nsf/mf/3101.0 was used as 
denominator for estimating the respective age, sex and calendar year specific risk of Q fever.  
Statistical analysis 
Descriptive statistics such as frequencies, proportions and data were visualised in order to characterize 
the Q fever notifications, hospitalizations and Q fever vaccination register records.  
The age, sex, and calendar year specific incidence rates of Q fever infection were estimated based on 
the following approach. All reported cases of Q fever were aggregated into specific categories of age, 
sex, and calendar-year that served as numerator for computing the risk. Yearly age and sex matched Q 
fever notification data was combined with the population time series data for Queensland between 
1991 and 2016 to get the Q fever notification rate per 100,000 mid-year population, which is a 
cumulative incidence rate.  
These age, sex and calendar-year specific incidence rates were used to calculate directly age-adjusted 
overall incidence rates using the 1991-2016 sex and age distribution of the Queensland population. In 
addition, sex-adjusted overall incidence rates was computed. Notification and admission calendar-
year were categorized into Q fever vaccination program periods: 1991-1991, 2000-2005 (the start of 
government funded program in limited number of abattoirs), 2006-2011 (the period of the nationally 
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expanded Q fever vaccination program) and 2012-2016 (when the vaccination program become 
private, i.e., when government funding ceased/ended).  
Poisson and Negative Binomial Models on Q fever Notification and Admission  
We fitted a Poisson regression model in order to estimate annual rate of Q fever notifications using an 
offset representing the population at risk.  
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A log-linear relationship between the mean (μ) and the covariate factors was specified with an offset 
option on the right hand side of the equation representing log(n) where  n refers to the population size 
per year (Lee et al. 2012).  
Note. In this thesis report, we used only yearly population size because estimates were not available at 
smaller time intervals and hence yearly notifications, admissions and vaccinations were reported in 
the models that follow.  
Dealing with Overdisperssion 
A Poisson distribution is expected to have an equal mean and variance (Lee et al. 2012; Rpubs 2017). 
This model assumption can be wrong due to overdispersed count data where the variance may be 
larger than the mean. In some cases count data may be underdispersed (variance less than the mean). 
We used quasi-Poisson and negative binomial modeling to allow adjustment of model parameters to 
acount for possible over- or underdispersion and generate value model coefficients. 
This project was completed with approval from the Medical Research Ethics Committee, University 
of Queensland (protocol number: 2016000696). Data from NOCS and QHAPDC databases was 
obtained with approval under the Public Health Act (2005) (PHA). Data from the Q Fever 
Vaccination Register was obtained with permission from the Register Technical Advisory Committee. 
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Results 
Q fever notifications data 
Description of Q fever notifications 
A total of 6,218 Q fever cases were reported between 1991 and 2016 in Queensland, Australia. Of 
these, 78.3% were males and between 15-21.4% of the notifications occurred in the age range 15-45 
years. More than one third (38.3%) of the notifications occurred in the Darling Downs PHU area 
while, respectively, Metro South, Rockhampton, and Townsville accounted for 10.8%, 10.0% and 
10.7% of the remaining notifications. The higher number of reported Q fever notification from 
Darling Downs could be due the presence of most of the abattoirs and slaughterhouses around Darling 
Downs Public Health Unit. According to “Yellow Pages”, there were 8 abattoirs in Darling Downs 
[https://www.yellowpages.com.au/find/abattoirs/darling-downs-qld]. And most of the abattoirs in 
Darling Downs are known for process large number of animals per day.  
Only approximately 50.0% of notifications had Indigenous status recorded and only 3.4% were from 
people who identified as Indigenous. For almost all (98.6%) the country of birth of the notified cases 
was unknown. A significant proportion of the notifications (38.3%) were reported during the 19991-
1999 vaccination period when the uptake of vaccination was relatively low and this figure is followed 
by the 2000-2005 vaccination period accounting for around 27.8% of the notification. See Table 6.1 
and Figure 6.1 for more details.  
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Table 6. 1 Socio demographics of notified cases of Q fever, 1991-2016, Queensland, Australia 
 
Variable  Variable Category Count (N) Percent (n/N) 
Sex Female 1350 21.71 
Male 4868 78.29 
Age 0-14 163 2.62 
15-24 1064 17.11 
25-34 1175 18.9 
35-44 1328 21.36 
45-54 1173 18.86 
55-64 857 13.78 
65-74 334 5.37 
75+ 105 1.69 
<NA> 19 0.31 
Public Health Units Wide Bay 152 2.44 
Cairns 448 7.2 
Darling Downs 2380 38.28 
Gold Coast 164 2.64 
Metro North 282 4.54 
Metro South 670 10.78 
Rockhampton 624 10.04 
Sunshine Coast 350 5.63 
Townsville 665 10.69 
West Moreton 483 7.77 
Indigenous Status Indigenous 213 3.43 
Non Indigenous 2546 40.95 
Not Stated/Unknown 3459 55.63 
Country of Birth Australia and others 57 0.92 
Not Stated 6128 98.55 
Others 33 0.53 
Q fever Vaccination 
Program Period 
1991-1999 2379 38.26 
2000-2005 1731 27.84 
2006-2011 956 15.37 
2012-2016 1152 18.53 
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Only 15.4% of notifications occurred during the government funded vaccination period (2006-2011). 
There was a slight increase in the number of notifications (18.5%) following the end of the 
government-funded NQFMP.  
 
Figure 6. 1 Q fever notification by Sex, Age and Public Health Units, from 1991 to 2016, 
Queensland, Australia 
The proportion of Q fever cases notified within each of the PHU areas remained relatively constant 
across each of the vaccination program periods (Figure 6.2).    
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Figure 6. 2 Q fever notification by vaccination program period and  public health units, from 1991 to 
2016, Queensland, Australia 
 
Q fever notification rate for Queensland  
The annual median notification rate ranged from 3.0 to 12.9 per 100,000 population per year and the 
median notification rate being 5.3 per 100,000 population per year over the 26 years period from 1991 
to 2016. The rate in females was significantly lower compared to males 2.5 per 100,000 per year and 
8.0 per 100,000 per year, respectively.  The maximum notification rates occurred in males and in 
people aged between 25-34 years.  In children 0-14 years, the rate was reported to be from 0.11 to 
1.94 per 100,000 population (Table 6.2 and Figure 6.2). Increasing notifications in children, 
especially, in rural areas could very likely be due exposure to birth products of cattle, sheep and goats 
(Barralet & Parker 2004). A report from Europe showed that most infections in children identified 
during the lamb birthing being a result of farm visits, or after exposure to placentas of dogs, cats, and 
rabbits (Reller & Dumler 2015). It is also highlighted, as many rural children cannot avoid potential 
exposure to Q fever, the need for a safe and effective vaccine for children (Barralet & Parker 2004). 
However, Q fever vaccine is not recommended in children aged <15 years and there are no data on the 
safety or efficacy of Q fever vaccine in this age group (NHMRC 2015).  
Table 6. 2 Average Q fever notification rate per 100,000 midyear populations by age and sex, 1991-
2016, Queensland, Australia 
Variable Name Variable Category Minimum Mean Median Maximum 
Sex Female 1.54 2.74 2.49 5.35 
Male 4.39 10.19 7.96 20.88 
Total 3.03 6.46 5.25 12.85 
Age 0-14 0.11 0.78 0.68 1.94 
15-24 2.05 7.85 5.5 21.5 
25-34 2.49 8.5 6.24 24.43 
35-44 3.36 9.36 7.32 19.05 
45-54 4.39 9.12 8.28 20.34 
55-64 2.69 8.46 8.07 17.89 
65-74 1.42 4.56 4.32 11.4 
75+ 0 1.9 1.49 6.69 
There was no cyclical pattern observed in the notification rate from 1991-2016 (Figure 6.3).  There 
were two peaks in the annual median notification rate in 1993 and during 2000 and 2001. Compared 
to Q fever notification rate in 2001, the notification rate declined significantly following the 
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expansion of the NQFMP to states other than QLD.  Notifications rates continued to decline and 
eventually stabilisied around 4 to 5 annual notification per 100,000 populations per year from 2006 
onwards.  
 
Figure 6. 3 Trend of Q fever notification rate per 100,000 population by sex, age and year, from 1991 
to 2016, Queensland, Australia.  
Negative Binomial model for the Q fever notifications in Queensland 
Table 6.3 presents the age and sex adjusted risk ratio from a negative binomial regression model. As 
can be seen from the model summary, the risk ratio significantly varies for sex, age and vaccination 
program periods. Males were 3.4 times more likely to be a Q fever notification compared to females.  
The risk of Q fever in children 0-14 years old was 89.0% lower than the reference age group 15-24 
years old.  
Compared with the reference age group, 15-24 years old, the risk ratio for the age ranges 35-44, 45-54 
and 55-64, respectively were, 1.4, 1.4, and 1.3. The risk of Q fever was 27.0% and 64.0% lower in the 
age ranges 65-74 and 75+ years old, respectively compared to the reference age group.  
The risk of Q fever was 46.0% lower for the years 2006-2011 and 25.0% lower for the 2012-2016 
vaccination period when the vaccination become private compared to 1991-1999.  
 125 
 
Table 6. 3 Multivariable Negative Binomial regression Model for the annual Q fever notification rate 
with age and sex adjusted populations as offset, 1991-2016, Queensland, Australia.  
Variable Name Variable 
Category 
Estimat
e 
Std. 
Error 
Z value Pr(>|z|) Risk 
Ratio 
95% CI 
LL UL 
(Intercept)  -10.25 0.08 -122.48 <0.001 0.00 0.00 0.00 
Sex Female (Ref)        
 Male 1.23 0.05 22.70 <0.001 3.43 3.08 3.82 
Age 0-14 -2.08 0.12 -17.25 <0.001 0.13 0.10 0.16 
15-24 (Ref)        
25-34 0.13 0.10 1.36 0.18 1.14 0.95 1.37 
35-44 0.30 0.10 3.14 <0.001 1.35 1.12 1.62 
45-54 0.34 0.10 3.55 <0.001 1.40 1.16 1.69 
55-64 0.29 0.10 3.02 <0.001 1.34 1.11 1.63 
65-74 -0.32 0.11 -2.98 <0.001 0.73 0.59 0.90 
75+ -1.10 0.14 -8.12 <0.001 0.34 0.26 0.43 
Vaccination 
Program 
Period 
1991-1999 
(Ref) 
       
2000-2005 0.06 0.07 0.87 0.38 1.06 0.93 1.22 
2006-2011 -0.62 0.07 -8.47 <0.001 0.54 0.46 0.62 
2012-2016  -0.29 0.07 -3.92 <0.001 0.75 0.64 0.87 
Ref = Reference Category 
Goodness of fit test (GOF) for the Possion and Negative Binomial models 
Goodness of fit testing is assessed using residual deviance and degrees of freedom, and if the residual 
deviance is close enough to the residual degrees of freedom, it indicates a good fit. A chi-squared test 
was employed to check the goodness of fit test of the model in which a large p-value means a good fit 
of the data. As it can be seen from Table 6.4, the GOF test indicates that the poisson model does not 
fit the data (p < 0.05). In addition, the extra-poisson variation (represented by the symbol ϕ and 
computed by dividing Pearson's chi-squared by its d.f) confirmed that the variance is proportional 
rather than equal to the mean indicating the problem of overdisperssion. We then fitted a negative 
binomial model which is a recommended model option for overdispersed count data which occurrs 
when the conditional variance is higher than the conditional mean. As it can be seen from the table, 
the residual deviance (approximately equal to 442) is close to the residual degrees of freedom 
(df=404) indicating negative binomial model an adequate fit of the data. Moreover, the GOF test 
confirmed adequacy of the negative binomial model as best fit of the data (p-value > 0.05). The 
ANOVA table (see Table 6.5) provides a summary of the residual deviance and degrees of freedom 
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for each addional of variable in the Possion and negative binomial regression models. The addion of 
more variables resulted in a larger reduction in residual deviance in the negative binomial model than 
the Possion model, supporting the negative binomial model.  
Table 6. 4 Model Goodness of fit summary table for Poisson and negative binomial models on the Q 
fever notification rate, 1991-2016, Queensland, Australia. 
Model Statistics Poisson neg. binomial 
Model Deviance (Residual Deviance) 1487.85 442.217 
Residual degrees of freedom 404 404 
Chi Square  451.87 451.87 
P-value 0.00 0.092 
Extra-Poisson Variation (ϕ) 3.85 5.865 
 
Table 6. 5 ANOVA table for the Poisson and negative binomial models on the Q fever notification 
rate, 1991-2016, Queensland, Australia. 
Model Variable in Model DF Deviance Residual DF Residual Deviance 
Poisson Null   415 6498.0 
Sex 1 2107.39 414 4390.6 
Age 7 2283.41 407 2107.2 
Vaccination Program Period 3 619.36 404 1487.9 
Negative 
Binomial 
Null   415 1810.74 
Sex 1 637.49 414 1173.25 
Age 7 637.24 407 536.01 
Vaccination Program Period 3 93.79 404 442.22 
DF= Degrees of Freedom 
Mean variance relationship for Poisson and negative binomial models with offset  
The Figure 6.4 shows the mean versus the variance and overlays the curves corresponding to the over-
dispersed Poisson model, where the variance is ϕμ, and the negative binomial model, where the 
variance is μ(1+μ/ϕ2). The Poisson variance function does not fit most of the data, and hence fails to 
capture the high variances of in Q fever notifications rate.  
The negative binomial variance function, being a quadratic, can rise faster and does a better job at the 
high end. Therefore, the negative binomial model provides a better description of the data than the 
over-dispersed Poisson model. 
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Figure 6. 4 Mean-variance relationship for the Poisson and Negative Binomial models on the Q fever 
notification rate, 1991-2016, Queensland, Australia. 
Negative binomial model with indigenous status and public health unit area as predictors of Q 
fever 
Further inclusion of other variables (Indigenous status and PHU area) from the notification data into 
regression models provided the model results presented in Table 6.6. The inclusion of more variables 
in the model further adjusts the risk ratio significantly for sex, age and vaccination program periods. 
Males were 1.81 [95% CI: 1.69-1.95] times more likely to be infected than females. The risk of Q 
fever infection in children aged 0-14 years was 66.0% [RR = 0.34, 95% CI: 0.28-0.41] lower 
compared to the reference age group 15-24 years old.  
The effect of age becomes insignificant for the rest of the age ranges except for the age ranges 55-64 
and 75+ years old. Individuals in the age range 55-64 years old were 1.16 [RR=1.16, 95% CI: 1.03-
1.29] times at greater risk of Q fever compared to the individuals in the reference age range and the 
risk for the age range 75+ the risk was 1.28 times higher [RR=1.28, 95% CI: 1.02, 1.60]. 
Non indigenous people and individuals with unknown Indigenous status had significant higher Q 
fever risk compared to people who identified as Indigenous with the risk ratio of 2.20 [95% CI: 1.92-
2.54] and 2.98 [95% CI: 2.60-3.44], respectively  
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The risk ratio for the Darling Downs PHU area was significantly higher (3.67 [95% CI: 3.06-4.42]) 
compared to the Wide Bay PHU area. There was significantly greater risk of Q fever in all of the PHU 
areas, except the Gold Coast, compared to the Wide Bay PHU area. The Townsville, Metro South and 
Rockhampton PHU areas had approximately equal risk of Q fever of ranging from 1.87 to 2.00 
compared with the Wide Bay PHU area. The corresponding risk ratios for Townsville, Metro South 
and Rockhampton, respectively, were of 2.00 [95% CI: 1.64-2.44], 1.94 [95% CI: 1.60-2.37] and 1.87 
[95% CI: 1.54-2.29] in contrast to Wide Bay.  
The risk of Q fever was 16.0% [RR=0.84, 95% CI: 0.77-0.91] lower for the years 2000-2005, 49.0% 
[RR=0.51, 95% CI: 0.46-0.56] lower for the years 2006-2011 and 37.0% [RR=0.63, 95% CI: 0.57-
0.69] lower for the 2012-2016 vaccination period during which the vaccination become private.  
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Table 6. 6 Negative binomial regression model for the annual Q fever notification rate with age and 
sex adjusted populations as offset, 1991-2016, Queensland, Australia.  
Variable Name Variable 
Category 
Estimate SE Z 
value 
P-
Value 
RR 95% CI 
LL UL 
(Intercept)  -13.30 0.13 -
103.48 
0.00 0.00 0.00 0.00 
Sex Female (Ref)        
 Male 0.60 0.04 16.60 <0.001 1.81 1.69 1.95 
Age 0-14 -1.08 0.10 -11.24 <0.001 0.34 0.28 0.41 
15-24(Ref)        
25-34 -0.04 0.05 -0.66 0.51 0.97 0.87 1.07 
35-44 -0.01 0.05 -0.27 0.79 0.99 0.89 1.09 
45-54 -0.01 0.05 -0.20 0.84 0.99 0.89 1.10 
55-64 0.14 0.06 2.56 0.01 1.16 1.03 1.29 
65-74 0.13 0.07 1.81 0.07 1.14 0.99 1.32 
75+ 0.25 0.11 2.18 0.03 1.28 1.02 1.60 
Public Health 
Units 
Wide Bay (Ref)        
Cairns 0.41 0.10 3.91 <0.001 1.50 1.23 1.85 
Darling Downs                     1.30 0.09 13.92 <0.001 3.67 3.06 4.42 
Gold Coast 0.08 0.12 0.65 0.51 1.08 0.85 1.38 
Metro North                       0.25 0.11 2.22 0.03 1.28 1.03 1.60 
Metro South                       0.66 0.10 6.63 <0.001 1.94 1.60 2.37 
Rockhampton                       0.63 0.10 6.20 <0.001 1.87 1.54 2.29 
Sunshine Coast                    0.33 0.11 3.07 <0.001 1.39 1.13 1.72 
Townsville 0.69 0.10 6.93 <0.001 2.00 1.64 2.44 
West Moreton                      0.50 0.10 4.85 <0.001 1.65 1.35 2.03 
Indigenous 
Status 
Indigenous 
(Ref)  
   <0.001    
Non Indigenous      0.74 0.08 9.29 <0.001 2.10 1.80 2.47 
Unknown  1.00 0.08 12.45 <0.001 2.71 2.32 3.18 
Vaccination 
Program Period 
1991-1999 (Ref)        
2000-2005 -0.18 0.04 -4.32 <0.001 0.84 0.77 0.91 
2006-2011 -0.68 0.05 -14.54 <0.001 0.51 0.46 0.56 
 2012-2016 -0.47 0.05 -10.11 <0.001 0.63 0.57 0.69 
Ref = Reference Category, SE = Standard Error, RR = Risk Ratio 
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Goodness of fit test for the Possion and negative binomial models 
The GOF test indicates that the Poisson model does not fit the data (p < 0.05). The findings indicate 
presence of overdispersion (with ϕ = 1.353). Accordingly, we fitted a negative binomial model and 
the GOF test indicates that the negative binomial model fits the data (p > 0.05).  
The ANOVA table (see Table 6.8) summarizes the residual deviance and degrees of freedom for each 
addional variable in the Possion and negative binomial regression models. The addion of more 
variables resulted in a larger reduction in residual deviance and degrees of freedom in the negative 
binomial model than the Possion model supporting the negative binomial model. 
Table 6. 7 Model Goodness of fit summary for the Poisson and negative binomial models on the Q 
fever notification rate, 1991-2016, Queensland, Australia. 
Model Statistics Poisson Neg. binomial 
Model Deviance (Residual Deviance) 3050.88 1865.38 
Residual degrees of freedom 2697 2697 
Chi Square  2818.93 2818.93 
P-value 0.00 1.00 
Extra-Poisson Variation (ϕ) 1.353 6.23 
 
Table 6. 8 ANOVA for the Poisson and negative binomial models on the Q fever notification rate, 
1991-2016, Queensland, Australia. 
Model Variable in Model DF Deviance Residual DF Residual Deviance 
Poisson NULL   2719 5610.9 
Sex 1 356.37 2718 5254.6 
Age 7 225.70 2711 5028.9 
PHU 9 1018.01 2702 4010.9 
Indigenous Status 2 529.43 2700 3481.4 
Vaccination Program Period 3 430.54 2697 3050.9 
Negative 
Binomial 
NULL   2719 3555.2 
Sex 1 269.68 2718 3285.6 
Age 7 153.82 2711 3131.7 
PHU 9 692.26 2702 2439.5 
Indigenous Status 2 333.46 2700 2106.0 
Vaccination Program Period 3 240.63 2697 1865.4 
DF= Degrees of Freedom 
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Varinace mean relationship for Poisson and negative binomial models with offset 
Figure 6.5 shows the mean versus the variance and overlays the curves corresponding to the over-
dispersed Poisson model, where the variance is ϕμ, and the negative binomial model, where the 
variance is μ(1+μ/ϕ2). The Poisson variance function does not fit most of the data, and hence fails to 
capture the high variances of in Q fever notifications rate.  
The negative binomial variance function, being a quadratic, can rise faster and does a better job at the 
high end. We conclude that the negative binomial model provides a better description of the data than 
the over-dispersed Poisson model. 
 
Figure 6. 5 Mean-variance relationship for the Poisson and negative binomial models on the Q fever 
notification rate, 1991-2016, Queensland, Australia. 
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Results of Q fever admissions data 
Description of Q fever Admission Data 
The average age of the Q fever patients admitted to hospital was 43.0 (std. dev. = 17.06) years. 
Around three fourths (76.0%), of the Q fever admissions were male, and between 14.0% and 20.0% of 
the admissions occurred in the age ranges from 15-24 to 55-64 years old. The majority (89.29%) of 
the admitted Q fever patients did not identify as Indigenous and 83.98% were born in Australia.  
About 53.0% of the hospitalized Q fever patients were married or de facto. Most of (75.1%) the 
admitted Q fever patients had health insurance status with the rest being private single (13.5%) and 
private shared (11.4%). More than 90.0% had emergency admission and in approximately 62.0% of 
the admissions, Q fever was present on admission (i.e. the cause of admission). Nearly, one third of 
the admissions took place in each of the vaccination program periods such as 2001-2005, 2006-2011 
and 2012-2015. The admitted Q fever patients had an average length of stay of approximately 6 days 
with a standard deviation of 5.1 days. Details can be seen from Table 6.9 and Figure 6.6.  
 133 
 
Table 6. 9 Demographic and admission characteristics of hospitalised Q fever patients, 2001-2015, 
Queensland, Australia.  
Variable Category Admissions Percent 
Sex Female 241 24.12 
Male 758 75.88 
Age 0-14 27 2.7 
15-24 140 14.01 
25-34 142 14.21 
35-44 201 20.12 
45-54 205 20.52 
55-64 173 17.32 
65-74 71 7.11 
75+ 40 4 
Marital Status Divorced 66 6.61 
Married/de facto 529 52.95 
Never Married 320 32.03 
Not stated/unknown 43 4.3 
Separated 18 1.8 
Widowed 23 2.3 
Health insurance status 
(Charge Status) 
Private shared 114 11.41 
Private single 135 13.51 
Public 750 75.08 
Admission Type Elective admission 69 6.91 
Emergency admission 922 92.29 
Not assigned 8 0.8 
Onset Type Condition present on admission 615 61.56 
Not stated/Unknown 384 38.44 
Indigenous Status Indigenous 56 5.61 
Non Indigenous 892 89.29 
Not Stated/Unknown 51 5.11 
Country of Birth Australia 839 83.98 
Others 160 16.02 
Vaccination Program 
Period 
2001-2005 354 35.44 
2006-2011 351 35.14 
2012-2015 294 29.43 
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Table 6. 10 Average age and length of hospital stay for Q fever admitted patients, 1991-2016, 
Queensland, Australia 
Variable Mean (Std. Dev.) 
Female Male Combined 
Age 44.42 (17.10) 43.56 (17.05) 43.77 (17.06) 
Length of Stay 5.84  (5.75) 5.32  (4.81) 5.45 (5.06) 
 
 
Figure 6. 6 Q fever admissions by Age, Sex, Marital Status and Charge Status, 1991-2016, 
Queensland, Australia.  
Plots of the monthly and yearly Q fever hospital admissions showed two peaks during the months of 
April and October and in the years 1993 and 2014 (see Figure 6.7).  
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Figure 6. 7 Monthly and yearly Q fever admissions, 1991-2016, Queensland, Australia.  
Age and sex specific annual Q fever admission rates for Queensland 
The median annual rate of Q fever admission was 1.9 per 100,000 population per year (2.1 for males 
and 0.8 for females) ranging between 0.4 and 2.6 per 100,000 population per year. The highest 
median annual Q fever admission rate occurred in the age range 75 years old and above (2.6 per 
100,000 per year). The median annual Q fever admission rate increased with an increase in age. 
Further details can be seen in Table 6.11 and Figure 6.8.   
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Table 6. 11 Age and Sex specific annual rate of Q fever admission per 100,000 populations 
 
Variable 
Name  
 
Variable 
Category 
Admission Rate 
Minimum Mean Median Std.Dev. Maximum 
Sex Female 0.25 0.77 0.78 0.29 1.31 
Male 1.74 2.45 2.06 0.90 4.67 
Total 0.36 1.60 1.88 0.79 2.64 
Age  0-14 0.00 0.57 0.56 0.51 2.11 
15-24 0.39 1.48 1.53 0.63 2.64 
25-34 0.60 1.55 1.62 0.64 2.39 
35-44 0.70 1.73 1.79 0.51 2.45 
45-54 1.00 1.94 1.86 0.62 3.09 
55-64 1.18 2.02 1.74 0.69 3.30 
65-74 0.64 2.43 2.08 1.41 5.52 
75+ 1.17 2.80 2.61 1.35 5.39 
Std.Dev. = Standard Deviation 
Hospital admissions were highest among males (4.5 per 100,000 male populations) and the age range 
55 years old and above (Figure 6.8).  
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Figure 6. 8 Age and Sex specific Q fever admission rates, 1991-2016, Queensland, Australia.  
Negative binomial model for admission rates 
In the negative binomial regression model, males were 3.2 times more likely to be hospitalised than 
females. An increasing rate of hospital admission was found across the age ranges between 15-24 and 
55-64 years old after which the rates declines significantly. Individuals in the age range 55-64 were 
11.7 times more likely to be admitted compared to children in the age range 0-14 years old.  
Vaccination program year had a protective effect with regards Q fever. During the 2006-2011 national 
vaccination program period, the risk of hospital admission was 26.0% less compared to the 
vaccination program period 2001-2005 (see Table 6.12).  
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Table 6.12 Negative binomial model on the rate of hospital admissions, 2001-2015, Queensland, 
Australia. 
Variable 
Name 
Variable 
Category 
Estimate Std. 
Error 
Z value Pr(>|z|) Risk 
Ratio 
95% CI 
LL UL 
(Intercept)  -11.66 0.14 -82.71 <0.001 0.00 0.00 0.00 
Sex Female (Ref)        
 Male 1.15 0.09 12.77 <0.001 3.17 2.66 3.79 
Age 0-14 -1.98 0.23 -8.48 <0.001 0.14 0.09 0.22 
15-24 (Ref)        
25-34 0.05 0.16 0.31 0.75 1.05 0.77 1.43 
35-44 0.37 0.15 2.48 0.01 1.45 1.08 1.95 
45-54 0.46 0.15 3.09 <0.001 1.59 1.19 2.14 
55-64 0.48 0.15 3.14 <0.001 1.62 1.20 2.19 
65-74 0.02 0.18 0.10 0.92 1.02 0.71 1.44 
75+ -0.22 0.21 -1.06 0.29 0.80 0.53 1.19 
Vaccination 
Program 
Period 
2001-2005 
(Ref) 
       
2006-2011 -0.30 0.10 -3.01 <0.001 0.74 0.61 0.90 
2012-2015 -0.16 0.11 -1.51 0.13 0.85 0.69 1.05 
Ref = Reference Category, LL= lower limit, UL = upper limit, CI= confidence interval 
Goodness of fit test for the Possion and negative binomial models 
The Goodness of fit test and the ANOVA table indicated inadequacy of the Poisson model. The GOF 
test indicates that the negative binomial model does fit the data (p-value > 0.05). We therefore used 
the negative binomial model for fitting the the age and sex specific admission rates (see Tables 6.13 
and 14).  
Table 6.13 Model Goodness of fit summary table for Poisson and negative binomial models on the 
rate of hospital admissions, 2001-2015, Queensland, Australia. 
Model Statistics Poisson Negative binomial 
Model Deviance (Residual Deviance) 386.053 259.352 
Residual degrees of freedom 229 229 
Chi Square  265.301 265.301 
P-value 0.00 1.00 
Extra-Poisson Variation (ϕ) 0.082 0.082 
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Table 6.14 ANOVA for Poisson and negative binomial models on the rate of hospital admissions, 
2001-2015, Queensland, Australia. 
Model Variable in Model DF Deviance Residual DF Residual Deviance 
Poisson NULL   239 1021.64 
Sex 1 283.75 238 737.89 
Age 7 332.65 231 405.24 
Vaccination Program Period 2 19.18 229 386.05 
Negative 
Binomial 
NULL   239 658.18 
Sex 1 192.941 238 465.24 
Age 7 196.805 231 268.43 
Vaccination Program Period 2 9.081 229 259.35 
DF= Degrees of Freedom 
Mean-variance relationship plot 
Figure 6.9 shows the mean versus the variance and overlays the curves corresponding to the over-
dispersed Poisson model, where the variance is ϕμ, and the negative binomial model, where the 
variance is μ(1+μ/ϕ2). The Poisson variance function does fit most of the data, and hence captures the 
high variances in the Q fever admission rate. Therefore, Poisson model provides a better description 
of the data than the Negative Bionomial Poisson model.
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Figure 6. 9 Mean – variance relationship plot for Poisson and negative binomial models on the rate of 
hospital admissions, 2001-2015, Queensland, Australia. 
Modelling the Q fever admission data with additional variables 
In the Poisson regression model, males were 1.5 times more likely to be hospitalised than females. 
Children were 61.0% less likely to be hospitalised compared to older age groups and the risk of 
hospital admission for individuals in the age range 25-34 was 27.0% lower compared to the reference 
age range 15-24 years old.  The highest risk of hospital admission was in people 75+ years old. 
Compared to the reference age 15-24, individuals in the age range 75 years old and above had 1.5 
times higher risk of hospital admission for Q fever.  
Individuals with Private Shared and Private Single charge status were, respectively, 37.0% and 33.0% 
less likely to be admitted. Non-Indigenous individuals were 1.9 more likely to be admitted compared 
to Indigenous individuals. Individuals with “other country” of birth were 26.0% less likely to be 
admitted than Australian-born individuals.  
During the 2006-2011 national vaccination program period, the risk of hospital admission was 40.0% 
less compared to the vaccination program period 2001-2005. Similarly, during the 2012-2015 private 
vaccination program periods, the risk of hospital admission was 47.0% less compared to the 
vaccination program period 2001-2005 (see Table 6.15).  
 141 
 
Table 6. 15 Poisson regression model on the rate of hospital admissions, 2001-2015, Queensland, 
Australia. 
Variable 
Name 
Variable 
Category 
Estim
ate 
Std. 
Error 
Z value Pr(>|z|) Risk 
Ratio 
95% CI 
LL UL 
(Intercept)  -12.40 0.28 -44.06 <0.001 0.00 0.00 0.00 
Sex Female (Ref)        
 Male 0.38 0.08 4.96 <0.001 1.46 1.26 1.69 
Age 0-14 -0.93 0.21 -4.41 <0.001 0.39 0.25 0.59 
15-24(Ref)        
25-34 -0.31 0.12 -2.52 0.01 0.73 0.57 0.93 
35-44 -0.11 0.12 -0.95 0.34 0.89 0.71 1.13 
45-54 -0.13 0.12 -1.09 0.28 0.88 0.69 1.11 
55-64 0.01 0.13 0.08 0.94 1.01 0.78 1.30 
65-74 0.28 0.16 1.76 0.08 1.33 0.96 1.81 
75+ 0.42 0.20 2.10 0.04 1.52 1.02 2.23 
Marital 
Status 
Widowed (Ref)        
Divorced -0.28 0.25 -1.10 0.27 0.76 0.47 1.26 
Married/de facto 0.22 0.23 0.99 0.32 1.25 0.82 2.00 
Never Married 0.01 0.24 0.05 0.96 1.01 0.65 1.65 
Unknown -0.46 0.27 -1.68 0.09 0.63 0.37 1.10 
Separated -0.49 0.33 -1.49 0.14 0.62 0.32 1.16 
Charge 
Status 
Public (Ref)        
Private shared -0.47 0.10 -4.50 <0.001 0.63 0.51 0.77 
Private single -0.40 0.10 -4.00 <0.001 0.67 0.55 0.82 
Onset Type Unknown (Ref)        
 Present 0.24 0.19 1.22 0.22 1.26 0.88 1.88 
Indigenous 
Status 
Indigenous 
(Ref) 
       
Non Indigenous 0.62 0.14 4.41 0.00 1.87 1.43 2.49 
Unknown 0.10 0.20 0.53 0.60 1.11 0.75 1.63 
Country 
Birth 
Australia (Ref)        
Others -0.31 0.09 -3.47 <0.001 0.74 0.62 0.87 
Vaccination 
Program 
Period 
2000-2005 (Ref)        
2006-2011 -0.52 0.19 -2.70 0.01 0.60 0.40 0.85 
2012-2015 -0.64 0.21 -3.09 <0.001 0.53 0.34 0.78 
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Ref = Reference Category, Onset Type = Condition present on admission (Q fever is diagnosed), LL= 
Lower Limit, UL= Upper Limit, CI = Confidence Interval  
Goodness of fit test for the Possion and negative binomial models with offset 
The Goodness of fit test and the ANOVA table indicated adeqauacy of the Poisson model. The GOF 
test indicates that the poisson model does fit the data (p-value > 0.05) (see Tables 6.16 and 6.17).  
Table 6. 16 Model Goodness of fit summary table for Poisson and negative binomial models on the 
rate of hospital admissions, 2001-2015, Queensland, Australia. 
Model Statistics Poisson 
Model Deviance (Residual Deviance) 281.477 
Residual degrees of freedom 616 
Chi Square  674.849 
P-value 1.00 
Extra-Poisson Variation (ϕ) 0.56 
 
Table 6. 17 ANOVA for Poisson and negative binomial models on the rate of hospital admissions, 
2001-2015, Queensland, Australia. 
Model Variable in Model DF Deviance Residual DF Residual Deviance 
Poisson NULL   637 472.42 
Sex 1 24.953 636 447.47 
Age 7 40.795 629 406.67 
Marital Status 5 27.406 624 379.27 
Charge Status 2 27.123 622 352.14 
Onset type 1 16.523 621 335.62 
Indigenous Status   2 30.395 619 305.23 
Country Birth 1 12.926 618 292.30 
Vaccination Program Period 2 10.824 616 281.48 
DF= Degrees of Freedom 
Approximating severity of Q fever 
Q fever hospital admission against notification as proximity of severity of the diseases 
The linked notification and admission data arranged by age, sex and year consisted of 3,105 cases 
from the Q fever notification data and 997 cases from Q fever admission data. That is, from among 
3,105 reported cases of Q fever between 2001 and 2015, only 997 (32.1%) were linked to the Q fever 
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admission data. On average, around 33.5% of the Q fever notification required hospital admissions 
with approximately equal proportions of admissions in males (33.3%) and females (44.1%). The 
highest (81.8%) hospital admission occurred in the age range 75 years old and above, this number is 
followed by children in the age range 0-14 years old (44.0%). Around one third of the notifications 
required admission across the age ranges from 15-24 to 65-74 years old (see Table 6.18 and Figure 
6.10).  
Table 6. 18 Q fever notifications that required admission, 2001-2015, Queensland, Australia 
Variable Category Minimum Mean Median Standard Deviation Maximum 
Total  22.77 33.45 31.51 6.38 46.94 
Sex Female 15.73 34.11 34.69 11.09 53.85 
Male 24.63 33.26 31.35 6.18 49.06 
Age 0-14 16.67 44.02 30.00 27.07 100.00 
15-24 20.83 38.26 33.33 15.34 75.00 
25-34 16.28 37.72 31.25 14.18 63.64 
35-44 15.00 31.07 30.00 10.74 56.67 
45-54 13.33 31.58 34.88 10.54 45.83 
55-64 11.76 29.35 29.73 10.78 50.00 
65-74 14.29 35.69 33.33 15.68 77.78 
75+ 30.00 81.79 66.67 50.95 200.00 
 
 
 144 
 
 
Figure 6. 10 Proportion of Q fever notifications that were admitted, 2001-2015, Queensland, 
Australia 
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Discussion 
Our analysis showed that the in cadence of Q fever has reduced over time but remained relatively high 
in Queensland.  This agrees with findings from national level reports that showed an overall decline in 
Q fever notifications (Graves & Islam 2016; Lowbridge et al. 2012). A recent study showed a 20.0% 
decline in the reported Q fever notification rate nationally [Incident Rate Ratio (IRR) = 0.82] at the 
end of the NQFMP in 2006 followed by a steady increase since 2009 [IRR 1.01–1.34] (Sloan-Gardner 
et al. 2016).  
The observation that more than one third (~35.0%) of Q fever notifications required hospital 
admission in line with a recent small follow-up study conducted from 2006 to 2012 that found that 15 
out of 39 (38.0%) notified cases were hospitalised (Karki et al. 2015).    
Gender disparity in median notifications with 2.5 per 100,000 female population per year and 8.0 per 
100,000 male populations per year was observed. In addition, around three fourths of (76.0%) of the 
Q fever admissions were among males and the median annual rate of Q fever admission was found to 
be 1.9 per 100,000 populations per year ranging from 0.4 to 2.6 per 100,000 populations per year. The 
gender analysis of Q fever notifications and hospital admission data showed that it is predominantly 
seen in males and likely to be linked with occupational exposures given the predominant age groups 
that are affected. Existing evidence also showed that Q fever is an occupational hazard for those who 
work in rural settings and in contact with animals, especially, the livestock industry (veterinarians, 
tanners, and wool carders) (Khalili et al. 2014; Schimmer et al. 2014).  Previous evidence of 
pronounced sex difference was found with 84.2% of the notifications in the Australian National 
Notifiable Diseases Surveillance System (NNDSS) being males (Garner et al. 1997; Sloan-Gardner et 
al. 2016). 
The lack of cyclical pattern in the notification rate suggests that there are no seasonal determinants of 
Q fever in Qld. There have been no published studies that identify seasonal patterns in Q fever 
notifications in any endemic country.  The decline in the Q fever notification rate in the recent 
notification periods could be due the decline in the number of susceptible individuals as a result of the 
expansion of the Q fever vaccination program and hence the resulting herd immunity.  
In this analysis males were 1.8 [RR = 1.81, 95% CI: 1.69-1.95] times more likely to be a notification 
and 1.5 times more likely to be admitted than females. This finding is consistent with the studies by 
Raoult et al. (2005) that reported being male and over the age of 15 are associated with increased risk 
of symptomatic disease (Raoult, Marrie & Mege 2005). Several similar research findings that showed 
the higher risk of Q fever among males are evidenced. For instance, males have been reported to be 5 
times (finding from Australia) (Garner et al. 1997) and 2.5 (finding from France) (Raoult et al. 2000) 
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times more likely than females to develop disease (Parker, NR, Barralet & Bell 2006). However, our 
finding was lower than the study finding by Sloan-Gardner et.al (2017) which showed that Q fever 
notiﬁcation rates were four times higher in males [IRR = 4.03, 95% CI: 3.51 – 6.64] compared to 
females (Sloan-Gardner et al. 2016).   
The risk of Q fever infection in children aged 0-14 years was 66.0% lower [RR = 0.34, 95% CI: 0.28-
0.41] and they were 61.0% less likely to be admitted compared to the reference age range 15-24 years 
old.  This could be due to the fact that children are less frequently symptomatic than adults following 
infection, and may have milder disease, and hence they might be less likely to be notified and 
admitted (Maltezou & Raoult 2002). Consistent results that confirm incidence of Q fever among 
children are evidenced from a study from Queensland (Parker, N, Robson & Bell 2010). a substantial 
rate of Q fever notifications (235) among children in Queensland is evidenced, indicating that the 
disease was not restricted to the at risk adult population (Tozer, Sarah Jane 2015). 
Moreover, higher risk of Q fever hospital admission was found in the 75+ years old category. The 
increased risk of hospital admission in this age group could be due associated with co-morbidities and 
may also be associated with longer hospital stay. A case control study showed strong association with 
age < 40 (OR=4.6, 95% CI: 1.1-40.3) and male sex (OR=15.2, 95% CI: 2.5-91.2)  (Armengaud et al. 
1997). Men were 5.2 (95% CI: 1.1–24.0) times likely to be infected (Wilson et al. 2010) and most 
cases (70.0%) occurred between the ages of 20 and 50 years (Garner et al. 1997). 
In our study, non-indigenous population and individuals with unknown indigenous status had 
significant higher Q fever risk compared to their indigenous counterparts. The lower risk of Q fever in 
indigenous patients in rural and remote areas may be because of lack of access to health services. 
According to Australia’s health 2016, there are, several areas where the indigenous population has 
very limited access to both indigenous-specific services and GP services in general [source: 
https://www.aihw.gov.au/getmedia/01d88043-31ba-424a-a682-98673783072e/ah16-6-6-indigenous-
australians-access-health-services.pdf.aspx]. 
When we see the public health units, the highest risk of Q fever was observed in Darling Downs 
public health unit which had a significant risk ratio of 3.7 [95% CI: 3.06-4.42] compared to Wide Bay 
public health unit. Significantly greater risk of Q fever infection was observed in all of the public 
health units except for Gold Coast public health unit. The public health units, Townsville, Metro 
South and Rockhampton had approximately equal risk of Q fever infection ranging from 1.9 to 2.00 in 
contrast to Wide Bay public health unit. The increased risk of Q fever in Darling Downs public health 
units could be due to the fact that Queensland has the largest proportion of feedlots (67.0%: 268 out of 
400 feedlots in Australia) with 59.0% of all intensive livestock activity on the Darling Downs, 31.0% 
 147 
 
in South East Queensland, 4.0% in the Wide bay Burnett region and 2.5% in Central Queensland 
(Department of Agriculture and Fisheries (DAF) 2012). 
The consistent burden of Q fever across PHU areas shows that the underlying conditions for Q fever 
have not changed in response to any specific public health interventions and geographic drivers.  This 
is important because the PHUs in areas with significant numbers of cases, such as the Darling 
Downs, have increased their health education activities to encourage people working with livestock 
to undergo testing and vaccination (Penny Hutchinson, pers. comm.).  The lack of change in relative 
incidence across PHUs suggest that public outreach activities alone may not be sufficient to effect a 
change in Q fever incidence.  It also supports the need to undertake a more thorough evaluation of 
vaccination coverage, which is not possible with currently available data.  
Consistent with previous reports, vaccination program period was found to have had a protective 
effect on the annual risk of Q fever infection and admission. The risk of Q fever infection was 16.0% 
[RR=0.84, 95% CI: 0.77-0.91] lower for the years 2000-2005 and this figure declined by half (49.0%) 
[RR=0.51, 95% CI: 0.46-0.56] during the expanded Q fever vaccination program (2006-2011).  
However, following the privatization of the Q fever vaccination (2012-2016), the decline in the Q 
fever incidence rate was only 37.0% [RR=0.63, 95% CI: 0.57-0.69]. Moreover, during the 2006-2011 
national vaccination program periods, the risk of hospital admission was 40.0% less compared to the 
vaccination program period 2001-2005 supporting the importance of the government funded 
vaccination program. Similarly, during the 2012-2015 private vaccination program periods, the risk of 
hospital admission was 47.0% less compared to the vaccination program period 2001-2005. The 
increased protection effect of the private vaccination program (47.0% compared to 40.0% during the 
government funded vaccination program) could be due the cumulative effect of the vaccination 
program as a result of herd immunity over years.  
In addition, slightly monthly and yearly variation was seen especially during the first few years of follow up 
(shown in Figure 6.7) and did not appear to be seasonal rather a secular trend was observed. Following a peak in 
the year 2002 and the sharp decline between 2002 and 2005, relatively steady increase in hospitalization rates 
over the study period may indicate possible admissions due to chronic Q fever cumulated over years. However, 
this is not warranted for program managers (to inform the timing and intensity of preventive programs) as we 
did not have data to verify whether the admissions in last past 6 years or so were due chronic Q fever. However, 
this finding was also consistent with the report of Queensland Health that showed presence of considerable 
month-to-month variations in the number of hospitalizations with absence of consistent seasonal pattern 
[http://www.health.gov.au/internet/publications/publishing.nsf/Content/cda-cdi34suppl.htm~cda-cdi34suppl-3-
vpd.htm~cda-cdi34suppl-3-vpd12.htm]. 
Consistent findings were reported in the study by Gidding (2009) that showed a decline in Q fever 
notification rate by over 50.0% between 2002 and 2006, particularly, in young adult males consistent 
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with the profile of the abattoir workforce who are the target of the vaccination program.  There was 
also a similar trend in hospitalisation (Department of Health (Australia) 2015; Gidding et al. 2009). 
Moreover, supporting evidence of substantial reduction in the number of Q fever notifications and 
corresponding workplace health and safety compensation claims has been reported (Queensland 
Health 2010).  
Supportive evidence that the decrease in notification was likely due to highly effective Q fever 
vaccination programs are documented (Bond et al. 2016; Milton et al. 2012). More evidenced of 
decline in the occurrence of Q fever cases as a result of vaccination along with environmental and 
biosecurity interventions (Bond et al. 2016) and reduction related to ending of drought conditions 
(Milton et al. 2012) have been demonstrated.  
However, a descriptive analysis of Q fever notifications in NSW from 2001-2010 found only 34.0% 
of the notified cases had vaccination status recorded and information on the occupation of the case 
was recorded for only 55.0% of notifications (Lowbridge et al. 2012). This raises doubt about the 
ability of researchers to attribute the reduction in notifications to the implementation of the Q fever 
vaccine. In addition, the need for more finely tuned vaccination policy that target risk individuals 
within the occupation was also indicated (Massey, P. D., Irwin, M. & Durrheim, D. N. 2009).  
Due to lack of comprehensive and complete enhanced risk factor data from the Q fever notification 
surveillance data, we were not able to address occupation as a risk factor in our models. In addition, 
we were not able to investigate possible associations or clustering in Q fever notifications because of 
limitations in spatial data including relatively spatial resolution in available population data (such as 
SA1, SA2, Mesh Block levels) in order to understand the spatial clustering of Q fever in Queensland.  
Conclusion 
Though substantial reduction (up to 50.0%) in the Q fever notification and admission (up to 40.0%) 
especially during the expanded Q fever vaccination program was gained, Q fever notification in 
Queensland remains high. In addition, following the privatization of the Q fever vaccination program, 
there appear to be a tendency for the Q fever notification rate to increase. This study has highlighted 
the importance of considering children in the risk group for Q fever. It also provides evidence of the 
need to evaluate the efficacy and safety of Q-VAX® in children under 15 years of age. The reductions 
in incidence and associated hospitalisations represents a significant decrease in the burden of disease 
that may warrant a re-instatement of the government sponsored/funded Q fever vaccination program. 
Further work is needed to understand the chronic sequelae and their impact on the health of Q fever 
cases. The most significant issue is endocarditis and chronic fatigue syndrome, which may cause 
significant disability and reduced quality of life.   
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CHAPTER 7: Q fever Exposure Risk Set: Application of Multiple Correspondence Analysis (MCA)  
 
Background 
Q fever is considered mainly an occupational hazard of working in the livestock and meat processing 
plants who are close contact with contaminated animals and their products (Garner et al. 1997; 
Marrie, Thomas J. & Raoult 2015). Meat workers, those working on farms, veterinarians, and those in 
close contact with native animals such as kangaroos and bandicoots (Marsupials), stockyard workers, 
shearers and animal transporters, are considered at greater risk (Queensland Health 2010) (Milton et 
al. 2012; NNDSS Annual Report Writing Group 2015).  In addition, a recent study showed that 
residing close to a farm with animals infected with Coxiella burnetii are associated with human Q 
fever (Georgiev et al. 2013). Several outbreaks of Q fever have been associated with infected farms in 
Germany (Gilsdorf et al. 2008; Hellenbrand, Breuer & Petersen 2001; Porten et al. 2006), Croatia 
(Medic et al. 2005) Italy (Manfredi Selvaggi et al. 1996; Starnini et al. 2005) and a Swiss Alpine 
valley (Dupuis et al. 1987).   
Risk factor investigation based on the outbreak occurred in Rollshausen, German (1996) found high 
(25%) attack rate among inhabitants. In the study, the risk of Q fever was twice higher among 
inhabitants nearby a sheep farm than those without this exposure (Centers for Disease Control and 
Prevention (CDC) 1997). A strong association with the meat industry is confirmed (Garner et al. 
1997; Greig et al. 2005). This is in accordance with studies that have shown that abattoir workers are 
notable at-risk group for Q fever who should be fully protected from this occupational disease (Bell, 
Patel & Sheridan 1997).  
Occurrence of infection with C. burnetii was strongly associated with distance from infected source 
(Brooke et al. 2015). Another investigation in Jena, Germany, showed increase in the odds of Q fever 
infection with close proximity to infected source (Boden et al. 2014). In the study, those people living 
within 60 m of infected farm were 14.7 [OR =14.7, 95% CI: 5.4 - 40.2] times at risk of Q fever 
infection than those who reside 500 m away from the infected source (Boden et al. 2014).  
Risk factors study in Germany, 2005, indicated 11.8% attack rate (AR) of people living within 50 m 
of the infected sheep farm and the odds of Q fever infection decreased with increase in the distance 
away from the infected source (Gilsdorf et al. 2008). In the study, those who lived within 50m of the 
infected farm areas were 8.7 times at greater risk of Q fever infection than those who lived at a 
distance from 350 to 400 m from the contaminated source [RR = 8.7, 95% CI: 4.5 – 17.1] (Gilsdorf et 
al. 2008).  
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Based on the 2007-2010 epidemics in the Netherland, the risk of Q fever exposure was associated 
with closeness of residency to contaminated farms (Bart et al. 2014; Schimmer et al. 2010). The risk 
of being infected with Q fever decline with the farthest away from contaminated dairy goat farms and 
the highest risk was found near farms with clinical symptoms (Commandeur et al. 2014). People 
residing within two kilometres the infected farm was 31.1 times higher than those people residing 
more than five kilometres away from the infected source [RR = 31.1, 95% CI: 16.4 - 59.1] (Schimmer 
et al. 2010).  
Evidence that outbreaks are strongly tied up with increased frequency and direction of wind blowing 
from the contaminated source are documented. For instance, higher incidence of Q fever infection 
was found to be associated with increased frequency of the wind blowing from the contaminated 
sheep breeding farm in outbreak occurred in the city of Marseille, France (Tissot-Dupont et al. 2004).  
In addition, investigation of the occurrence of Q fever in urban area, Gwent, South Wales, attributed 
to contaminated straw, manure, and dust brought by vehicles that travelled along the road where 
infected people were residing (Salmon et al. 1982). The importance of transportation routes as means 
of Q fever transmission to human is confirmed in a Swiss study in which 415 Q fever infections 
among people who reside on along a valley road in which sheep were herded to mountain pastures 
(Dupuis et al. 1987). Moreover, the role of wind was also confirmed in an investigation of outbreak 
the occurred in England during 2007 using prospective and retrospective investigation of an outbreak 
of Q fever (Wallensten et al. 2010). The study confirmed the possibility of windborne spread of C. 
burnetii from nearby sheep farms as the most likely source of infection (Wallensten et al. 2010).  
Manufacturing plant associated risk of Q fever were also documented. For instance, cardboard 
manufacturing plant associated outbreak was occurred in South Wales, United Kingdom (van 
Woerden et al. 2004). Further investigation of the outbreak using observational study designs revealed 
that during drilling into contaminated straw board as source of infection and the odds of Q fever 
infection was 3.46 times higher among employees in the factory’s office [OR = 3.46, 95% CI: 1.38 – 
9.06](van Woerden et al. 2004). Additional evidence of risk of Q fever associated with waste-sorting 
plant was found in a study in Spain (Alonso et al. 2015). In the study, workers who did not never wear 
respiratory mask 2.8 time more likely to be infected with Q fever than those workers who did not use 
[OR=2.8, 95% CI: 1.1–7.1] (Alonso et al. 2015).  
Slaughterhouse associated risk of Q fever infection have been reported. For instance, a case control 
study showed the increased risk of Q fever infection with the extent of exposure to slaughterhouse: 
from low exposure (OR=3.0) to high (OR=15.0) (Armengaud et al. 1997). Supportive evidence of risk 
of Q fever infection associated with slaughterhouse was found in a study conducted in a Scottish co-
located slaughterhouse and cutting plant (Wilson et al. 2010). 
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School based evidence of Q fever infection was also shown using a case control study conducted in 
urban school in Central Israel (Amitai et al. 2010). Being a student [OR = 11.09, 95% CI: 3.07 – 
40.07], boarding at school [OR = 13.9, 95% CI: 4.45 – 43.45], and dining regularly at the school 
canteen [OR = 8.57, 95% CI: 2.05 – 35.79] were factors found significantly related to being infected 
with Q fever (Amitai et al. 2010). Supportive evidence of school based risk of Q fever was evidenced 
from a study in France which showed increased frequency school canteen to be associated with higher 
risk of Q fever infection (King et al. 2011). 
Outbreaks or clusters of Q fever have also been associated with windborne dust from livestock 
saleyards (O'Connor, Tribe & Givney 2015), livestock transport corridors (Salmon et al., 1982) and 
grossly contaminated farms (Roest et al. 2011; Schneeberger et al. 2014)..  Furthermore, a number of 
outbreaks have been linked to an increased frequency and direction of wind blowing from a 
contaminated source (Tissot-Dupont et al. 2004).  This suggests that direct to livestock and indirect 
exposure via working in abattoirs are not necessarily the main risk factors for Q fever. Indeed, a 
number of studies have correlate risk of Q fever with the distance from the likely source (Boden et al. 
2014; Brooke et al. 2015; Gilsdorf et al. 2008).  
Information that characterizes more detailed risk factors for Q fever in Australia is lacking.  
Therefore, this study was conducted to identify and classify the risk of Q fever using enhanced 
surveillance data available for Q fever cases in Queensland.  
Objective 
Therefore, the intended objectives were to  
1. To identify the potential high risk groups and, 
2. Classify the risky Q fever exposures based on the enhanced surveillance data using multiple 
correspondence analysis.  
Methods 
Data 
Q fever notification (Queensland Health Notifiable Conditions Systems - NOCS) data from 1991 to 
2016 was employed for identifying the risk activities within abattoir environment. The Q fever 
notification data consists of data on individuals regarding previous screening and vaccination for Q 
fever along with occupational and lifestyle exposure factors such as the location of their home 
residence with regards likely sources of infection. The variables are summarized in Table 7.1.1. 
(Appendix 7.1).  
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Statistical analysis 
Multiple Correspondence Analysis (MCA)was conducted in order to identify the most at risk 
individuals. It is the generalization of simple correspondence analysis for two categorical variables 
(Abdi & Valentin 2007; Nenadic & Greenacre 2005). Multiple Correspondence Analysis allows us to 
approach the individuals, the variables, and their categories with the aim of investigating similarities, 
differences and associations. 
For detailed theoretical approach on MCA and R packages used in the analysis, see Appendix 7.1. 
This project was completed with approval from the Medical Research Ethics Committee, University 
of Queensland (protocol number: 2016000696). Data from NOCS and QHAPDC databases was 
obtained with approval under the Public Health Act (2005) (PHA). Data from the Q Fever 
Vaccination Register was obtained with permission from the Register Technical Advisory Committee. 
Results 
Descriptive of previous exposure information from NOCS 
Around 48.09% of Q fever cases reported awareness of Q fever vaccination but only 8.44% had 
undertaken pre-vaccination screening and 3.5% reported that they had been vaccinated. Only 26.11% 
considered that they were at risk of Q fever, with 10.51% reporting exposure to an abattoir and 6.85% 
worked inside an abattoir. A significant proportion of Q fever notifications reported that they had 
assisted and observed animal birth (27.07%), worked in the skinning section of a meat processing 
plant (21.82%), worked with straw and animal bedding (23.09%) and worked with animal manure 
(36.62).  Half of the cases (50%) lived on a farm and 50.32% had visited a farm. Around 53.5% were 
exposed to livestock transport and 29.14% were involved in laundering clothes and worked as an 
animal worker.  Around 46.34% had contact with untreated water and 72.93% had exposure to 
paddock dust. A total of 62% lived and worked within 1km of an abattoir and 68.31% lived and 
worked within 300m of bush (see Table 7.1).  
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Table 7.1 Frequency distribution of responses of notified cases of Q fever from the enhanced Q fever 
exposure data, 1991-2016, Queensland, Australia  
   Variable Name  Variable Category Count (N=628) Percent (n/N) 
Previous Screening Yes 53 8.44 
Previous Vaccination Yes 22 3.5 
Aware Q Fever Vaccination               Yes 302 48.09 
At Risk of Q Fever Yes 164 26.11 
Abattoir Exposure           Yes 66 10.51 
Work Inside Abattoir Yes 43 6.85 
Work in Grounds Abattoir                 Yes 16 2.55 
Contract Worker             Yes 10 1.59 
Visitor to Abattoir Yes 16 2.55 
Assist Observe Animal Birth       Yes 170 27.07 
Skinning Meat Process Etc                Yes 137 21.82 
Shooting Hunting Yes 125 19.9 
Work with Wool           Yes 63 10.03 
Work in Shearing Shed   Yes 65 10.35 
Work in Wool Processing Yes 30 4.78 
Work with Straw Animal Bedding     Yes 145 23.09 
Work with Animal Manure Etc     Yes 230 36.62 
Live on Farm                      Yes 314 50.00 
Visit Farm Yes 316 50.32 
Exposed to Livestock Transport Yes 336 53.5 
Launder Clothes Animal Worker    Yes 183 29.14 
Contact with Infected Person Yes 35 5.57 
Consume Unpasteurised Milk Etc Yes 42 6.69 
Contact with Untreated Water    Yes 291 46.34 
Exposure to Paddock Dust Etc   Yes 458 72.93 
Live Work within 1km Abattoir Yes 390 62.1 
Live Work within 300m Bush Etc Yes 429 68.31 
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Eigen values and variance explained by the principal dimensions 
Table 7.2 presents the proportion of variance explained for the first 10 dimensions. The first two 
dimensions, respectively, explained 16.98% and 10.80% of the variability in the Q fever exposure 
data, explaining 27.78% the total variability.  
Table 7.2 Eigenvalues: the variances and the percentage of variances explained by each dimension.  
Dimension Eigen value Percentage of variance Cumulative percentage of variance 
dim 1 0.17 16.98 16.98 
dim 2 0.11 10.80 27.78 
dim 3 0.07 7.45 35.22 
dim 4 0.05 5.45 40.67 
dim 5 0.05 4.80 45.47 
dim 6 0.04 4.12 49.59 
dim 7 0.04 4.05 53.64 
dim 8 0.04 3.96 57.60 
dim 9 0.04 3.58 61.17 
dim 10 0.03 3.29 64.46 
Note: An eigenvalue is the total amount of variance in the variables in the dataset explained by the 
common factor (principal component). 
Both eigenvalues and scree plot are used to determine the number of principal components. According 
to the eigenvalues in Table 7.2 and the scree plot in Figure 7.1, two principal dimensions (factors) 
explain most of the variation in the Q fever exposure data. Therefore, two sets of variables that 
explains most of variation in the Q fever exposure data can be retained: Principal Component 1 and 
Principal Component 2 (dim 1 and dim 2 in Table 7.2 which are represented by the first two bars in 
the scree plot in Figure 7.2). 
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Figure 7.1 Scree plot showing the percentage of variance explained by the first 10 principal 
components of the MCA on the Q fever exposure variables.  
Note: The scree plot orders the eigenvalues from maximum to minimum. The ideal pattern of in the 
scree plot is a steep curve, followed by a bend, and then a straight line extending to the right. The 
principle is, to use the components in the steep curve before the first point that starts the line trend. 
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Figure 7.2 The graph of categories for the first two principal components (28.0% of the explained 
inertia) is provided for the Q fever exposure variables. 
Contributions of variables to dimensions 
Assessment of the contribution of the variables in constructing the principal dimensions is based on 
the following criteria: if the contribution of variable categories were uniform, the expected value 
would be 1/(number of categories) = 1/56 = 1.8%. The red dashed line on the graph above indicates 
the expected average contribution. For a given dimension, any category with a contribution larger 
than this threshold could be considered as important in contributing to that dimension. Figure 7.3 
confirms that ten of the variables shown in the bar plot have contributed to dimension 1.  
Therefore, exposure to paddock dust, working with wool, assisting and observing animal birth, and 
working in shearing and shed were the most risky exposures for Q fever infection. 
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Figure 7.3 Bar plot showing the top 10 contributing categories of the Q fever exposure variables on 
dimension 1.  
In addition, those workers who worked inside abattoir, had abattoir exposure, being previously 
screened and vaccinated for Q fever were the second most at risk for Q fever (see Figure 7.4). 
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Figure 7.4 Bar plot showing the top 10 contributing categories of the Q fever exposure variables on 
Dim 2.  
The total contribution of a category, on explaining the variations retained by Dim.1 and Dim.2, is 
calculated as follow : (C1 * Eig1) + (C2 * Eig2). C1 and C2 are the contributions of the category to 
dimensions 1 and 2, respectively. Eig1 and Eig2 are the eigenvalues of dimensions 1 and 2, 
respectively. The expected average contribution of a category for Dim.1 and Dim.2 is : (1.8 * Eig1) + 
(1.8 * Eig2) = (1.8x18.7) + (1.8x10.5) = 33.66 + 18.90 = 52.56 (see Figures 7.3 and 7.4).  
 159 
 
Scatter plot of contributions 
 
Figure 7.5 Scatter plot of the first top 10 contribution of Q fever expousre variables 
From Figure 7.5, it is evident that the categories AT_RISK_OF_Q_FEVER_Yes, 
WORK_WITH_WOOL_Yes, ASSIST_OBSERVE_ANIMAL_BIRTH_Yes and 
SKINNING_MEAT_PROCESS_ETC_Yes have an important contribution to the positive pole of the 
first dimension. In addition, CONTRACT_WORKER_Yes, WORK_IN_GROUNDS_ABATTOIR_ 
Yes, WORK_INSIDE_ABATTOIR_ Yes, ABATTOIR_EXPOSURE_ Yes, and 
PREV_SCREENING_Yes have an important contribution to the positive pole of the second 
dimension.  
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Discussion 
The low level of awareness of the availability of Q fever vaccination is a cause for concern given the 
significant number of high-risk exposures reported by individuals.  Furthermore, the very low rate of 
pre-vaccination screening and vaccination suggests that this cohort are not receiving preventive health 
information associated with Q fever. This is rather surprising given the Australian immunisation 
handbook specifically mentions many of the occupational groups identified by the majority of the 
notified cases included in this study (Australian Technical Advisory Group on Immunisation 
(ATAGI) 2018; NHMRC 2015). Indeed, this reported level of awareness of vaccination is lower than 
that identified in a recent case series from New South Wales (NSW) that showed reasonable (70%) 
awareness of Q fever vaccination. In the NSW study, previous history of vaccination against Q fever 
was not reported by respondents and low Q fever risk perception was found though the barriers to 
immunisation remained unclear and it entails need further investigation (Massey, Peter D., Irwin, 
Melissa & Durrheim, David N. 2009).   
Similarly, an investigation of Q fever cluster among workers at an abattoir in South-Western Sydney, 
Australia, 2015, reported that the majority (75%) of employees were not vaccinated against Q fever 
despite the high-risk setting (Lord et al. 2016). Further field investigation revealed that management 
and staff lacked knowledge and awareness of Q fever(Lord et al. 2016). This awareness gap was also 
reported in a survey of Australia’s veterinarians and veterinary nurses where the vaccination rate 
among veterinarians and veterinary nurses was 74% and 29%, respectively (Sellens et al. 2016). The 
authors noted the reasons given to explain the poor vaccination coverage included: low perceived risk 
of Q fever, cost associated with the Q fever vaccine, time constraints, lack of access to vaccine 
provider, and low level of knowledge and awareness of Q fever and its vaccination (Sellens et al. 
2016). In the current study, we also found low risk perception among Q fever notified cases with only 
26.11% considering that they were at risk of Q fever.  
The low proportion of cases that reported abattoir exposure and working inside an abattoir may reflect 
the lower risk in these settings as a result of the workplace vaccination programs in place in the 
industry.   It is a concern that a significant proportion of the notified cases reported that they had a 
range of high risk exposures associated with their place of residence (near abattoirs, bush, on a farm 
and near livestock transport).  This is because these groups of people are not identified in the 
immunisation handbook (Australian Technical Advisory Group on Immunisation (ATAGI) 2018; 
NHMRC 2015) which means that they are unlikely to receive preventive advice from a general 
practitioner.  These findings also raise the prospect that there has been a shift in the extent of the 
relative risk of Q fever risk due to occupational exposure with an increase in associations due to non-
abattoir exposures.  This conclusion was also reached by Massey et al. (2009) who analysed enhanced 
surveillance data for notified cases in NSW, Australia (Massey, Peter D., Irwin, Melissa & Durrheim, 
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David N. 2009). However, their study used a smaller dataset and less sophisticated analysis compared 
to the current study.   
It is interesting to note that the results of the Bayesian latent class analysis (presented in Chapter 4) 
estimated the prevalence of previous exposure to C. burnetii was 12.4% in ‘Livestock workers’, 8.8% 
in ‘Meat workers’ and 8.1% in ‘Contractor or Visitors’.  This confirms that exposure to C. burnetii 
may be more widespread than is represented by the list of at risk groups identified in the 
immunisation handbook (Australian Technical Advisory Group on Immunisation (ATAGI) 2018; 
NHMRC 2015).   
In addition, seropositivity associated risk factors study among veterinary medicine students identified 
the “field of study” [OR = 3.27, 95% CI: 2.14 – 5.02] and “ever reside on a ruminant farm” [OR = 
2.73, 95% CI: 1.59 – 4.67] as predictors of infection with C. burnetii (de Rooij et al. 2012). In 
addition, a case series (2005–2013) from NSW showed that the majority of patients (89%) reported 
animal contact from which 63% has contact with cattle, 11% had contact with sheep, and 7% had 
contact with kangaroos (Graves & Islam 2016).  
In the month prior to illness onset, 27.07% assisted and observed animal birth and 21.82% were 
working in the skinning section of a meat process plant. This figure was similar to the report from 
NSW which showed that 31% had contact with animal serological or body fluids, 32% assisted 
animals with parturition and 46% participated in activities that involved general handling of animals 
(Massey, Peter D., Irwin, Melissa & Durrheim, David N. 2009). Consistent findings were reported 
from the study in South-Western Sydney. In the study, the possible high-risk exposures included 
animals aborting/giving birth in the holding yards and at the evisceration point where staffs on the kill 
floor would have potentially been exposed to the aerosolization of the birthing products (Lord et al. 
2016).  
The majority of the notified cases (72.93%) had exposure to paddock dust which was much higher 
than the NSW report showing only 22% having had indirect contact with dusts that were 
contaminated by animals tissues, products or excreta (Massey, Peter D., Irwin, Melissa & Durrheim, 
David N. 2009). However, the high rate of exposure to dust supports the findings of a case-control 
study following an outbreak of Q fever in rural South Australia reported that the probable source of 
infection to be a single exposure at a saleyard from infected sheep and dust (O'Connor, Tribe & 
Givney 2015).  
Of the notified cases, 23.09% reported working with straw and animal bedding and 36.62 were 
working with animal manure.  Around 46.34% had contact with untreated water and 72.93% had 
exposure to paddock dust. Risk profile and exposure assessment simulation study found that Q fever 
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transmission through consumption of unpasteurised milk and milk products. It was predicted that the 
probability of exposure per person to one or more C. burnetii through the daily cumulative 
consumption of raw milk in the UK to be 0.4203 (Gale et al. 2015).  
In the multiple correspondence analyses, we identified two principal dimensions: dimension 1 and 
dimension 2, respectively, which explained 16.98% and 10.80% of the variability within the enhanced 
Q fever exposure data; explaining 27.78% of the total variability. The categories exposure to paddock 
dust, work with wool, assist and observe animal birth, work in shearing and shade as the most 
important in the definition of the first dimension. In addition, work inside abattoir, abattoir exposure, 
work inside abattoir, previous screening and previous vaccination were identified as variables that 
contributed the most to dimension 2. 
Complete data was available from only 628 out of 6218 notified Q fever cases from 1991 to 2016, in 
Queensland, Australia. The small number of complete records probably reflects the large amount of 
time required to complete the data collection and the potential difficulty of locating cases. Lack of 
completeness of the enhanced Q fever exposure data from the Notifiable Condition System (NOCS) 
was the main limitation in this particular component of analysis. We based our analysis only on 628 
cases of Q fever from the NOCS for which complete data can be found on the enhanced Q fever 
exposure data. Moreover, all of the occupational exposures are recoded as Yes or No response and 
there is no detail on the methods for estimating the extent of exposure for this potential variables. 
Therefore, this result should be taken with caution as the findings might suffer from selection bias of 
the cases available for inclusion in the analysis. 
Conclusion 
Those workers who were exposured to paddock dust, worked with wool, assisted and observed animal 
birth, and worked in shearning and shed were the most at higher risk groups. In addition, those 
workers who worked inside abattoir, had abattoir exposure, previously screened and vaccined for Q 
fever were the second most at risk for Q fever. Working in the above list of types of work and 
exposure to dust, wool and shearing and shed lead to increased Q fever infection risk. In addition, 
being previously screened and vaccined for Q fever was also found to be an other risk set. These 
results suggest that personal protective equipment, such as fine dust masks (N95), should be 
considered as an adjunct to compulsory Q fever vaccination to protect workers in high risk 
occupations. 
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CHAPTER 8: Summary of key findings, discussion, conclusions and future directions 
This study was intended to fill the gaps in knowledge of confirmed Q fever vaccine failures and the 
duration of immunity in vaccinated and unvaccinated individuals considered to be immune for C. 
burnetii infection.  The impetus for this study was the recent publication of cases of Q fever in 
vaccinated individuals and anecdotal information about failure to adhere to vaccination protocols.  In 
addition, there is a need to understand the impact of the government-funded Q fever management 
program on notification and hospitalisation rates in Queensland.   
The thesis used a novel approach with linked data from three databases containing information on Q 
fever vaccination (Q fever vaccine registry), notifications (NOCS) and hospital admissions 
(QHAPDC).  This design presented an opportunity to link the findings of pre-screening tests, risk of 
Q fever in vaccinated and unvaccinated individuals, and the risk sets from the Q fever enhanced 
surveillance data, as well as the resulting notification and hospital admissions data during the Q fever 
vaccination program periods from 1991 – 2016.  
The major limitation of this study is the use of a vaccine registry that was established by an 
organisation representing abattoir owners.  This means that the results are not necessarily 
representative of the general population.  However, in recent years the number of non-abattoir 
workers recorded in the registry has increased, including cohorts of veterinary students.  In addition, 
the registry covers the highest risk occupational groups (abattoir workers), which traditionally 
represent the greatest burden of disease.  The results of this thesis are discussed in relation to the 
current Q fever vaccination protocol, which has been established primarily for these high risk groups.  
The findings of this study are also limited due to lack of comprehensive and complete enhanced risk 
factor data from the Q fever notification surveillance data, and hence this study was unable to address 
occupation as risk factor in our models. 
The results of the systematic review of Q fever seropositivity showed that a significant proportion of 
people employed in high risk occupations had been exposed to C. burnetii and that exposure was 
independent of evidence of an “outbreak”. Hence, a relatively constant seroprevalence of C. burnetii 
can be expected regardless of outbreaks.  It is interesting to note that this estimate of the 
seroprevalence is significantly higher (3 times) than the exposure prevalence calculated in among 
people seeking vaccination for Q fever (Chapter 4).  This confirms the high relative risk of Q fever 
among people working in abattoirs and slaughterhouses.   
This is the first time that the longevity of immunity of Q vax® has been determined at a population 
level using linked data from a large cohort over a long follow-up period.  The observation that 98% of 
vaccinated individuals remained disease-free after 20 years confirms the high level of immunity 
generated from administration of a single dose of vaccine.  This improves the current knowledge of 
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the longevity of immunity, which is based on the results of a single short-term follow up study 
(Ackland, Worswick & Marmion 1994; Marmion, BP et al. 1990).  This emphasises the importance of 
maintaining high rates of vaccine coverage in high-risk occupational groups such as abattoir workers 
and people involved in livestock industries.   
In contrast, the observation that unvaccinated individuals have a high probability (0.5) of developing 
Q fever over a period of 20 years is alarming.  This risk translates to an annual incidence that is 
similar to the rates of disease prior to the introduction of Q vax®.  This result was the stimulus to 
explore the accuracy of the screening tests used to determine the immune status of individuals prior to 
vaccination.  It is important because in the absence of a published study of the adverse events 
associated with the vaccine it is impossible to determine the needs and benefits of pre-vaccination 
screening.  These results strongly suggest that a systematic analysis of adverse events associated with 
Q vax® is necessary to inform future vaccination protocols.   
There have been a number of recent publications that documented small numbers of cases of 
confirmed failure of vaccination with Q-VAX®.  For instance, confirmed Q fever vaccine failure has 
been reported in a recent case series investigating Q-VAX® failure rate in Victoria, Australia, which 
found 13 cases of 34 who were previously vaccinated according to the national protocol (Bond et al. 
2017). The results of this study showed that there have been a small number of confirmed vaccine 
failures in the 26 year time series.  This study also revealed failure to adhere to vaccination protocols.  
A number of individuals were vaccinated despite prior disease notification (failure of screening) and a 
number developed Q fever and were notified less than 14 days following vaccination (premature entry 
into workplace).  These findings support the need for further enhancement of the implementation of 
the vaccination protocol for Q fever. 
The unexpected finding of higher incidence of Q fever in individuals considered to be immune as a 
result of positive pre-screening tests raised the possibility that the testing protocol is not accurate and 
individuals are misclassified.  Bayesian Latent Class Analysis was used to determine the accuracy of 
serological and skin tests to determine prior immunity because the structure of the dataset enabled its 
use and it is able to provide an unbiased estimate in the absence of a gold standard reference test.   
The estimated true prevalence of immunity to C. burnetii observed in individuals recorded in the 
vaccine registry was lower compared to previous reported studies.  However, the “baseline” rate of 6-
12%, depending on occupational group, is still relatively high and suggests that there is widespread 
exposure to C. burnetii in the general population.  Conversely, these findings highlight the need for 
vaccination in people working in high risk occupations because the majority do not have prior 
immunity.   
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The overall accuracy of pre-screening tests were only moderate when the positive predictive values 
were considered.  The purpose of the pre-screening tests is to confirm the presence of individuals with 
pre-existing immunity who should not be vaccinated to avoid adverse reactions.  The assumption is 
that this pre-existing immunity confers lifelong protection against infection with C. burnetii.  
However, the results from, Chapter 4 strongly suggest that this test-positive individuals are not 
necessarily immune.  The results of the BLCA show that the use of serology and skin tests in parallel 
may be responsible for the misclassification of immunity via an unacceptably high false-positive rate 
(low PPV).  This was shown to be largely due to the poor specificity of the skin test.  The BCLA also 
showed that the PPV of the serological tests is significantly higher and that these tests alone would 
reduce the false positive rate and improve the overall immunity of people seeking vaccination.  
Moreover, the skin test is logistically difficult to use because it requires two visits to a GP 7 days 
apart, which also increases its cost.  If the vaccine protocol was amended so that testing was only 
performed using serological assays then it is possible that uptake of the vaccine and compliance with 
the protocol would improve given a less complicated and expensive procedure. 
The analysis of the notifications of Q fever from Queensland confirmed that link between high risk 
occupational settings (abattoirs) and activities (exposure to birth products, working in dusty paddocks 
etc.).  Those workers who were exposed to paddock dust, worked with wool, assisted and observed 
animal birth, and worked in shearning and shed were the group most at risk.  The observationb that 
the risk of Q fever in abattoir workers reflects the high levels of vaccination required prior to 
employment.  However, the persistence of risk in this occupational group strongly suggests that 
vaccination alone is insufficient, particularly in those people working in high risk areas of an abbatoir.  
Ctivities.  Personal protective equipment, such as fine dust masks (N95), should be considered as an 
adjunct to compulsory Q fever vaccination to protect workers in high risk activities, for example 
working with wool and working in dusty animal yards.  The feasibility of this recommendation 
requires investigation.  
A review of the phases of the NQFMP showed that there have been significant reductions in the 
incidence of Q fever over the lifetime of the program, which is strong evidence of the effectiveness of 
the program.  The changes to policy and scope of the program are also reflected in the resulting drop 
in notifications following implementation.  The plateau, and possible increase, in notification recently 
is cause for concern as it may indicate a reduction in the uptake of vaccination by high risk 
occupational groups.  However, Q fever is an important vaccine-preventable disease and the results 
from this study suggest that further research is required to determine the cost effectiveness of 
government subsidies (i.e. NQFMP).  Given the long term sequelae of Q fever, that include chronic 
fatigue syndrome, it is important to consider the quality of life gains that can be achieved through 
vaccination.   
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An interesting observation from the risk analysis was that the relative rates of Q fever in different 
PHU areas has not changed significantly over the past 26 years.  It is difficult to interpret this finding 
because there are no published reports of public health interventions implemented by PHUs.  It would 
be reasonable to assume that a targeted intervention to increase vaccination coverage would reduce 
the overall rates of Q fever in a PHU area.  However, this is potentially confounded by the possibility 
that increased communication will lead to increased detection rates and resultant notifications.   
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Appendix 
Appendix 4.1: Details of the Bayesian Latent Class Analysis  
Model formulation and description 
In the definition below, we used exposure to represent previous immunity for Q fever so that to 
conform to the terminology and notation used in diagnostic/ or screening tests. Details of the 
definitions, notation and model choice issues are described in more details elsewhere (Lewis & 
Torgerson 2012; Menten, Boelaert & Lesaffre 2008; Tang et al. 2014).  
We used Bernoulli distribution as the probability model to describe sampling error for estimating 
exposure prevalence.  
The possible test results and the corresponding probabilities of occurrence for the test results 
combinations is shown in Figure 4.1.1. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1.1 Diagram showing possible test results and the corresponding probabilities of occurrence 
for the test results combinations.  
Given there are in total Nxπ exposed subjects and Nx(1 - π) non exposed subjects, the number of 
subjects with negative results on both tests is: 
0) = D|0 = ST 0, = P(BT  ) - (1N + 1) = D|0 = ST 0, = P(BTN      (1) 
N = Total Screened for Q fever 
Exposed individuals = Nπ Unexposed individuals = N(1-π) 
Serology Test Skin Test Serology Test Skin Test 
+Ve -Ve +Ve -Ve +Ve -Ve +Ve -Ve 
Prevalence of exposure (π)                                                            Proportion unexposed (1-π) 
 
   
 
 
 Se1             1-Se1        Se2             1- Se2                        1-Sp1             Sp1      1-Sp2            Sp2 
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If we assume the test results are independent within the exposed subjects and within the non-exposed 
subjects, this corresponds to: 
0)] = D|0 = ST P(0)D|0 = P(BT  ) - (1 + 1) = D|0 = ST P(1)D|0 = P(BT[N    
or 
]SpSp  ) - (1 + )Se-1 ()Se-1([N 2121         (3) 
where Se1, Sp1 and Se2, Sp2 are the sensitivity and specificity of Serological Test and Skin Test,. In 
addition, BT and ST, respectively, represent the Serological Test and Skin Test.  
Assumptions: 
Diagnostic tests are uncorrelated 
Under this assumption, the amount of agreement between the two tests is fully explained by the 
underlying exposure status. The full conditional distributions of parameters for two conditionally 
independent tests (conditional independence model: where neither test considered a gold standard) is 
well described in Joseph et al. (1995), Martinez et al. (2008) and Limmathurotsakul et al. (2012). 
With the assumption that screening tests are uncorrelated and non-of them are gold standard, the 
amount of agreement between the two tests is fully explained by the underlying exposure status. 
Hence, the true but unknown exposure status (denoted by Y) of the ith individual (0: non-exposed or 1: 
exposed for Q fever) can be modelled from Bernoulli (pi) distribution with success probability, pi = Pr 
(E=1|Ti1=ti1,Ti2=ti2) for k =1,2.  
The above BLCA formulation for two conditionally independent tests is summarized using formula 
notation in Table 4.1.1.  
Table 4.1. 1 Diagnostic accuracy measures for independent diagnostic tests 
Note: The total number in each row consists of the number of exposed individuals (Nπ) and 
unexposed individuals (N(1-π)). For the first row, the proportion of exposed individuals in “(1,1)” is 
Serology 
Test (T1) 
Skin Test 
(T2) 
Possible outcome 
code 
Probability for each possible outcomes for the ith 
subject Pr(ith =(1st test, 2nd test)) 
+Ve +Ve (+Ve, +Ve) = (1,1) Pr(ith =(1, 1))= πSe1Se2 + (1-π)(1-Sp1)(1-Sp2) = 
q[i,1] 
+Ve -Ve (+Ve, -Ve) = (1,0) Pr(ith =(1, 0))=πSe1(1-Se2)+(1-π)(1-Sp1)Sp2 = q[i,2] 
-Ve +Ve (-Ve, +Ve) = (0,1) Pr(ith =(0, 1))=π(1-Se1)Se2+(1-π)Sp1(1-Sp2) = q[i,3] 
-Ve -Ve (-Ve, -Ve) = (0,0) Pr(ith =(0, 0))=π(1-Se1)(1-Se2)+(1-π)Sp1Sp2 = q[i,4] 
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equal to the product of Se of both tests, and the proportion of unexposed individuals in “(1,1)” is 
equal to the product of (1-Sp) of both tests (Limmathurotsakul et al. 2012). For N=1, the resulting 
proportions are Bernoulli probabilities for observing test result for a given individual.  
π = prevalence (probability of Q fever exposure in the study population). Or the probability of that an 
individual in the study population is exposed for Q fever. 
Se = the probability that an exposed individual has a positive test result for a given diagnosis test.  
Sp = the probability that unexposed individual has a negative test result for a given diagnosis test.  
q[i,j], for j=1,…,4, is the probability of the observed test results for ith individual.  
Full conditional distributions of parameters for two conditionally independent tests (where 
neither test considered a gold standard) 
Let O11 be the observed number of positive test 1 and test 2 results, and O10 be the observed number 
of positive test 1 and negative test 2 results, and O01 the observed number of negative test 1 and 
positive test 2 results, and O00 be the observed number of negative test 1 and test 2 results, in the 
sample of O11+O01+O01+O11= N subjects.  
Let the unobserved latent data U11, U01, U01 and U11 represent the number of true positive subjects out 
of the observed cell values O11, O01, O01 and O11, respectively. Since any subject, whether truly 
exposed for Q fever or not, can test positively or negatively on each test, there are four possible 
combinations. The likelihood contribution of the various combinations of test outcomes in 
summarized in Table 4.1.2. 
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Table 4.1.2 Likelihood contributions of the various combinations of test outcomes for conditionally 
independent tests 
Note: The likelihood is proportional to the product of each entry in the last column of the table raised 
to the power of the corresponding entry in the first column of the table (Joseph, Gyorkos & Coupal 
1995; Limmathurotsakul et al. 2012).  
The likelihood function of the observed and latent data is given by (from Table 4.1.2): 
(4)                                                                     ])1[()]1()1[(
])1)(1[()]1)(1)(1[(
)]1)(1([])1([)]1([][
),,,,|,,,,,,,(
00000101
10101111
00011011
2121
2121
21212121
21210001101100011011
UOUO
UOUO
UUUU
SpSpSpSp
SpSpSpSp
SeSeSeSeSeSeSeSe
SpSpSeSeUUUUOOOOL









 
Hence, Bayesian latent class analysis was applied to find estimates of π, Se1, Sp1, Se2, and Sp2 from 
these set of equations.  However, dependency between the two tests is not warranted and hence we 
fitted conditionally independent model based on the BLCA framework shown in Table 4.1.1 and the 
corresponding likelihood contributions shown in Table 4.1.2.  
LCMs require the observed outcomes to be independent within the categories of the latent class. In 
this model, we assumed that the true exposure status of a person is an unobserved, or latent, variable 
with two mutually exclusive categories, ‘exposed’ and ‘non-exposed’. This unobserved variable 
determines the probability to test positive or negative to the two diagnostic tests. We assumed the data 
arise from two conditionally independent dichotomous diagnostic tests from a population with known 
exposure status that follow a Bernoulli distribution (Girardi et al. 2009). We further assumed constant 
sensitivity and specificity, and prevalence of the exposure to be similar in the population being 
studied.  
Serology 
Test 
Skin Test Possible outcome code Exposure (E=e)  Likelihood Contribution 
+Ve +Ve U11 1 πSe1Se2 
+Ve -Ve U10 1 πSe1(1-Se2) 
-Ve +Ve U01 1 π(1-Se1)Se2 
-Ve -Ve U00 1 π(1-Se1)(1-Se2) 
+Ve +Ve O11 -  U11 0 (1-π)*(1-Sp1)(1-Sp2) 
+Ve -Ve O11 -  U11 0 (1-π)*(1-Sp1)*Sp2 
-Ve +Ve O11 -  U11 0 (1-π)*Sp1*(1-Sp2) 
-Ve -Ve O11 -  U11 0 (1-π)*Sp1*Sp2 
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Hence, counts (O) of the possible outcomes of test results (in a total of 22 possible patterns) follow a 
Bernoulli distribution: 
O[i,j]|Sek, Spk, π ~Bernoulli(q[i,j]);  
Where i = 1, …, N individuals, j = 1, …, 4 test outcomes and k = 1, 2 screening tests.  
q[i, j] is a constant probability of observing the possible outcomes of test results in the population for 
the ith individual which is defined as: 
q[(i,1)] = πxSe1xSe2+(1- π)x(1-Sp1)x(1-Sp2) 
q[(i,2)] = πxSe1x(1-Se2)+(1- π)x(1-Sp1)xSp2 
q[(i,3)] = πx(1-Se1) xSe2+(1- π)xSp1x(1-Sp2) 
q[(i,4)] = πx(1-Se1) x(1-Se2)+(1- π)x(1-Sp1)(1-Sp2)   
 (1) The prevalence of the exposure is assumed to follow a beta prior distribution with parameters α, 
and β, π~ Beta(απ, βπ).  
(2) The sensitivities and specificities are also assumed to have beta prior densities such that αSek, and 
βSek, Sek~ Beta(αSek, βSek), k=1,2 and that αSpk, and βSpk, Spk~ Beta(αSpk, βSpk), k=1,2.  
The Gibbs sampler was used to construct the marginal posterior densities of all parameters of interest.  
The Gibbs sampler was used to construct the marginal posterior densities of all parameters of interest. 
It is the most common MCMC algorithm used to alleviate the curse of dimensionality through the use 
of probabilistic sampling from the posterior distribution. Gibbs sampler samples from the conditional 
distributions of parameters when their joint distributions are unknown.  
Below, description of the Gibbs sampler to estimate the marginal posterior densities of all test 
parameters based on a conditional independence assumption is provided. Further, we assumed that 
results from the two screening tests are available on a random sample of workers where neither test 
can be considered a perfect gold standard. The interest is in the marginal posterior densities of the 
prevalence of the Q fever exposure in the population from which the sample was drawn, π, as well as 
the sensitivities, Se1 and Se2, specificities, Sp1 and Sp2 of the two tests, given the data and any 
available prior information. 
Here, all parameters are assumed to follow beta prior distributions. Accordingly,  
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(1) The prevalence of the exposure is assumed to follow a beta prior distribution with parameters α, 
and β, π~ Beta(απ, βπ).  
(2) The sensitivities and specificities are also assumed to have beta prior densities such that αSej, and 
βSek, Sek~ Beta(αSek, βSek), k=1,2 and that αSpk, and βSpk, Spk~ beta(αSpk, βSpk), k=1,2.  
Remember, for two conditionally independent screening tests the likelihood function of the observed 
and latent data is given by (from Table 4.1.2): 
Then, following the Bayes Theorem the joint posterior density is proportional to this likelihood times 
the prior distribution: 
(5)                                                           )1(
)1()1(
)1()1(
),,,,,,,|,,,,(
1)()(
2
1)()(
2
1)(
2
1)(
2
1)()(
1
1)()(
1
1)(
1
1)(
1
1)(1
00011011000110112121
201110111200100010
2001020111110111011100010001
10001110110001101100011011






SpSp
SeSeSpSp
SeSe
UUOOUUOO
UUUUUUOOUUOO
UUUUUUUUNUUUU
SpSp
SeSeSpSp
SeSe
UUUUOOOOSpSpSeSef


  

 
Where, N = O11+ O10+ O01+ O00 subjects in the two by two data of Table 4.1.3.  
Table 4.1.3 Observed data from two diagnostic tests, in the absence of a gold standard 
 T2  
Subtotal + - 
T1 + O11 O10 O11 + O10 
- O01 O00 O01 + O00 
Subtotal  O11 + O01 O10 + O00 N 
Note: N = O11 + O10 + O01 + O00 denotes the sample size 
For two independence diagnostic tests, the implementation of the Gibbs sampler requires specification 
of the full conditional distributions of the parameters as follows: 
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In order to implement the Gibbs sampler for the above full conditional model, the latent observations 
U11, U10, U01, and U00 are generated from the respective models in equations 5.1 through 5.4, 
conditional on the starting values of the other parameters. Then π is generated from equation (5.5) 
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conditional on the U11, U10, U01, and U00 entities just sampled. Drawing Se1, Se2, Sp1 and Sp2 from 
the full conditional given in the respective expressions 5.6 – 5.9, respectively, using the just sampled 
values of U11, U10, U01, and U00 completes the first cycle. The random samples generated by repeating 
the above cycle 10, 000 times are then used to reconstruct the marginal posterior densities of each 
parameter, and to find credible sets, marginal posterior means or medians, or other inferences. Details 
of the Gibbs sampler described above are given in (Lu 2006). 
In the following, the BLCA framework is summarized using mathematical notation adapted from 
Joseph et al. (1995), Martinez, et al. (2008) and Martinez, et al. (2009) (Joseph, Gyorkos & Coupal 
1995; Martinez, Edson Zangiacomi et al. 2009; Martinez, E. Z. et al. 2008). Considering k = 2 
screening tests, let Tk = 1 if the result of test kth is positive and Tk = 0 if the result of test kth is 
negative, for k = 1, ..., K. Let Sek and Spk be the sensitivity and the specificity of the kth test, 
respectively and let u be an observation of a binary latent variable U. For two independent test 
outcomes, denoting the set of the observations and this latent variable for the ith individual by 
},,{ 21 iii
T
i uttX  where tk is a realization of Tk, we have the joint density function 
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We have 2k + 1 parameter to be estimated, that is, Se1, Se2, Sp1, Sp2 and π. Then, the likelihood 
function L(θ), where θ = (Se1, Se2, Sp1, Sp2, π: k = 1, ..., K) is the vector of parameters, is given by 
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Following the Bayes formula, the latent variable U, has a Bernoulli distribution shown below: 
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Considering beta prior densities Beta(αθ , βθ) for all parameters in θ, where αθ , and βθ generically 
denotes fixed hyperparameters and combining the likelihood function for θ with the prior densities, 
Gibbs sampler algorithm is used to simulate samples for the posterior distribution for θ. These 
samples are simulated from the full conditional posterior distributions for π, Sek and Spk. 
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Following Equations (1) and (2) and considering k=2 screening tests, the conditional posterior 
distributions for the components of θ needed for the Gibbs sampling algorithm are given by: 
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for k = 1, ..., K. This model is adapted from the models developed by Joseph et al. (1995) and 
Martinez, et al. (2008) (Joseph, Gyorkos & Coupal 1995; Martinez, E. Z. et al. 2008).  
 
Derivation of probabilities for two conditionally independent diagnostic tests.  
 
Table 4.1. 4 Probabilities for each test results combinations for two conditionally independent 
diagnostic tests 
  Exposure (E) Probability for each possible outcomes for 
the ith subject Pr(ith =(1st test, 2nd test)) 
 E=1 E=0 E=1 E=0 
Serological 
Test (T1) 
+Ve (T1+, E=1) (T1+, E=0) Pr(T1+, E=1) = 
Pr(T1+|E=1)Pr(E=1) 
= θSe1 
Pr(T1+, E=0) = 
Pr(T1+|E=0)Pr(E=0) 
= (1-θ)(1-Sp1) 
-Ve (T1-, E=1) (T1-, E=0) Pr(T1-, E=1) = 
Pr(T1-|E=1)Pr(E=1) 
= θ(1-Se1) 
Pr(T1-, E=0) = 
Pr(T1-|E=0)Pr(E=0) 
= (1-θ)Sp1 
Skin Test 
(T2) 
+Ve (T2+, E=1) (T2+, E=0) Pr(T2+, E=1) = 
Pr(T2+|E=1)Pr(E=1) 
= θSe2 
Pr(T2+, E=0) = 
Pr(T2+|E=0)Pr(E=0) 
= (1-θ)(1-Sp2) 
-Ve (T2-, E=1) (T2-, E=0) Pr(T2-, E=1) = 
Pr(T2-|E=1)Pr(E=1) 
= θ(1-Se2) 
Pr(T2-, E=0) = 
Pr(T2-|E=0)Pr(E=0) 
= (1-θ)Sp2 
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Sp2)-Sp1)(1-θ)(1-(1+θSe1Se2 =
 0)=0)Pr(E=E|0)Pr(T2+=E|Pr(T1+ + 1)=1)Pr(E=E|1)Pr(T2+=E|Pr(T1+ =
 0)=E|T2+Pr(T1+, + 1)=E|T2+Pr(T1+, =  E)Pr(E)|T2+Pr(T1+, = T2+)Pr(T1+,
           
(1.1) 
Sp1)Sp2-θ)(1-(1+Se2)-θSe1(1 =
 0)=0)Pr(E=E|0)Pr(T2-=E|Pr(T1+ + 1)=1)Pr(E=E|1)Pr(T2-=E|Pr(T1+ =
 0)=E|T2-Pr(T1+, + 1)=E|T2-Pr(T1+, =  E)Pr(E)|T2-Pr(T1+, = T2-)Pr(T1+,
              
(1.2) 
Sp2)-θ)Sp1(1-(1+Se1)Se2-θ(1 =
 0)=0)Pr(E=E|0)Pr(T2=E|Pr(T1- + 1)=1)Pr(E=E|1)Pr(T2=E|Pr(T1- =
 0)=E|T2Pr(T1-, + 1)=E|T2Pr(T1-, =  E)Pr(E)|T2Pr(T1-, = )T2Pr(T1-,


              
(1.3) 
θ)Sp1Sp2-(1+Se2)-Se1)(1-θ(1 =
 0)=0)Pr(E=E|0)Pr(T2=E|Pr(T1- + 1)=1)Pr(E=E|1)Pr(T2-=E|Pr(T1- =
 0)=E|T2-Pr(T1-, + 1)=E|T2-Pr(T1-, =  E)Pr(E)|T2-Pr(T1-, = T2-)Pr(T1-,
              (1.4) 
Elicitation of Priors 
We used informative priors for the corresponding parameters of the model. Previous evidence 
showed that past exposure can be expected in 6% of the population and current infection in 6%. Q 
fever phase II Complement Fixation (CFT) antibodies were detected in 12% of the population with 
Q fever phase I (CFT) in 3%. Q fever phase 2 IgM antibodies were positive in the absence of CFT 
antibodies in 4%. Convalescent sera were available for 13% of this group (Riley et al. 2001).
 199 
 
Overall sensitivity and specificity of serologic methods using the disease state as a gold standard (Herremans, Tineke et al. 2013). 
Table 4.1. 5 The sensitivity and specificity of serology methods from previously published literature considered as priors for the sensitivity and specificity of 
serology test. 
 Sensitivity (%) Mode (%) Specificity (%) Mode (%) 
Serology 
Method 
Phase I Phase II Phase I Phase II Phase I Phase II Phase I Phase II 
ELISA 50, 60, 67, 80, 84, 
87.2,  
13, 60, 66.7, 83.3, 
97.7 
  64.7, 86.6, 90, 97.3–98.7, 
99, 100 
75.9, 79.1, 100,   
EIA 78.6, 98.4, 100   88.2, 95.7, 98.6,    
CFT 17,61, 67, 100   95 95   
Source: Peter et al. (1985), Slaba et al. (2005), D'Harcourt et al. (1996), Field et al. (2002a), Fournier et al. (1998a) (D'Harcourt et al. 1996; Field, Peter R. et al. 
2002; Fournier, P-E, Marrie, TJ & Raoult, D 1998; Peter et al. 1985; Slaba, Skultety & Toman 2005). 
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The corresponding priors from a specific Beta prior distributions for Se, Sp and Prevalence (AusVet 
Animal Health Services Pty Ltd 2017; Chun-Lung SU 2017) were computed. The prior distributions 
for each of the parameters were defined as follows:  
Prior specification for the exposure prevalence (pr): 
Our best guess for the prevalence was 0.07, and we were also willing to assert that we are 80% certain 
that the prevalence is less than 0.50, then the shape1 and shape2 parameters for a beta distribution.  
Pr (mode of 7%, with 95% certainty that Pr does not exceed 50%) as pr~Beta(1.11,2.51); true 
prevalence with 7% mode and 95% level of confidence 
Prior specification for the sensitivities: Se1 and Se2 
Our best guess for the diagnostic sensitivity was 0.68, and we were also willing to assert that we are 
80% certain that the sensitivity is greater than 0.60, then the shape1 and shape2 parameters for a beta 
distribution satisfying these constraints was obtained as follows: 
Sensitivity (mode of 68%, with 95% certainty that Se exceeds 60%) as 
Se1~Beta(21.52,10.66); 95% sure it is greater than 0.6 and mode of 0.68  
Se2~Beta(21.52,10.66); 95% sure it is greater than 0.6 and mode of 0.68  
Prior specification for the specificities: Sp1 and Sp2 
Our best guess for the diagnostic specificity was 0.89, and we were also willing to assert that we are 
80% certain that the specificity is greater than 0.80, then the shape1 and shape2 parameters for a beta 
distribution satisfying these constraints was obtained as follows: 
Specificities (mode of 89%, with 95% certainty that Se exceeds 80%) as 
Sp1~Beta(19.98,3.35); 95% sure it is greater than 0.80 and mode of 0.89 
Sp2~Beta(19.98,3.35); 95% sure it is greater than 0.80 and mode of 0.89 
Initial values: 
A 27% sensitivity and 89% specificity during the first week of onset, and between 4th and 6th weeks of 
onset 61-67% sensitivity and 94-99% specificity were recorded (Peter et al. 1985). 
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Appendix 7.1: Multiple Correspondence Analysis (MCA)  
Multiple Correspondence Analysis (MCA), which is the generalization of simple correspondence 
analysis for two categorical variables (Abdi & Valentin 2007; Nenadic & Greenacre 2005) was 
employed to identify risk groups from the notification Q fever exposure information.   The Q fever 
notification data consists of data on individuals regarding previous screening and vaccination for Q 
fever along with occupational associated exposures and whether or not they reside near areas where Q 
fever infection risk is considered to be high. The variables are summarized in Table 7.1.  
Within the Q fever exposure data, MCA allows us to approach the individuals, the variables, and their 
categories with the aim of investigating similarities, differences and associations. The Q fever 
notification data consists of data on individuals regarding previous screening and vaccination for Q 
fever along with occupational associated exposures and whether or not they reside near areas where Q 
fever infection risk is thought to be high.  
In MCA, an indicator (dummy) matrix is constructed from a data table of individuals with x variables 
with individuals in the rows and all of the categories for every variable in the columns.  
If we denote xij as the category chosen by the individual i for exposure variable j; i varies from 1 to I 
and j from 1 to J. We consider categorical variable j to have Kj categories. The element xik of this table 
has a value of 1 if individual i carries category k, and 0 if it does not.  
This table has IxK dimensions (with 


J
j
jKK
1
) and is composed entirely of 0 and 1. 
The resulting indicator matrix is called the complete disjunctive table (CDT) and it this table which is 
actually used in the actual analysis. Hence, an individual indicator matrix represents Q fever exposure 
profile which can be considered as a vector of exposure profiles.  
Distances between the Individuals 
By using the above indicator matrix, the distances (squared) between individuals is expressed as 

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k
kiik
ii
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xx
Cd
1
2
'
',
2 )(
; where C is a constant. 
Inter-Individual Variability 
One individual = one row of the CDT = set of categories. Individuals that belong to a single row are 
analyzed based on the set of categories they belong to and used when we want to compare individuals. 
We say individuals are similar to each other if they are in similar set of categories and different if they 
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have no many categories in common. The set of these similarities and differences is called inter-
individual variability.  
MCA approaches this problem using multidimensional point of view by extracting principal 
components, i.e., extract dimensions which separates, for example, extremely different individuals 
from average individuals. These dimensions will be interpreted in terms of the categories.  
R Packages used in MCA 
For running the MCA, we used ‘FactoMineR’ R package (Lê, Josse & Husson 2008) along with 
‘factoextra’ R package for customizing the plots from the MCA objects[source: https://cran.r-
project.org/web/packages/factoextra/index.html] . In addition, we have used ‘missMDA’ which is 
recommended R package for handling missing values in MCA (Josse & Husson 2016). In some of the 
MCA analysis, we used the R package ‘ggplot2’ for plotting the clouds of the variable categories and 
individuals (Wickham 2016). Moreover, for exporting and customizing the ggplots, we applied the 
following R packages: ‘gridExtra’ (used to create multiple plots in one page) [source: 
https://mran.microsoft.com/snapshot/2017-05-16/web/packages/gridExtra/gridExtra.pdf] and ‘ggpubr’ 
(used to easily create ggplot2-based publication ready plot’[source: 
http://www.sthda.com/english/rpkgs/ggpubr] and ‘grid’ (to create a complex layout using the function 
grid.layout()).  
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Table 7.1. 1 Q fever exposure information from enhanced Q fever notification surveillance data, 
1991-2016, Queensland, Australia 
Variable Name  Variables Code Responses 
Previous Screening PREV_SCREENING Yes, No 
Previous Vaccination  PREV_VACCINATION  Yes, No 
At Risk of Q Fever  AT_RISK_OF_Q_FEVER  Yes, No 
Aware Q Fever Vaccination               AWARE_Q_FEVER_VACCINATION               Yes, No 
Abattoir Exposure           ABATTOIR_EXPOSURE           Yes, No 
Work Inside Abattoir  WORK_INSIDE_ABATTOIR  Yes, No 
Work In Grounds Abattoir                 WORK_IN_GROUNDS_ABATTOIR                 Yes, No 
Contract Worker             CONTRACT_WORKER             Yes, No 
Visitor to Abattoir  VISITOR_TO_ABATTOIR  Yes, No 
Assist Observe Animal Birth       ASSIST_OBSERVE_ANIMAL_BIRTH       Yes, No 
Skinning Meat Process Etc                SKINNING_MEAT_PROCESS_ETC                Yes, No 
Shooting Hunting  SHOOTING_HUNTING  Yes, No 
Work with Wool           WORK_WITH_WOOL           Yes, No 
Work in Shearing Shed         WORK_IN_SHEARING_SHED         Yes, No 
Work in Wool Processing  WORK_IN_WOOL_PROCESSING  Yes, No 
Work with Straw Animal Bedding     WORK_WITH_STRAW_ANIMAL_BEDDING     Yes, No 
Work with Animal Manure Etc     WORK_WITH_ANIMAL_MANURE_ETC     Yes, No 
Attend Saleyard Animal Show  ATTEND_SALEYARD_ANIMAL_SHOW  Yes, No 
Live on Farm                      LIVE_ON_FARM                      Yes, No 
Visit Farm  VISIT_FARM  Yes, No 
Exposed to Livestock Transport EXPOSED_TO_LIVESTOCK_TRANSPORT Yes, No 
Launder Clothes Animal Worker    LAUNDER_CLOTHES_ANIMAL_WORKER    Yes, No 
Contact with Infected Person  CONTACT_WITH_INFECTED_PERSON  Yes, No 
Consume Unpasteurised Milk Etc  CONSUME_UNPASTEURISED_MILK_ETC  Yes, No 
Contact with Untreated Water    CONTACT_WITH_UNTREATED_WATER    Yes, No 
Exposure to Paddock Dust Etc   EXPOSURE_TO_PADDOCK_DUST_ETC   Yes, No 
Live Work within 1km Abattoir  LIVE_WORK_WITHIN_1KM_ABATTOIR  Yes, No 
Live Work within 300m Bush Etc LIVE_WORK_WITHIN_300M_BUSH_ETC Yes, No 
 
